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‘When you have eliminated the impossible, 
whatever remains, however improbable, 
must be the truth.’
Sherlock Holmes
- The Sign of Four
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Current aquaculture practice is not sustainable
In 2013 the aquaculture production for human consumption has been estimated 
to be approximately 60 million tonnes of seafood (finfishes, crustaceans, molluscs, 
amphibians, freshwater turtles, sea cucumbers, sea urchins, sea squirts and edible 
jellyfish). With an expected annual growth rate of 2.5%, aquaculture production will 
reach 85 million tonnes in 2022. Clearly, the aquaculture industry is one of the fastest-
growing global food-producing sectors [59]. Finfish production is a very important 
part of aquaculture practices and will continue to be [198, 200, 232].
Traditionally, commercial aquafeeds for marine carnivorous species such as Atlantic 
salmon (Salmo salar) and gilthead seabream (Sparus aurata) consist of fishmeal 
and fish oil that are derived from so-called forage, reduction or feed fisheries 
(predominantly pelagic species) and from by-product trimmings (e.g., skeletons, 
viscera and skin) that result from the processing of fish [178, 207]. Fishmeal is 
produced by cooking and pressing of fresh raw fishes and fish by-products and 
finalized by drying and milling of the meal. A mixture of fish oil, water and dissolved 
and suspended proteins, vitamins and minerals is obtained from pressing cooked 
fish that is further refined and purified into fish oil [178]. Around 60% and 80% of the 
annual global fishmeal and fish oil supply, respectively, is used in the manufacture of 
aquafeeds [24, 178, 199].
The steadily growing aquaculture leads to an increased pressure on the limited supply 
of highly valuable marine aquafeed ingredients [178, 198, 207]. Besides rising global 
prices of finite marine ingredients, ecological sustainability and the ethical issue of 
using fishery resources for animal feeding rather than for direct human consumption 
are important incentives in the development of alternative ingredients for aquafeeds 
[12, 24, 59, 166, 212, 214]. The challenge faced by the rapidly growing industry is 
to relieve pressure on ‘traditional’ feed ingredients through substitution of fishmeal 
and fish oil by alternative aquafeed ingredients. Over the last two decades extensive 
research is carried out to evaluate potential alternative ingredients in commercial 
aquafeeds [12, 199-201, 214]. Fishmeal is a preferred aquafeed ingredient because 
of its high protein content, essential amino acid profile, required micronutrient 
concentrations, high digestibility and absence of so-called anti-nutrients (e.g., lectins 
in plant material) that can interfere with nutrient absorption [12, 59, 65]. Fish oil is 
mainly included as oil source in aquafeeds because it provides n-3 polyunsaturated 
fatty acids (PUFA) that are essential for optimal growth and health of farmed fish 
and consumers [198, 214]. Besides the benefits for farmed fish, n-3 PUFA play a 
crucial role in human health as deficiencies can lead to cardiovascular and mental 
7disorders [153]. The World Health Organization (WHO), the Food and Agriculture 
Organization of the United Nations (FAO) and the European Food Safety Authority 
(EFSA) recommend a daily intake of 250–500 mg n-3 PUFA for human adults [53, 58, 
227]. Therefore, the production of fish species that contribute to an adequate intake 
of n-3 PUFA is of significant value for human nutrition [12].
Alternative ingredients for fishmeal and fish oil substitution 
Alternative feed ingredients for fishmeal and fish oil are selected on the basis of their 
nutritional composition and economical criteria. Currently used alternatives in the 
European Union (EU) include marine products other than fish (zooplankton, such 
as krill), terrestrial vegetable ingredients (proteins and lipids derived from beans, 
cereals and oilseeds), and microbial ingredients (single-cell protein and oil extracted 
from  microorganisms). Other alternatives, but currently not used in the EU, include 
terrestrial animal by-products (poultry meal, blood meal and insect meal) and 
genetically modified plant products or algae rich in n-3 PUFA [86, 122, 141, 178, 198]. 
Vegetable-based ingredients are viable alternatives and already extensively applied 
in commercial salmon aquafeeds. In 2013, less than 30% of the Atlantic salmon diet 
was composed of marine ingredients while approximately 56% was composed of 
vegetable ingredients [65, 198, 232].  
Replacing fish oils with vegetable oils alters the nutrient profile of aquafeeds. The 
use of vegetable oils increases dietary levels of monoene and n−6 fatty acids while 
levels of n−3 PUFA decrease [9, 10, 94, 137, 208-210]. Partial substitution up to 75% of 
fish oils by single or a mixture of vegetable oils, such as linseed, rapeseed, sunflower, 
soybean, palm or olive oil, did not negatively affect growth in different life stages of 
Atlantic salmon [12, 214]. Even complete replacement with a vegetable oil mixture 
of rapeseed oil, palm oil, and linseed oil did not significantly affect growth from 
juvenile fish up to slaughter size [211]. Partial replacement of fish oil by (mixtures 
of) vegetable oils did not significantly affect growth in rainbow trout (Oncorhynchus 
mykiss) [29, 46, 84, 166, 215]. In the carnivorous marine fishes such as European sea 
bass (Dicentrarchus labrax) and gilthead seabream, replacement of 60% of dietary 
fish oils by soybean oil, rapeseed oil and linseed oil or a mixture of these did not 
affect growth [93, 94, 165, 225]. Predictably, the use of vegetable oils in the diet of 
omnivorous and herbivorous fish such as tilapia (Oreochromis niloticus) and common 
carp (Cyprinus carpio), does not affect growth performances when requirements of 
essential fatty acid are met [12, 214]. Therefore, in general dietary fish oils can be 
replaced by substantial amounts of vegetable oils for many fish species without 
affecting growth or feed efficiency [12, 198, 214].
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Vegetable-based aquafeeds are contaminated with PAHs
Unfortunately, the use of vegetable meal and oil to improve aquafeed marine 
sustainability comes with new challenges that were previously not associated 
with marine aquafeeds composed of traditional ingredients [12, 65, 143, 198]. 
Fish oils extracted from marine pelagic fish species contain relatively high levels 
of fat-soluble persistent organic pollutants (POPs), such as polychlorinated 
biphenyls (PCBs), dioxins [polychlorinated dibenzo-p-dioxins (PCDDs) and 
polychlorinated dibenzofurans (PCDFs)], polybrominated diphenyl ethers 
(PBDEs), and organochlorine pesticides that accumulate in the aquatic food chain 
[15, 88]. Farmed oily fish is an important source of POPs in the human diet and its 
consumption raised concerns for public health [88]. The (partial) replacement of 
fish oil by vegetable oil has substantially reduced POPs in farmed salmonids [11, 
13, 46, 64]. However, technical processing of vegetable oils produces polycyclic 
aromatic hydrocarbons (PAHs). The inclusion of vegetable oils in aquafeeds 
introduces these potentially carcinogenic fat-soluble PAHs that were previously 
not associated with farming of salmon [14].
PAHs are ubiquitous environmental non-polar lipophilic contaminants mostly 
formed from incomplete combustion of organic matter from natural sources (e.g., 
oil seeps, forest fires, and volcanoes) and anthropogenic sources (e.g., combustion 
of fossil fuels, vehicle emissions, petroleum spills, and oil well blow-outs) [134, 
157]. The carcinogenic and mutagenic properties of a broad spectrum of PAHs 
raise important public health concerns [52]. Apart from tobacco smoke, diet is the 
major source for PAH exposure in humans; meat products, oils, fats, cereals, fruits 
and vegetables are the main contributors [51].
PAHs can be categorized as ‘light’ PAHs that have 2 to 4 fused aromatic rings or 
‘heavy’ PAHs with 4 to 6 fused aromatic rings. Vegetable oil obtained from oil-
producing seeds such as soybeans, rapeseeds, olive seeds and sunflower seeds, 
can be contaminated indirectly from airborne PAH deposits on crops and/or 
directly by thermal feed processing like toasting and gas drying [51, 135, 202]. 
Of the 16 potentially genotoxic and carcinogenic PAH congeners listed by EFSA 
no less than 131  were detected in vegetable-based aquafeeds [14, 16, 37, 202]. 
Besides these 13 PAH congeners, the non-genotoxic and/or non-carcinogenic 
PAHs fluoranthene (FA), naphthalene (NA), anthracene (AN) and phenanthrene 
(PHE) are also extensively present in vegetable oils [14, 37, 202].
In vegetable oil-based aquafeeds, elevated levels were detected of the two 
9Figure 1.1: Chemical structure of BaP (C20H12) and PHE (C14H10).
Benzo[a]pyrene Phenanthrene
PAH congeners benzo[a]pyrene (BaP) and especially PHE, compared to fish 
oil-based aquafeeds [14]. Based on the findings of Berntssen et al. (2010), BaP 
and PHE (Fig. 1.1) were chosen to use as relevant PAH indicators present in 
vegetable oil-based aquafeeds as the two PAHs differ in physical chemical 
properties such as lipophilicity (log octanol/water partition coefficient; Kow) 
as well as toxic action. The log Kow is defined as the ratio of the concentration 
of a compound in n-octanol and water at equilibrium at a specified 
temperature. Log Kow values can be used to predict bioaccumulation in aquatic 
organisms. Lipophilic compounds with high log Kow values (i.e., > 5) are of great 
concern because they cannot be efficiently cleared from the body to the water 
via gill ventilation, and thus have the potential to accumulate and bio-magnify 
in aquatic organisms [104]. BaP is highly lipophilic (log Kow = 6.31) and an agonist 
to the aryl hydrocarbon receptor that induces cytochrome P4501A (cyp1a) 
expression [112, 113]. PHE is less lipophilic than BaP (Kow = 4.5) and not an aryl 
hydrocarbon receptor agonist [19].
Lipophilic PAHs can interfere with lipid digestion and uptake
The introduction of PAHs in aquafeeds with vegetable oils has increased PAH 
levels in fillets of Atlantic salmon reared on these diets [14]. 
The tissue concentration, distribution and bioavailability of lipophilic contaminants 
depend on luminal transport by micelles, intestinal uptake, metabolism and 
1 Benzo[a]anthracene (BaA), benzo[b]fluoranthene (BbFA), benzo[j]fluoranthene (BjFA), benzo[k]
fluoranthene (BkFA), benzo[g,h,i]perylene (BghiP), benzo[a]pyrene (BaP), chrysene (CHR), 
cyclopenta[c,d]pyrene (CPP), dibenzo[a,h]anthracene (DBahA), dibenzo[a,e]pyrene (DBaeP), 
dibenzo[a,l]pyrene (DBalP), indeno[1,2,3-cd]pyrene (IP) and benzo[c]fluorine (BcFL).
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excretion [33, 49, 95, 160, 231]. After oral ingestion, PAHs solubilize in the lipophilic 
core of emulsified oil droplets and micelles [97, 104, 160]. Vetter et al. (1985) 
observed that BaP remained strongly associated with lipids throughout lipid 
digestion, absorption and assimilation. The lipophilic nature of PAHs promotes 
solubilization in lipophilic domains where they can affect enzymatic digestion of 
lipids by digestive lipases, luminal transfer of free fatty acids by micelles, and their 
transmembrane and transepithelial uptake (Fig. 1.2).
Dietary fat is known to enhance intestinal uptake of a wide range of lipophilic 
compounds such as drugs, vitamins and contaminants. Indeed, in the seventies 
of the previous century, it was already  postulated that lipid absorption could 
accompany intestinal BaPabsorption [164]. Since dietary fat can have significant 
effects on the absorption of lipid derivatives, lipophilic drugs and fat-soluble 
vitamins [160, 222], it has been suggested that the intestinal transport and uptake 
of lipophilic organic contaminants, such as PAHs, are also influenced by lipids [47, 
48, 77, 104, 222].
Lipid structure and function
Lipids comprise a heterogeneous group of non-polar compounds found in all 
living cells. Lipids, fats and oils include monoacylglycerides, diacylglycerides, 
triacylglycerides, FFA, phospholipids (PL), eicosanoids, resolvins, docosanoids, 
sterols, sterol esters, carotenoids, vitamins A and E, fatty alcohols, hydrocarbons 
and wax esters [58]. They are important forms of stored energy, structural 
components for cell membranes (e.g., phospholipids) and/or precursors to cell 
signaling molecules [1].
Figure 1.2: Potential interactions between contaminating PAHs and dietary lipids on digestion, 
uptake across the intestinal mucosa, metabolism and further peripheral distribution of lipids 
and their digestion products. A) The highly lipophilic PAHs solubilize readily in oil droplets 
and micelles in the intestinal lumen that can affect enzymatic lipid digestion by altering 
lipase activity. B) The lipid composition of micelles is an important component in intestinal 
delivery and transfer of lipophilic PAHs. Therefore, the fatty acid composition of micelles could 
affect transepithelial PAH transport and intracellular PAH metabolism which in turn can alter 
PAH transfer to the systemic circulation. C) Micelles ferry lipophilic PAHs across the unstirred 
water layer to the apical brush border membrane of enterocytes. Once micelles arrive at the 
brush border membrane, PAHs are released from the micelles and can then be absorbed by 
enterocytes by passive diffusive diffusion and/or carrier-mediated transport. PAHs and/or their 
metabolites can also be excreted into the intestinal lumen by efflux transporters. Modified from 
Porter et al. (2007).
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The most dominant lipids in the diet are triacylglycerides, contributing to 90-95% 
of the total energy derived from dietary lipids [92, 147]. Triacylglycerides are 
composed of three fatty acids esterified to a single glycerol and principally stored 
in adipose tissue (Fig. 1.3). Here, beta-oxidation of fatty acids generates acetyl-
CoA that enters the citric acid cycle and is key in the generation of ATP [142]. 
Fatty acids are carboxylic acids with hydrocarbon chains ranging from short-
chain (less than eight carbon long; < C8), medium-chain (carbon chain length 
between C8 and C13), long-chain (carbon chain length between C14 and C20) to 
very long-chain fatty acids (more than 21 carbons) [58]. Unsaturated fatty acids 
contain one or more ethylenic (double) bonds that introduce a rigid bend in the 
hydrocarbon tail while saturated fatty acids contain no double bonds and have a 
relatively straight structure [205]. Lipases secreted by the exocrine pancreas into 
the intestinal lumen hydrolyze emulsified lipids into FFA, monoacylglycerides 
and, after complete hydrolysis, to glycerol [5, 147, 205]. In mammals, the 
exocrine pancreas secretes three major lipolytic enzymes - pancreatic lipase, 
phospholipases, and bile salt-activated lipase (BAL) [109, 223]. Digestive lipases 
hydrolyze ester bonds of triacylglycerides, phospholipids, cholesterylesters, 
wax and vitamin esters. Pancreatic lipase mainly hydrolyses the sn-1 and sn-3 
positions of the triacylglycerides to release 2-monoacylglyceride and FFA 
[224]. 2-monacylglyceride is the predominant form and is rapidly absorbed 
by the small intestine. Formation of 1-monacylglyceride by isomerization 
promotes complete hydrolysis to glycerol and FFA [92]. Pancreatic  lipase is the 
principal digestive lipase in mammals, is inhibited by bile salts and requires 
colipase for its hydrolytic activity [26, 124]. Phospholipase A2 is the key enzyme 
in the hydrolysis of phospholipids at the sn-2 position into lysophospholipids and 
fatty acids [54, 170, 196]. In fish, several studies have concluded that BAL is the 
most important digestive lipase in species such as rainbow trout, Atlantic  salmon, 
Atlantic cod (Gadus morhua) and turbot (Scophthalmus maximus) [23, 147, 170, 
197, 205].
BAL has a broad substrate specificity and is more efficient than pancreatic lipase 
in hydrolyzing PUFAs, which are abundant in the diet of marine and freshwater 
fish [35, 70, 223]. BAL is often referred to as carboxyl ester lipase, non-specific 
lipase, cholesterol esterase, or carboxyl-esterase, lysophospholipase. Contrary to 
pancreatic lipase, BAL is a non-specific lipase that requires activation by bile salts 
to hydrolyze mono-, di- and triacylglycerides, cholesteryl esters, phospholipids, 
lysophospholipids, ceramides and fat-soluble vitamins [90, 132, 147, 223].
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Figure 1.3: Structures of the polyunsaturated fatty acid; eicosapentaenoic acid (EPA), the mono-
unsaturated fatty acid; oleic acid and a triacylglyceride. Numbering of carbon atoms, from the 
methyl terminus, is indicated on the EPA structure. The arrow illustrates the unsaturated bond (n 
from the methyl end).
Eicosapentaenoic acid (20:5n-3)
Oleic acid (18:9n-1)
Triacylgyceride
Luminal transport of lipophilic compounds
When the critical micelle concentration is exceeded, biliary components in the 
intestinal lumen (e.g., bile salt and cholesterol) self-aggregate with FFA and, to 
lesser degrees, with mono-, di- and triacylglycerides, into water-soluble spherical 
aggregates called micelles [5, 156, 224, 231]. The hydrophilic ends of polar 
lipids face the intestinal lumen, creating a hydrophobic core favorable for the 
partitioning of lipophilic compounds. The solubilization of lipophilic compounds 
in micelles can increase their luminal concentration 100- to 1000-fold [156].
Micelles, and bile salts as well, facilitate the transport of lipophilic contaminants 
to the brush border membrane [226]. Micelles act as a vector ferrying 
monoacylglycerides, FFA, cholesterol, fat-soluble vitamins and even lipophilic 
contaminants across the unstirred water layer of the enterocyte’s apical brush 
border membrane [44, 48, 104, 160]. Indeed, the solubility of, for instance, the 
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PCBs Aroclor 1242 and 3,3’,4,4’-tetrachlorobiphenyl had increased 2.5-fold in 
micelles composed of unsaturated long-chain fatty acids compared to micelles 
composed of saturated medium-chain fatty acids [44, 110]. The solubility of 
the PAHs 3-methylcholanthrene and 7,12-dimethylbenz[a]anthracene had 
also increased in micelles composed of the mono-unsaturated fatty acid oleic 
acid (18:1n-9) compared to micelles composed of the medium-chain saturated 
octanoic acid (8:0) [110]. These results suggest that the composition, carbon-
chain length and degree of saturation of fatty acids play an important role in the 
intestinal uptake of lipophilic compounds. Since fish oil-based diets contain more 
PUFAs with longer hydrocarbon chains and a higher degree of unsaturated bonds 
than vegetable oils, the intestinal bioavailability of lipophilic contaminants in 
alternative aquafeeds is likely to be affected by the dietary lipid composition. 
Transport across the apical membrane’s unstirred water layer
The first step in intestinal transfer of lipophilic contaminants is the transfer of 
luminal micelles through the unstirred water layer towards the enterocyte’s 
apical membrane. The unstirred water layer is defined as the viscous mucus 
layer with high water content (ca. 95%) and glycoproteins, free proteins, lipids 
and mineral salts therein [231]. Micelles facilitate the movement of lipophilic 
compounds across the unstirred water layer towards the brush border membrane 
of enterocytes, and enhance intestinal absorption [44, 48, 104, 221, 222].
Transfer of PAHs from micelles can occur via a vesicle-mediated uptake process 
or via direct absorption following a collisional mechanism leading either to 
membrane fusion or to an exchange of membrane lipids [140, 160]. Alternatively, 
the dissociation of micelles is promoted by the acidic microclimate of the 
unstirred water layer when ionized fatty acids are converted to non-ionized fatty 
acids that reduce the solubility of FFA in micelles. The acidic microclimate in the 
unstirred water layer is generated by a H+/Na+-antiporter located in the brush 
border membrane of enterocytes. Once arrived at the brush border membrane, 
monoacylglycerides, FFA and lipophilic compounds released from micelles can 
then be absorbed across the membrane of enterocytes [145, 179].
Lipid absorption across the brush border membrane
In fish, lipids are absorbed throughout the entire intestine but mainly in the 
pyloric caeca (when present in a particular species) and proximal intestine [108, 
205]. Besides the chemical composition, the lipid content of dietary lipids is an 
15
important determinant of the intestinal bioavailability of lipophilic compounds. 
Dietary uptake of some highly lipophilic compounds (log Kow > 6.3) decreased 
with increased dietary lipid content, while the uptake of some moderately 
lipophilic compounds (4.5 < log Kow < 6.3) did not vary between diets differing in 
lipid content from < 0.2% to 13.5% [55, 77, 103, 110, 177]. Furthermore, when the 
non-absorbable oil ‘Olestra’, a compound composed of sucrose bonded by ester 
links to short-chain (C6 to C8) fatty acids, was included in the diet, intestinal uptake 
decreased and subsequently fecal excretion of lipophilic compounds increased 
[67, 96, 136, 139]. 
Protein-independent passive diffusion and protein-dependent mechanisms have 
been implicated in the uptake and transport of FFA across a plasma membrane 
[102, 127]. It is believed that the uptake of long-chain fatty acids across the 
brush border membrane in enterocytes occurs by two concentration-dependent 
processes. At relatively low, micromolar luminal fatty acid concentrations, plasma 
membrane-associated protein transporters facilitate FFA uptake, whereas at high, 
millimolar concentrations the majority of fatty acids is taken up by the enterocytes 
passively [213].
The protein-independent diffusion model suggests that FFA are adsorbed to 
the membrane surface, move across the phospholipid bilayer by a ‘flip–flop’ 
conformational change and desorbed from the internal bilayer into the absorptive 
enterocyte. Flip-flop efficiency seems to be dependent on the FFA chain length as 
increasing chain lengths decrease uptake rates. FFA uptake rates are also dependent 
on the degree of unsaturation as FFA with one unsaturated bond showed increased 
uptake rates compared to saturated FFA of the same chain length [101].
A number of candidates are proposed to be involved in protein-dependent uptake 
of FFA, viz. the plasma membrane-associated fatty acid-binding protein (FABPpm), 
the fatty acid transport protein 4 (FATP4) and the fatty acid translocase CD36 
[92, 127, 145]. Following transmembrane uptake, the absorbed lipid digestion 
products are resynthesized into triglycerides which are subsequently packaged 
with phospholipids and apolipoproteins to form chylomicrons [127]. In summary, 
there is strong evidence that passive diffusion and protein-mediated facilitated 
transport are important mechanisms for fatty acid uptake across the membrane.
Transmembrane PAH transport pathways in enterocytes
Following their arrival at the brush border membrane, PAHs are transported across 
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the intestinal epithelium [6, 91, 106, 172, 186, 189]. Although the exact mechanism 
has not been elucidated yet, it has been suggested that lipophilic contaminants 
such as PAHs have the capacity to diffuse through biological membranes because 
of their lipophilicity [44, 77, 104]. ‘Light’ PAHs, with a lower lipophilicity, appear 
to cross the intestinal barrier more rapidly, while ‘heavy’ lipophilic PAHs are 
more slowly transported [33]. The unstirred water layer creates a barrier to PAH 
absorption that increases with PAH lipophilicity [49]. Therefore, diffusion through 
the unstirred water layer seems to be a rate-limiting step for high-Kow compounds, 
whereas micellar-mediated transport and diffusion through the phospholipid 
bilayer appears to be rate-limiting for low-Kow compounds [104]. Besides passive 
uptake, energy-dependent transporters mediate the uptake of lipid derivatives, 
lipid-soluble vitamins and perhaps lipophilic contaminants as well. For instance, 
human intestinal brush border membrane vesicles showed ATP-dependent 
transmembrane BaP uptake [154]. 
The uptake of small lipophilic compounds such as lipophilic vitamins and 
cholesterol has long been assumed to be a process of simple passive diffusion. In 
the past decade, several studies have investigated the potential role of intestinal 
transport proteins for lipophilic vitamins and cholesterol, reviewed by Iqbal and 
Hussain (2009). Recently, it has been shown that the uptake of vitamin E is a rapid, 
saturable process. In contrast, the uptake of vitamin A at physiological 
concentrations is via saturable carrier-mediated processes but employs non-
saturable diffusion-dependent processes at pharmacological concentrations [3, 
92]. The absorption of lipid soluble vitamins involves molecular, biochemical, and 
cellular mechanisms closely related to overall lipid and lipoprotein homeostasis 
[92], and there might be parallel transport proteins for the intestinal uptake of 
lipophilic contaminants as well. For instance, scavenger receptor class B type I 
(SR-BI) plays a role in cholesterol as well as vitamin E absorption. Cholesterol is a 
steroid alcohol while vitamin E includes both tocopherols and tocotrienols 
(methylated phenols). Since SR-B1 seems to be involved in the intestinal uptake of 
the lipophilic compounds cholesterol and vitamin E, which have a chemically 
different structure, protein transporters that are involved in the uptake of diverse 
lipophilic compounds could, therefore, also be candidates for the uptake of 
lipophilic contaminants such as PAHs.
PAH metabolism and excretion
Net intestinal uptake of lipophilic PAHs is related to the transport properties of 
enterocytes and their capacity to metabolize PAHs [228]. Unlike POPs, PAHs typically 
17
do not bioaccumulate in organisms as their whole-body concentrations can be 
significantly reduced through biotransformations where non-polar lipophilic 
contaminants are converted into more polar and water-soluble metabolites that 
can be excreted. The metabolic response to xenobiotics is often divided in three 
phases: oxidation, conjugation, and excretion [174]. The cytochrome P450 (Cyp) 
family plays a central role in phase I metabolism by catalyzing the oxidation of 
xenobiotics to less toxic metabolites.
Following uptake, the intestine is the first barrier for PAH uptake from the diet. 
Apart from the liver, the intestine plays an important role in PAH metabolism 
in metabolizing BaP [129]. Intracellularly, PAHs are endogenously activated to 
reactive metabolites by xenobiotic-metabolizing enzymes, forming diol-epoxides 
[16]. Cyp1a-mediated metabolism of BaP can result in toxic intermediates, such 
as benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE), that are very reactive and can 
bind to cellular proteins or form DNA adducts [130, 146, 219]. Of the currently 
18 annotated Cyp families in fish, four families (Cyp1, Cyp2, Cyp3 and Cyp4) 
are induced by xenobiotics or involved in their biotransformation [216]. The 
Cyp1 family members (1a, 1b and 1c) are of particular interest for their ability to 
metabolize PAHs to reactive metabolites. In zebrafish (Danio rerio), all Cyp1s are 
highly inducible by the aryl hydrocarbon receptor, with the exception of Cyp1d1 
[175, 216]. Many PAHs, but not all, have the ability to bind to the aryl hydrocarbon 
receptor, induce Cyp1a activity and enhance their own biotransformation [18, 
19, 112, 180]. The aryl hydrocarbon receptor has a high affinity for ‘heavy’ PAH 
compounds while it has no or low affinity for ‘light’ PAHs [7, 8, 18].
In phase II reactions, oxidized phase I products are conjugated to form water-
soluble substrates for enzymes such as UDP-glucuronosyltransferase, glutathione-
S-transferase and sulfotrans-ferase [174]. Both phase I and II reactions have been 
shown to be affected by nutrients and contaminants and play a central role in lipid 
metabolism, detoxification, reactive metabolite formation, cellular respiration 
and antioxidant activity [174]. The formation of reactive metabolites due to phase 
I activity is one of the best known cytotoxic mechanisms following PAH exposure 
[174].
When PAHs are oxidized by Cyp450s, enterocytes extrude the metabolites into 
the intestinal lumen [28, 33]. Excretion is most likely facilitated by ATP-binding 
cassette (ABC) proteins that excrete  highly hydrophobic compounds into the 
gastrointestinal tract as native, non-metabolized xenobiotics or water-soluble 
conjugates from phase I and II. Indeed, exposure of tilapia (Oreochromis niloticus) 
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to waterborne BaP resulted in an up-regulation of abcc2 (multidrug resistance-
associated protein 2) mRNA expression in the gills and an increase in abcg2 
mRNA expression in the liver and proximal intestine [39]. The ABCG2 transporter 
is involved in the efflux of BaP conjugates in the human colon adenocarcinoma 
cell line Caco-2 [50] whereas ABCB1 (P-glycoprotein) and the multiple resistance 
associated proteins (MRP) ABCC1 (MRP1) and ABCC2 (MRP2) were ruled out as 
possible candidates involved in the efflux of BaP metabolites [27, 112].
PAHs that are not oxidized by Cyp450s remain associated with lipids during 
chylomicron formation and are secreted into the systemic circulation [121, 218]. 
Once PAHs have entered the systemic circulation they are primarily excreted via 
the bile and to a lesser extent via the urine [98, 176].
Aim and outline of this thesis
The introduction of vegetable oils to substitute for fish oil in aquaculture feeds 
is a promising development towards more sustainable aquafeeds that are 
less dependent on ingredients obtained from wild fish. Unfortunately, the 
introduction, with vegetable oils, of contaminating PAHs in aquafeeds will to 
some extent counteract this positive development and seems to present a 
Catch-22 (paradoxical) situation. This presents a challenge in the development of 
alternative aquafeeds, and warrants further research.
The main aim of this thesis was to explore the interactions between contaminating 
PAHs and dietary lipid composition on uptake across the intestinal mucosa, 
metabolism and further peripheral distribution of lipids and their digestion 
products. The emphasis of this thesis is on generating fundamental knowledge 
on the combined effects of PAHs and lipids in model systems at several different 
levels of biological organization, e.g., at the level of enzymatic lipid hydrolysis, 
intestinal membrane delivery, intestinal membrane transfer and whole-body 
distribution. 
Chapter 2 investigates the effects of dietary lipid composition on the intestinal 
uptake and peripheral distribution of BaP and PHE in Atlantic salmon fed either 
a ‘traditional’ fish oil-based diet or an alternative vegetable oil-based diet. In 
chapter 3, the effects of BaP and PHE on the enzymatic hydrolysis of rapeseed oil 
and fish oil in intestinal extracts is described. We hypothesized that the different 
lipid compositions of rapeseed oil and fish oil affect PAH solubility in micelles and, 
subsequently, lipase activity. Chapter 4 describes the effects of eicosapentaenoic 
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acid (EPA), a typical fish oil-derived fatty acid and oleic acid, a typical vegetable 
oil fatty acid on intestinal transmembrane uptake of BaP and PHE. The intestinal 
enterocyte is a typical polarized cell with distinct apical and basolateral membrane 
domains, differing in phospholipid and cholesterol make-up and each harboring 
specific integral membrane proteins, among which enzymes and transporters. A 
purified brush border membrane vesicle preparation was used to measure the 
first step of intestinal transmembrane PAH uptake. To further investigate the 
interaction between diet-contaminating PAHs and lipid hydrolysis products, 
BaP and PHE were solubilized in micelles composed of EPA or oleic acid and 
administrated to the mucosal side of intact intestinal epithelia mounted in Ussing 
chambers. The results of this study are described in chapter 5.
This thesis concludes with a general discussion, where the results of the studies 
described in the topical chapters, are discussed in the context of the main aim 
and put into a wider perspective of the production of novel alternative aquafeeds. 
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Chapter 2
The effect of dietary lipid composition on the intestinal 
uptake and tissue distribution of benzo[a]pyrene and 
phenanthrene in Atlantic salmon (Salmo salar)
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Abstract
Uptake of polycyclic aromatic hydrocarbons (PAHs) across the intestine is 
suggested to occur in association with dietary lipids. Partial replacement of fish 
ingredients by vegetable ingredients in aquafeeds has led to increased levels of 
PAHs in marine farmed fish. We therefore investigated, intestinal uptake, tissue 
distribution and PAH metabolism after a single dose of 14C-benzo[a]pyrene (BaP) 
or 14C-phenanthrene (PHE) given to Atlantic salmon (Salmo salar) acclimatized 
to a fish oil or vegetable oil-based diet. Both BaP and PHE were absorbed along 
the intestine. Fish oil-based feed increased BaP concentration in the pyloric caeca 
and that of PHE in the proximal intestine. In contrast, vegetable oil increased BaP 
concentrations in the distal intestine. Extraction of whole body autoradiograms 
removed PHE-associated radiolabeling almost completely from the intestinal 
mucosa, but not BaP-associated radiolabeling, indicating presence of BaP 
metabolites bound to cellular macromolecules. This observation correlates with 
the increased cyp1a expression in the proximal intestine, distal intestine and 
liver in the BaP exposed group. Furthermore, BaP-induced cyp1a expression was 
higher in the distal intestine of salmon fed fish oil compared to the vegetable 
oil fed group. PHE had no significant effect on cyp1a expression in any of these 
tissues. 
We conclude that dietary lipid composition affects intestinal PAH uptake. Fish oil-
based feed increased intestinal PAH concentrations probably due to an enhanced 
solubility in micelles composed of fish oil fatty acids. Increased BaP accumulation 
in the distal intestine of vegetable oil fed fish seems to be associated with a reduced 
Cyp1a-mediated BaP metabolism. 
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Introduction
Aquaculture is a fast-growing global food-producing sector, with the production 
of approximately 1.9 million metric tons of Atlantic salmon (Salmo salar) in 2014 
[59]. Traditionally, marine fish oils and fishmeal have been used as the main feed 
ingredients in high energy commercial feeds for carnivorous farmed fish species 
such as Atlantic salmon. However, the rapidly growing aquaculture cannot 
continue to rely on fisheries for the supply of fish oil and fishmeal [24, 59, 166]. 
Therefore, there is a need to develop sustainable alternative aquafeed ingredients, 
such as oil and meal from vegetable sources. Partial or complete substitution of 
fish oils by vegetable oils does not seem to negatively affect growth, survival 
and/or feed nutrient utilization in several aquaculture species [9, 29, 93, 119, 166, 
206, 208, 209]. In 2013, less than 30% of the Atlantic salmon diet was composed 
of marine ingredients while approximately 56% was composed of vegetable 
ingredients [232]. The use of vegetable oils will increase dietary levels of monoene 
and n-6 fatty acids. Contrary, levels of n-3 long-chain C20 and C22 polyunsaturated 
fatty acids (PUFAs) will decrease [9, 212]. 
Thermal processing of oil producing seeds and grains have been shown to elevate 
polycyclic aromatic hydrocarbons (PAH) contents in vegetable-based fish feeds 
[14, 51]. As a consequence, the use of vegetable feed ingredients in aquafeeds 
also increase the concentration of contaminants that have not been associated 
before with Atlantic salmon farming, such as PAHs [13, 16]. PAHs are ubiquitous 
lipid-soluble non-persistent organic pollutants that are biotransformed by 
oxygenation by the cytochrome P4501A (Cyp1a) family [18, 85]. Atlantic salmon 
fed ‘alternative’ diets based on partial replacement of fish oil and fishmeal with 
vegetable oil and vegetable meal, were found to have elevated tissue levels of 
several PAH congeners, including benzo[a]pyrene (BaP) and phenanthrene (PHE) 
[14]. BaP and PHE differ in their physico-chemical properties as well as their 
potential toxic actions. BaP consists of five fused benzene rings, is highly lipophilic 
(octanol/water partition coefficient, log Kow = 6.31) and is an agonist to the aryl 
hydrocarbon receptor that induces Cyp1a-mediated metabolism [112]. PHE has 
three fused benzene rings, is less lipophilic than BaP (log Kow = 4.5) and is not an 
aryl hydrocarbon receptor agonist [18], with, consequently, a slower metabolism 
than BaP [32]. 
Tissue concentration, distribution and bioavailability of PAHs depend on 
transport, uptake, metabolism and excretion. Intestinal transport and uptake of 
dietary PAHs has been suggested to occur in association with dietary lipids [49, 104, 
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221]. Vetter et al. (1985) observed that lipids and BaP were co-transported from 
the intestinal lumen and co-incorporated in chylomicrons within one hour after 
digestion. Because PAHs have a low solubility in the aqueous environment of the 
gut lumen, it has been proposed that dietary lipids influence the uptake of highly 
hydrophobic xenobiotics [49, 221, 222]. In practice, aquafeeds are composed of 
vegetable and fish oil blends and an alteration in feed composition could affect 
the uptake of PAHs. In fish, lipids are absorbed throughout the entire intestine 
but predominantly in the proximal region and the pyloric caeca [100, 108, 205]. 
When PAHs enter the gastrointestinal tract, transport from the lumen to the apical 
brush border membrane of enterocytes can be facilitated by micelles [44, 221, 
222]. The solubility of hydrophobic xenobiotics is higher in micelles composed 
of unsaturated long-chain fatty acids compared to saturated short-chain fatty 
acids [44, 110]. Furthermore, lipid digestion rates increase with the degree of 
unsaturation, and decrease with increased chain length of the constituting fatty 
acids [181]. The lower digestibility of vegetable n-9 and n-6 fatty acids compared 
to fish n-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) is mainly due to the lower degree of unsaturation in plant PUFAs [208]. 
For dietary exposures, the intestine is the first barrier for PAH uptake from the diet. 
The intestine plays an important role in PAH metabolism with near similar abilities 
as liver (on protein basis) in metabolizing BaP [129]. PAHs are metabolized to 
epoxides and hydroxylated derivatives during phase I metabolism. Excretion of 
phase I products is facilitated by conjugation to more water-soluble glucuronides 
and sulfates during phase II metabolism. Fatty acid levels and in particular PUFAs 
can induce BaP metabolism by increasing intestinal cytochrome P450 activity 
[230]. All in all, the increased inclusion of vegetable oils in aquafeeds increase 
PAH concentrations in farmed fish while the presence of vegetable and fish oils in 
the diet could alter the solubility of PAHs, their intestinal uptake, bioavailability, 
metabolism and, ultimately, the animal’s exposure to PAHs. 
Differences in solubility of PAHs in micelles and different digestion and absorption 
rates of different fatty acids can affect the uptake of PAHs from the diet. The 
objective of the present study was to investigate the effects of dietary lipid 
composition on the uptake and distribution of BaP and PHE across the intestinal 
tract in Atlantic salmon fed either a “traditional” fish oil-based diet or an alternative 
vegetable oil-based diet. 
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Material and Methods
Animals and diet formulation
The study was conducted at the Industrial and Aquatic Laboratory (I-Lab), Bergen, 
Norway. Locally bred seawater-acclimated Atlantic salmon (Salmo salar) weighing 
approximately 200 g were kept in indoor 1-m3 fibre glass tanks (26 fish per tank) 
supplied with running seawater with a salinity of approximately 31‰. The study 
was performed at a temperature of 10.0 ± 0.2 °C (average ± SD).
Fish were fed for three weeks with either a diet based on fish oil or a diet based on 
vegetable (rapeseed) oil to acclimatize the intestinal tract to the diet. The fish were 
reared under 12:12 dark:light conditions and fed by automatic feeders twice a day 
for two hours according to standardized in-house growth tables for salmonids 
modified after Austreng et al. (1987), with a feed intake of approximately 1.2% 
of body weight per day. The three weeks acclimatization period was chosen to 
ensure approximately 15 intestinal passages of the diet based on an assumed 
mean transit times of 28–29 hours in 140–145 g rainbow trout at 10 ºC fed two 
meals a day with a pelleted feed [60].
Table 2.1 shows that the fish oil-based diet was enriched in long-chain 
polyunsaturated omega-3 fatty acids (PUFA-n-3), whereas the vegetable oil-based 
diet had a low PUFA-n-3 content. The diets were designed to meet the nutritional 
requirements of Atlantic salmon. The choice of alternative feed ingredients as well 
as the composition of vegetable protein and oils was based on earlier studies on 
the replacement of fishmeal and fish oil and [14, 212]. The two diets were selected 
for low background levels of BaP and PHE of 0.06 and 5.1, and 0.07 and 8.3 µg ∙ kg-1 
in the fish oil and vegetable oil-based diets, respectively. 
Gavage preparation, dosing and sampling.
A single pulse-chase dose of 14C labeled BaP or PHE was administrated [91] to 
follow the uptake across the intestinal tract over time. For the purpose of liquid 
scintillation counting of tissue homogenates and whole body autoradiography, 
salmon were given either a fish oil or a vegetable oil-based feed enriched with 
[7-14C]BaP (26.6 mCi  ∙ mmol-1; chemical purity was 99%; American Radiolabeled 
Chemicals, St Louis, U.S.A.) or [9-14C]PHE (52 mCi ∙ mmol-1; chemical purity was 99%; 
Larodan Fine Chemicals AB, Malmö, Sweden). A single dose of 2.5 kBq ∙ g-1 body 
mass, equivalent to approximately 0.64 µg BaP ∙ g-1 body mass or 0.23 µg PHE ∙ g-1 
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Fish oil-based feed Vegetable oil-based feed
Proximate composition
Fish meal ingredients 150 150
Plant meal ingredients 569 569
Vitamin and mineral mixture 44 44
Fatty acid composition
14:0 2.4 0.6
16:0 15.1 14.8
18:0 2.2 2.3
Sum saturates 20.4 18.3
16:1n-7/9 2.3 0.6
18:1n-9/7 35.6 42.8
20:1n-9 2.6 1.3
22:1n-11/9 2.6 0.8
Sum monoenes 43.7 45.9
18:2n-6 13.5 16.6
20:4n-6 0.2 0.0
Sum n-6 14.2 16.7
18:3n-3 10.1 13.2
18:4n-3 0.7 0.1
20:4n-3 0.2 0.0
20:5n-3 2.8 0.7
22:5n-3 0.4 0.1
22:6n-3 2.4 0.7
Sum n-3 16.7 14.8
Table 2.1: Proximate feed (g ∙ kg-1) and fatty acid compositions (area % of total fatty acids) in pellets 
(4 mm) of the fish oil and the vegetable oil-based feeds.
body mass was administered to each fish. The dose of 2.5 kBq ∙ g-1 body mass was 
chosen to ensure an adequate radioactive signal for autoradiogram development 
[2]. The dose 2.5 kBq ∙ g-1 body mass exceeds the natural background levels 
of PAH residues in feed (500- and 50000-fold for PHE and BaP, respectively). 
However the present study aimed to assess dietary oil matrix-PAH interaction by 
a single 14C pulse-chase study, rather than employing a feeding trial with natural 
background PAH residue levels. 
Feed pellets of either the fish oil or the vegetable oil-based diet were separately 
crushed and mixed with water (1:1.5 w/v) to form a paste. PHE or BaP were dissolved 
in methanol and toluene, respectively, and added to the designated feed pastes. 
The pastes were air-dried (ca. 1 hour) to evaporate methanol and toluene. Each 
paste was thoroughly mixed and loaded in a 1-mL syringe with cut-away tip and 
smooth, polished edges. Control feeds were prepared using methanol and toluene 
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vehicles only, and were otherwise treated similarly as the experimental diets. All 
syringes were air and light protected before oral administration. 
For the purpose of the analysis of PAH metabolites and gene expression studies, 
the feed pastes were made as described above but mixed with a non-radio-
labeled BaP or PHE (Sigma-Aldrich Co, St Louis, U.S.A.) in similar concentrations as 
for the liquid scintillation and autoradiograms (i.e., 0.64 µg BaP ∙ g-1 body mass or 
0.23 µg PHE ∙ g-1 body mass was administered to each fish). 
After exposure to a single dose the fish were euthanized at the designated time 
points by a blow to their head and selected organs were sampled. This pulse-
chase experiment was designed to study initial effects of dietary lipids on PAHs 
uptake within 12 hours after oral administration. The experimental design obeyed 
Norwegian legislation and was approved by the Norwegian Animal Research 
Authority.
Administration of experimental feeds
Feeds were administered according to Amlund et al. (2006). Briefly, prior to oral 
administration of the experimental feed, fish were starved for 1.5 days in order 
to ensure an empty stomach and gastrointestinal tract. Fish were anaesthetized 
using 0.1% (w/v) tricaine methanesulfonate (MS-222) in seawater and weighed. 
The experimental feed was orally administrated to the stomach in a single dose 
of 0.3% body weight (v/w), which was chosen as to fill the stomach content. The 
1-mL syringe with the designated feed paste was carefully inserted through the 
mouth and positioned at the posterior end of the stomach. The syringe was then 
slowly retracted while the feed paste was administered. Fish were placed in a 
separate tank to recover, and then transferred to the experimental tank. This also 
allowed a visual check of potential regurgitation, which did not occur in any of 
the fed fish.
Intestinal transit time 
Fish reared on the same conditions as the experimental fish (n = 2 for each time 
point) were anaesthetized in seawater using 0.1% (w/v) MS-222 and were fed 
vegetable oil-based feed pastes to which 2% chromium(III)oxide was added. 
Dissection following euthanasia showed that three hours post-feeding the 
feed was located in the pyloric caeca and in the proximal part of the proximal 
intestine. After 6 hours the feed was mainly located in the proximal intestine 
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and after 12 hours the feed was also present in the distal intestine. The proximal 
intestine was defined as the region between the most caudal pyloric caecum and 
the junction with the distal intestine, which was larger, darker in appearance and 
characterized by annular rings. From this pilot study we chose sampling times to 
be 3, 6 and 12 hours.
Liquid scintillation counting
Fish (n = 4 for each treatment and time point) were sampled at 3, 6 and 12 hour 
post-feeding the experimental feeds. Immediately after weighing, 0.4 mL blood 
was sampled from the caudal vein by puncture with a heparinized needle directly 
caudal to the anal fin. Bile was collected by puncture of the gall bladder. Liver, 
gastrointestinal tract, spleen, gills, kidney and head kidney were dissected and 
collected in glass vials. The gastrointestinal tract was cleaned of its visceral fat and 
separated in stomach, pyloric caeca, proximal intestine and distal intestine. The 
mucosa of the stomach, proximal intestine and distal intestine was scraped off its 
underlying muscle layers with the aid of glass microscope slides. The mucosa of 
the pyloric caeca could not be collected. Instead the whole organ was measured. 
Organs were weighed and homogenized in 3 volumes of saline solution (150 mM 
NaCl) in a glass Potter-Elvehjem device fitted with a motorized PFTE pestle 
operating at 800 rpm.
Whole bile fluid, duplicate samples of blood (0.4 mL; to which 1 mL 2-propanol 
was added) and triplicate samples of 37.5 mg homogenized tissue were transferred 
to polyethylene vials and dissolved overnight in 1 mL of tissue solubilizer 
(SOLVABLE™, Packard BioScience BV, Groningen, The Netherlands) at 37 °C. 
Ten mL of liquid scintillation cocktail (Ultima Gold™ LTT, Packard BioScience BV, 
Groningen, The Netherlands) was added to the vials. Radioactivity was measured 
in a liquid scintillation counter (Tri-Carb® 2100TR, Packard), where the counting 
efficiency was controlled by measurement of the spectral quench parameters 
(SQP). The dependence of SQP on counting efficiency was determined using a 
14C standard (No. 1210-122, lot No. 103209, LBK Wallac Oy, Turku, Finland) to which 
dichloromethane as quencher was added in increasing amounts to establish an 
efficiency vs. SQP curve. The measured SQP-value for each sample was then used 
to convert the measured radioactivity count rate to becquerel (Bq). The organ 
concentrations (ng PAH ∙ g-1 organ) were calculated according Equation [1]:
  [1]
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where HØ is radioactivity (Bq) in the homogenate; Blank is the radioactivity (Bq) in 
a counted blank sample (Control fish which only had been given the experimental 
feed) for each selected organ. SpA (Bq ∙ ng-1 PAH) is the specific radioactivity of the 
radiotracer and HØ ww is the wet-weight (g) of the homogenate. Radioactivity in 
the homogenate samples was corrected for background radioactivity. Thereafter, 
the amount of PAHs (ng) in each homogenate was calculated by dividing the 
measured radioactivity by the SpA of the radiotracer. Organ concentrations 
(ng PAH ∙ g-1 organ) were calculated by dividing the total amount of PAHs (ng) per 
organ by the homogenate wet-weight (g). Additionally the sample was corrected 
for organ weight (g) to obtain the total amount of PAHs (ng) per organ.
Whole body autoradiography
Fish (n = 2 for each treatment and time point) were sampled 3, 6 and 12 hours 
post-feeding. Each fish was immediately frozen on dry ice and stored at -20 °C 
until further sample preparation. Frozen fish were individually embedded in a 
pre-cooled (0 - 4 °C) aqueous gel of 1% carboxymethylcellulose (w/w in tap water) 
on dry ice and sectioned with a cryomicrotome (PMV, 450 MP, Sweden). Sagittal 
sections (20  µm) containing the pyloric caeca, proximal and distal intestine, 
liver, bile and kidney were collected on acrylic adhesive tape No. 821 (3M Co, 
Minnesota, USA). Neighboring sections were collected on acrylic adhesive tape 
No. 356 (3M Co, Minnesota, USA) for extraction with polar and non-polar solvents. 
All sections were freeze-dried overnight at -20 °C. Extraction was performed 
with 5% trichloroacetic acid (1 min), 50% methanol (30 s), 100% methanol (30 s), 
heptane (15 s), 100% methanol (30 s) and 50% methanol (30 s). After washing for 
10 min in running tap water, sections were dried overnight at room temperature. 
Further processing of native sections took place at -20 °C to avoid melting and 
diffusion of fat in the sections [91], whereas extracted sections were prepared at 
room temperature. The autoradiograms obtained from native sections showed 
the locations of 14C-BaP or 14C-PHE and their related metabolites. Autoradiograms 
obtained from solvent-extracted sections were interpreted to show 14C-BaP or 
14C-PHE and associated metabolites bound to cellular macromolecules [91]. Both 
native and extracted sections were exposed to X-ray-film (Structurix D7 DW ETE, 
Agfa-Gevaert, Belgium) for one week. The films were developed (XR D-1.5 NDT, 
Dürr, Germany) and fixated (XR F-1.5 NDT, Dürr, Germany) for four and eight min 
respectively, followed by rinsing in running tap water for 30 min and air-dried. 
The native sections and autoradiograms from native and extracted sections were 
digitalized (HP ScanJet 6200c). Images of the native sections have been adjusted 
to increase the contrast and autoradiograms have been inverted to photo 
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positives and adjusted to increase the contrast (Adobe Photoshop Elements, 8.0).
Analysis of gene expression
Fish (n = 4 for each treatment) were euthanized 12 hours post-feeding and the 
pyloric caeca, proximal intestine, distal intestine and liver were immediately 
dissected. The intestinal samples were cleaned of luminal content by washing with 
saline solution after which the mucosa of the proximal and distal intestine was 
scraped off its underlying muscle layers with a glass microscope slide. Samples 
thus obtained were immediately frozen in liquid nitrogen and stored at -80 °C 
until RNA isolation.
RNA isolation
Tissues were homogenized using a MagNA Lyser Green beads homogenizer 
(Roche Applied Science). Total RNA was extracted with Trizol reagent (Invitrogen 
Ltd, Paisley, UK) using the Qiagen® BioRobot® EZ1® (Hilden, Germany). Samples 
were treated with DNase according to the manufacturer’s instructions and diluted 
in 50 µL RNase-free MilliQ water. The quality of the RNA was assessed with the 
Nano-Drop ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE, USA) and the Agilent 2100 Bioanalyzer (Agilent Technologies, 
Palo Alto, CA, USA). The RNA 6000 Nano LabChip kit (Agilent Technologies, Palo 
Alto, CA, USA) was used to evaluate the RNA integrity of 12 randomly selected 
samples. The RNA integrity number was at least 8.1 for the liver samples and at 
least 5.8 for analyzed pyloric caeca, proximal- and distal intestine samples.   
RT-PCR
Reverse transcriptase (RT)-PCR was performed using TaqMan reverse transcription 
reagents (Applied Biosystems, Foster City, CA, USA). PCR efficiency was calculated 
from a standard curve composed of serial dilutions (1000 to 31 ng) of a RNA pool 
from randomly chosen samples. Total RNA input was 500 ng in each reaction for 
all genes. Control reactions contained no template (no template control, ntc) or 
no reverse transcriptase (nrc). Reverse transcription was performed at 25°C for 
10 min, 48°C for 60 min, 95°C for 5 min followed by a decrease to 4°C, using oligo 
dT primers (2.5 µM) for all genes in 50-µL total volume. The other chemicals (final 
concentration given in parentheses) were: MgCl2 (5.5 mM), dNTPs (500 µM of 
each), 10  ·  TaqMan RT buffer (1x), RNase inhibitor (0.4 U ∙ µL-1) and Multiscribe 
reverse transcriptase (1.67 U ∙ µL-1).
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RT-qPCR
Two µL of the two-fold diluted cDNA from each RT reaction was transferred to 
a 384-well reaction plate. Real-time quantitative PCR (qPCR) was performed 
in 10-µL reactions on a LightCycler 480 Real-Time PCR System (Roche Applied 
Sciences, Basel, Switzerland). Real-time qPCR was performed using SYBR Green 
PCR Master Mix (Roche Applied Sciences, Basel, Switzerland), forward and reverse 
gene specific primer oligonucleotides (50 µM; see Table 2.2 for oligonucleotide 
sequences and target gene names). Reaction conditions were: a 5 min activation 
and denaturing step at 95 °C, followed by 45 cycles with each cycle consisting 
a 10 s denaturing step at 95 °C, a 10 s annealing step at 60 °C and finally a 10 s 
synthesis step at 72 °C, followed by a melt curve analysis and cooling to 4 °C.
Mean normalized expression (MNE) for each target gene was determined 
using a normalization factor calculated by the geNorm software based on the 
selected reference genes. PCR primer sequences used for the quantification of 
the reference genes encoding β-actin, elongation factor 1 alpha (elf1α), acidic 
ribosomal protein (arp) and the target genes are given in table 2.2. As target genes, 
phase I (i.e., cyp1a1, cyp2m, cyp3a27), phase II (glutathione S-transferase P (gstp), 
UDP glucuronosyltransferases (ugt)) and phase III (ATP-binding cassette (abcb1, 
abcc2, abcg2)) detoxification genes were selected as well as genes involved in 
transport proteins for fatty acid transport (fatty-acid-binding proteins (fabp 1, 5)). 
PCR efficiencies are presented in the supplementary information (Table S2.1).
Gene GenBank accession # 5’-3’ forward primer 3’-5’ reverse primer
arp BT050383 TCATCCAATTGCTGGATGACTATC CTTCCCACGCAAGGACAGA
elf1α AF321836 CCCCTCCAGGACGTTTACAAA CACACGGCCCACAGGTACA
β-actin BG933897 CCAAAGCCAACAGGGAGAA AGGGACAACACTGCCTGGAT
rpl13 NM_001141291 CCAATGTACAGCGCCTGAAA CGTGGCCATCTTGAGTTCCT
cyp1a1 BT059507 TGGAGATCTTCCGGACTCT CAGGTGTCCTTGGGAATGGA
cyp2m BT058453.1 ATGGATGTGAAAGCGCCATAC CCTTGATAGCCTGATAGCCAGAGA
cyp3a27 DQ361036.1 ACTAGAGAGGGTCGCCAAGA TACTGAACCGCTCTGGTTTG
gstp BT049972.2 ATTTTGGGACGGGCTGACA CCTGGTGCTCTGCTCCAGTT
ugt DY802180 ATAAGFACCGTCCCATCGAG ATCCAGTTGAGGTCGTGAGC
abcb1 AY863423 AGCAGTGGCTGTGGGAAGAG CCCTCAGCCAATGGATGTTC
abcc2 DY719572 GACTGACCCACGAGGTGTCA CCACAGCAGCTGTAGCCCTCAT
abcg2 DW557921 GCATCCCTCGGTACGGACTA GAAGTCTTCCCCCGTGCAT
fabp1 CB504560 CACGGGCACCAAGGTCATAG CCATTAGCTTGTTCCCAACCA
fadsd5 NM_001123542.2 GGAACCACAAACTGCACAAGT GTGCTGGAAGTGACGATGGT
 Table 2.2: Primer oligonucleotide sequences used for quantitative real-time PCR.
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Preparation of bile samples and HPLC/fluorescence analyses
Bile was collected by puncture of the gall bladder by a 1 mL syringe from euthanized 
fish (n = 4, for each treatment and time point) 3 and 12 hours post-feeding. 
Preparation of hydrolyzed bile samples was performed as described by Krahn et 
al. (1992). Briefly, bile (20 µL) was mixed with an internal standard (triphenylamine, 
Sigma-Aldrich Co, St Louis, U.S.A.), diluted with demineralized water (50 µL), 
and hydrolyzed with glucuronidase/arylsulfatase (20 µL, 1 hour at 37 °C) [107]. 
Methanol (200 µL) was added, the sample was centrifuged (13000 g, 10 min) and 
the supernatant analyzed. HPLC was performed after Grung et al. (2009). Briefly: a 
Waters 2695 separation module with a 2475 fluorescence detector attached was 
used. The column used was a Waters PAH C18 (4.6 × 250 mm) with 5-µm particles. 
Twenty-five µL of extract was injected for each analysis [82]. Each run lasted 
30  min where the mobile phase consisted of a 40:60 acetonitrile:ammonium 
acetate (0.05 mM, pH 4.1) and gradually increased to a 100% acetonitrile gradient 
at a flow of 1 mL ∙ min-1, the column was heated to 35 °C. Fluorescence excitation/
emission wavelengths were measured at the optimum for each analyte: OH-PHE 
at 256/380 nm and OH-BaP at 350/430 nm. Standards of 1-OH-PHE and 3-OH-BaP 
(Chiron AS, Trondheim, Norway) were included measured at similar wavelengths 
and used to determine metabolite concentrations (µg OH-PAH ∙ g-1 bile). 
Statistics
Organ PAH accumulation over time were analyzed using multilevel linear 
models in the statistical programming language R (version 3.0.2) [162]. In brief, 
a basic fixed intercept model predicting the relative BaP or PHE organ load from 
the intercept was created (BaP/PHE ~1) using the generalized least squares 
(gls) function of the package nmle [159]. A basic fixed intercept model was 
used instead of random intercepts (i.e., no need to account for inter-individual 
differences over time as the fish were terminally sampled at each time point). In a 
subsequent step, different time trajectories (linear and second order polynomial) 
were added to the models (BaP/PHE ~Time/Time2). The produced models were 
compared to each other using Log likelihood tests and the best fitting (ANOVA, 
p ≤ 0.05) and most parsimonious model was chosen for further analyses in which 
the type of dietary oil was added as predictor (BaP/PHE ~Time/Time2 + type of oil). 
Statistical significance was accepted at p ≤ 0.05. A comprehensive overview of all 
models created and all parameters determined is presented in the supplementary 
information (Table S2.2 – S2.3). Data were checked for homogeneity of variance 
by D’Agostino-Pearson normality test. Bile metabolite data were heterogeneous 
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and assessed with a Kruskal-Wallis test between the control group, 3 and 12 hours 
post-feeding per PAH per feed type. A Mann-Whitney U test was performed to 
analyze differences per PAH between oil-based diets after 12 hours. The gene 
expression data 12  hours after exposure was assessed with a factorial (2x2) 
ANOVA to analyze the effects of the two factors “type of oil” (fish oil-based feed 
and vegetable oil-based feed) and presence or absence of “BaP” or “PHE”. When 
the interaction of the two factors was significant, multiple comparison post-hoc 
testing was performed in order to elucidate the simple effects among treatments. 
Results were considered statistically significant when p < 0.05 (two-tailed).
Results
BaP and PHE organ concentrations
Table 2.3 shows the PAH organ concentrations of salmon fed a single dose of 
either BaP or PHE pre-fed a fish oil or vegetable oil-based diet. The concentrations 
of both PAHs gradually increased along the entire intestinal tract during 12 hours. 
After 12 hours, the intestine (pyloric caeca, proximal and distal intestine) contained 
24% ± 5.7% (mean ± SD) and 19% ± 2.2% of the given BaP dose in Atlantic salmon 
acclimatized to a fish oil or vegetable oil-based feed, respectively. The amount of 
PHE in the intestine, 12 hours post-feeding, was 18% ± 1.5% in salmon pre-fed a 
fish oil-based diet and 14% ± 1.8% in salmon pre-fed a vegetable oil-based diet. 
The highest PHE concentration was detected in the bile after 12 hours. 
Figure 2.1 shows BaP and PHE concentrations during the first 12 hours in Atlantic 
salmon acclimatized to a fish oil or vegetable oil-based feed. The accumulation of 
BaP in the pyloric caeca, distal intestine and spleen differed significantly over time 
between fish fed a fish oil or vegetable oil-based feed. For PHE, only the proximal 
intestine concentration was significantly influenced by type of oil. No significant 
differences in PAH concentrations of other peripheral organs (liver, head kidney, 
kidney and gills) between the fish oil and vegetable oil groups were found. 
Fish oil-based feed significantly increased BaP concentrations (p =  0.041) in the 
pyloric caeca compared to salmon fed a vegetable oil-based diet (Fig. 2.1A). A 
second order polynomial model describes the BaP concentrations that increase 
from 3 to 12 hours post-feeding. As opposed to the pyloric caeca, fish oil-based 
feed significantly decreased (p = 0.037) BaP concentrations in the distal part of 
the intestine (Fig. 2.1B). The model confirms a linear increase in BaP concentration 
over time. Of the other peripheral organs only spleen had significantly (p = 0.008) 
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higher BaP organ concentrations after the fish were fed a fish oil-based diet 
(Fig. 2.1C). Modeling BaP presence in the spleen showed an initial decrease from 
3 to 6 hours followed by an increase 12 hours post-feeding. A detailed list of all 
regression model parameters for BaP organ concentrations are presented in the 
supplementary information (Table S2.2).
PHE organ concentrations were significantly increased (p = 0.047) in the proximal 
intestine of fish fed a fish oil-based diet (Fig. 2.1D). A second order polynomial 
ng PHE ∙ g-1 organ
Fish oil-based feed Vegetable oil-based feed
3 6 12 3 6 12
Stomach 1024 ± 493 601 ± 301 195 ± 44 801 ± 198 717 ± 604 197 ± 155
Pyloric caeca 1130 ± 709 1680 ± 271 1487 ± 159 1101 ± 266 2703 ± 211 1810 ± 488
Proximal intestine* 701 ± 724 1350 ± 588 1657 ± 1252 236 ± 184 854 ± 173 988 ± 622
Distal intestine 78 ± 14 112 ± 33 402 ± 129 111 ± 27 135 ± 109 333 ± 43
Liver 249 ± 160 618 ± 91 505 ± 123 164 ± 64 894 ± 330 423 ± 181
Bile 55 ± 20 621 ± 446 19195 ± 2382 88 ± 85 2983 ± 2375 27983 ± 28963
Blood 0.39 ± 0.35 1.0 ± 0.28 2.5 ± 0.30 0.17 ± 0.13 1.6 ± 0.15 1.4 ± 0.72
Third gill arch 42 ± 45 226 ± 209 53 ± 20 150 ± 147 87 ± 61 76 ± 72
Head Kidney 69 ± 96 36 ± 8.9 58 ± 12 26 ± 32 83 ± 58 114 ± 63
Kidney 26 ± 24 55 ± 11 131 ± 27 35 ± 44 82 ± 23 81 ± 32
Spleen 13 ± 11 33 ± 11 61 ± 43 9,9 ± 5,8 26 ± 15 31 ± 17
ng BaP ∙ g-1 organ
Fish oil-based feed Vegetable oil-based feed
3 6 12 3 6 12
Stomach 1685 ± 332 1468 ± 932 1712 ± 1127 1364 ± 568 1600 ± 497 616 ± 691
Pyloric caeca* 1202 ± 479 6252 ± 2482 7735 ± 703 2118 ± 514 3296 ± 1395 5065 ± 1489
Proximal intestine 1382 ± 719 6495 ± 3717 8688 ± 5165 3317 ± 2065 5176 ± 2770 15180 ± 7097
Distal intestine* 69 ± 22 440 ± 397 1096 ± 1107 158 ± 44 632 ± 222 4198 ± 1809
Liver 85 ± 115 151 ± 20 799 ± 209 40 ± 9.4 128 ± 28 704 ± 268
Bile 71 ± 75 734 ± 315 7688 ± 3363 268 ± 244 1012 ± 481 11261 ± 7406
Blood 0.070 ± 0.022 1.1 ± 0.60 1.1 ± 1.0 0.22 ± 0.12 0.68 ± 0.12 1.57 ± 0.34
Third gill arch 158 ± 141 490 ± 339 64 ± 27 178 ± 247 120 ± 187 81 ± 27
Head Kidney 34 ± 6.4 36 ± 20 27 ± 7.8 17 ± 18 74 ± 102 83 ± 28
Kidney 5.7 ± 1.7 26 ± 6.2 74 ± 29 4.6 ± 2.1 15 ± 2.7 100 ± 28
Spleen* 43 ± 12 31 ± 4.5 99 ± 63 8.6 ± 4.7 14 ± 2.2 51 ± 8.2
Table 2.3: Organ accumulation of benzo[a]pyrene (BaP) or phenanthrene (PHE) in Atlantic salmon 
per organ (ng PAH ∙ g-1 organ). Atlantic salmon were fed either a fish oil or vegetable oil-based diet 
spiked with either BaP or PHE. Mean values ± SD, n = 4; are shown. An asterisk indicates a significant 
accumulation of a PAH over time between fish fed fish oil or vegetable oil in the respective organ 
and are shown in figure 2.1. Statistical parameters are presented in the supplementary information 
(Table S2.2 & S2.3).
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model describes PHE levels that increase from 3 to 12 hours post-feeding. A 
detailed list of regression model parameters of all PHE organ concentrations is 
presented in the supplementary information (Table S2.3).
Organ distribution of BaP and PHE
Figure 2.2 and 2.3 show the disposition of 14C-BaP and 14C-PHE 3 and 12 hours 
post-feeding. Three hours after oral administration, most of the BaP-associated 
radioactivity was detected in the mucosa of the pyloric caeca and proximal 
intestine. Radioactivity increased over time and after 6 hours BaP-associated 
radioactivity was present in liver and bile. Furthermore, after 12 hours, radioactivity 
was also detected in the kidney (inserts in Fig. 2.2D). 
Three hours after administration, most PHE-associated radioactivity was present in 
the stomach and a very weak signal was detected in the intestinal tract (Fig. 2.3C). 
After 6 hours PHE-associated activity was detected in bile, liver, kidney and urine 
Figure 2.1: Time-course of accumulation of benzo[a]pyrene (BaP) or phenanthrene (PHE) in 
Atlantic salmon per organ (ng PAH ∙ g-1 organ) which had significant difference between type of 
feed. Solid black lines represent fish oil-based feed spiked with either BaP or PHE and dashed lines 
represent vegetable oil-based feed spiked with either BaP or PHE. Only organs are shown which 
had significant different PAH accumulation over time between both diets. BaP: pyloric caeca (A), 
distal intestine (B), spleen (C). PHE: proximal intestine (D). Points represent experimental data 
(mean values ± SD; n = 4). 
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Figure 2.2: Autoradiograms of adjoining sections from Atlantic salmon, after a single oral dose of 
[14C]-benzo[a]pyrene (2.5 kBq ∙ g-1 body mass) corresponding to approximately 0.64 µg BaP ∙ g-1 
body mass (w/w). Sections represent a native section (top), the corresponding autoradiogram 
of the native section (middle) and an adjacent, solvents-extracted section (bottom). Bar = 1 cm. 
White areas correspond to high concentrations of radiolabeled compound. Numbers on the 
autoradiograms represent the following organs; 1) pyloric caeca, 2) proximal intestine, 3) distal 
intestine, 4) liver, 5) gall bladder, 6) kidney, 7) urinary tract, 8) central nervous system. A) 3 hours 
post-feeding a fish oil-based feed. B) 12 hours post-feeding a fish oil-based feed. C) 3 hours 
post-feeding a vegetable oil-based feed. D) 12 hours post-feeding a vegetable oil-based feed. 
An additional autoradiogram was inserted in D to include the kidney as no section with both 
proximal intestine and kidney was obtained.
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Figure 2.3: Autoradiograms of adjoining sections from Atlantic salmon, after a single oral 
dose of [14C]-phenanthrene (2.5 kBq ∙ g-1 body mass) corresponding to approximately 0.23 µg 
PHE ∙ g-1 body mass (w/w). Sections represent a native section (top), the corresponding 
autoradiogram of the native section (middle) and an adjacent, solvents-extracted section 
(bottom). Bar = 1 cm. White areas correspond to high concentrations of radiolabeled 
compound. Numbers represent the following organs; 1) pyloric caeca, 2) proximal intestine, 
3) distal intestine, 4) liver, 5) gall bladder, 6) kidney, 7) urinary tract, 8) central nervous system. 
A) 3 hours post-feeding a fish oil-based feed. B) 12 hours post-feeding a fish oil-based feed. 
C) 3 hours post-feeding a vegetable oil-based feed. D) 12 hours post-feeding a vegetable oil-
based feed. The autoradiogram of the extracted section in panel A has some artifacts (tape 
stuck on the film) which appear white and should not be misinterpreted as radioactivity 
(illustrated with an asterisk).
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while most of the radioactivity had disappeared after 12 hours with the exception 
of the bile. 
Distinctive differences were observed between BaP and PHE in the extracted 
autoradiograms. After the extraction procedure, the distribution of BaP-associated 
activity in the intestinal tract had not changed, indicating the presence of non-
extractable cellular bound radioactivity. In contrast, BaP-associated radiolabeling 
was almost completely extracted from the bile, except for some activity in the 
gall bladder walls. Only low levels of PHE-associated activity were detected in 
the gallbladder and liver, indicating an almost complete extraction. No apparent 
differences were observed between salmon fed a fish oil or vegetable oil-based diet 
in either the BaP or the PHE group. 
Figure 2.4: mRNA expression 12 hours post-feeding of cyp1a in the pyloric caeca (A), proximal 
intestine (B), distal intestine (C) and the liver (D) of Atlantic salmon acclimatized to a fish oil (black 
symbols) or a vegetable oil-based diet (open symbols) following a single oral dose of benzo[a]
pyrene (BaP) or phenanthrene (PHE). Significant interactions are indicated with a dashed 
line following post-hoc testing with a dotted line. Main effects are indicated with a solid line. 
Significant differences are indicated with; * (p < 0.05), ** (p < 0.01) and *** (p < 0.001).
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Up-regulation of cyp1a expression after BaP administration
Figure 2.4 shows the gene expression level of cyp1a in the pyloric caeca, proximal 
intestine, distal intestine and liver. Of all genes tested (see table 2.2), only the 
expression of cyp1a was significantly up-regulated following exposure to BaP. 
In the distal intestine, the factor “fish oil/vegetable oil” significantly interacted 
(p  = 0.015) with BaP-induced cyp1a expression (Fig. 2.4C). In the proximal intestine 
and liver, BaP exposure resulted in a significantly increased cyp1a expression 
compared to controls. No significant changes in gene expression were observed 
for salmon fed PHE.
Bile metabolites of BaP and PHE
The levels of PAH metabolites in bile (µg OH-PAH ∙ g-1 bile) after diet exposure are 
illustrated in figure 2.5. The concentration of OH-BaP was significantly increased 
12 hours post-feeding in fish fed fish oil (p = 0.007) when compared to the control 
group. Vegetable oil had no significant effect after 3 or 12 hours compared with the 
control group but a significant difference was detected between the 3 and 12 hours 
post-feeding (p = 0.045). After 12 hours the bile had significantly increased OH-PHE 
concentrations in fish fed a fish oil-based diet (p = 0.012) or a vegetable oil-based 
diet (p = 0.006). Between salmon pre-fed a fish oil or vegetable oil-based diet no 
significant differences in OH-BaP (p = 0.10) or OH-PHE (p = 0.06) concentrations 
were observed 12 hours post-feeding.
Figure 2.5: PAH metabolites in bile (µg OH-PAH ∙ g-1 bile). Metabolites were measured in Atlantic 
salmon acclimatized either to a fish oil-based diet (black symbols) or a vegetable oil-based diet 
(open symbols) and 3 and 12 hours after a single oral dose of either benzo[a]pyrene (A; BaP) 
or phenanthrene (B; PHE). Mean values ± SD are shown, n = 3 for BaP and n = 4 for PHE. Letters 
above groups indicate significant differences assessed by a Kruskal-Wallis test. Groups that do 
not share corresponding letters are significantly different from each other (p < 0.05).
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Discussion 
Atlantic salmon showed prominent differences between the intestinal uptake 
and organ distribution after intragastric administration of a single pulse-chase 
dose of BaP and PHE. BaP increased the expression of cyp1a in liver and intestine. 
In addition, the type of dietary fat, viz. fish oil or vegetable oil, altered intestinal 
BaP and PHE uptake and distribution. 
BaP and PHE differences in tissue distribution and metabolism
Twelve hours post-feeding, both BaP and PHE were transported across the 
intestinal tract as evidenced by the increased concentration of radiolabeled 
compounds in liver and bile. Both compounds were still present along the 
entire intestinal tract, although PHE-associated radioactivity concentrations had 
declined in the intestine and were mostly found in bile. The high concentration 
of PHE, and to a lesser extent BaP, in bile and urine are evidence for hepatic and 
renal clearance pathways. Besides excretion of PAHs by bile to the feces, urine is 
also an important excretory pathway for water soluble PAH metabolites in other 
teleost species [115, 189]. 
A similar distribution pattern was observed when BaP was administrated 
intragastrically to channel catfish (Ictalurus punctatus), polar cod (Boreogadus saida) 
or rainbow trout (Oncorhynchus mykiss), where most BaP-associated radioactivity 
was detected in the intestinal tract and bile [6, 91, 106, 172]. Furthermore, oral 
administration of PHE to flounder (Platichthys flesus), polar cod and rainbow trout 
showed comparable results where most of the PHE-associated radioactivity was 
detected in the gall bladder [6, 186, 188]. 
The higher levels of unextractable BaP-associated radioactivity in the intestinal 
mucosa, compared to the extractable PHE-associated radioactivity, indicate 
macromolecule-bound BaP-residues [91, 172]. Cyp1a-mediated metabolism 
of BaP can result in toxic intermediates, such as benzo[a]pyrene-7,8-diol-9,10-
epoxide (BPDE). Epoxide intermediates are very reactive and can bind to cellular 
macromolecules such as proteins or DNA forming adducts that can lead to 
cellular damage [130, 146, 219]. BaP is an aryl hydrocarbon receptor agonist 
[18, 19] and so induces its own metabolism by Cyp1a. BaP caused significant 
up-regulation of cyp1a expression in the proximal intestine, distal intestine and 
liver. This BaP-induced cyp1a expression coincides with macromolecule-bound 
BaP-residues observed in the autoradiograms of intestinal mucosa and liver. 
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Unfortunately, too little sample material was available to assess Cyp1a protein 
levels or ethoxyresorufin O-deethylase (EROD) activity together with cyp1a 
mRNA expression. However, several studies have shown the use of cyp1a mRNA 
expression as marker for elevated Cyp1a protein [114] or EROD activity [116] during 
short-term BaP exposures in fish. The presence of unextractable BaP-associated 
radioactivity could also contribute to the higher BaP concentrations in the pyloric 
caeca, proximal intestine and distal intestine compared to PHE concentrations as 
well as lower BaP bile levels (Table 2.3). Solvent extraction of whole-body sections 
resulted in faint traces of PHE-associated radioactivity. In contrast to BaP, PHE 
does not induce the aryl hydrocarbon receptor and has no effect on cyp1a mRNA 
expression, which is corroborated by our observations and other studies [8, 112]. 
For dietary exposures, the intestine is the first barrier for foodborne PAH uptake and 
plays an important role in PAH metabolism [129]. The lower intestinal metabolism 
of PHE compared to BaP may explain the higher accumulation of PHE in the liver 
and bile, as BaP metabolites can bind to intestinal cellular macromolecules while 
PHE is less extensively metabolized and probably transported faster across the 
intestinal tract, towards the liver and bile. Earlier studies have also emphasized 
the role of intestinal metabolism on intestinal transport of different dietary PAH 
congeners. Accordingly, BaP was metabolized at a faster rate and crossed the 
intestinal barrier slower compared to naphthalene which was absorbed faster but 
less readily metabolized [21]. Furthermore, when pyrene and PHE were incubated 
with intestinal Caco-2 cells, they were less extensively metabolized than BaP but 
transported faster across Caco-2 epithelia [33].
In addition to the intestine, the liver is a main site for phase I and phase II 
biotransformation of dietary PAHs and subsequently excretes the metabolic 
products in the bile of the gall bladder [82, 115, 189]. Metabolites of PAHs in fish 
bile have been extensively used as biomarkers for PAH exposure and studies have 
shown that PAH metabolites in fish bile correlate well with PAH exposure [82, 
107]. Although PAH metabolites in bile mainly consists as conjugates, treatment 
of the bile samples with deconjugation enzymes is stimulated as available 
conjugation standards are poorly available [17]. The total bile concentration of 
PHE was higher than that of BaP (Table 2.3), although the given dose of PHE via 
gavage was lower. The higher PHE compared to BaP bile concentrations could 
probably be explained by the lower fraction of PHE metabolites bound to cellular 
macromolecules in the intestine and liver causing a faster intestinal and hepatic 
transports of PHE. In contrast, OH-BaP metabolite concentrations in the bile were 
higher than OH-PHE metabolite concentrations (Fig. 2.5). In addition, of the total 
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BaP bile concentration, 26% and 14% were OH-BaP metabolites with a fish oil 
and vegetable oil-based feed while the percentage of OH-PHE metabolites was 
only 4.7% and 2.1%, respectively. The higher percentage of OH-BaP metabolites 
in the bile coincides with the increased cyp1a expression and the unextractable 
BaP-associated radioactivity in the liver. Although PHE does not stimulate its 
own biotransformation, metabolites detected in the bile illustrate that PHE is 
metabolized in marine animals [187].
Effects of dietary oil on intestinal uptake of BaP and PHE
In addition to differences in PAH congeners, dietary fat composition also affected 
the intestinal uptake of PAHs in Atlantic salmon. Earlier studies have shown that 
dietary lipids influence intestinal uptake of hydrophobic xenobiotics [48, 110, 221, 
222]. In the intestinal lumen, fatty acids and hydrophobic contaminants disperse 
after lipid hydrolysis into mixed micelles [44, 110, 222], which provide a more 
suitable hydrophobic environment for lipophilic molecules than the aqueous 
lumen [48]. Long fatty acid chains and a high degree of unsaturated bonds 
increase the solubility of PAHs in micelles [44, 110], which can lead to an increased 
intestinal delivery and transfer [44]. Fish oil-based diets have more PUFA’s such as 
eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) 
that have longer fatty acid chains and a higher degree of unsaturated bonds 
than vegetable oil-based diets (Table 2.1). Therefore, this knowledge coincides 
well with the increased BaP and PHE concentrations with a fish oil-based diet in 
the pyloric caeca and proximal intestine, respectively, which are the main sites 
for fatty acid uptake [100, 108, 205]. It seems that fish oil-based feed not only 
contributes to increased intestinal concentrations of BaP but also to increased 
peripheral distribution as indicated by higher organ concentration in spleen. 
In contrast to the increased BaP levels in the pyloric caeca, BaP levels in the distal 
intestine were lower when Atlantic salmon was fed a fish oil-based diet compared to 
a vegetable oil-based diet. Although the distal intestine is not the main site for fatty 
acid uptake, for BaP exposed fish, the type of dietary oil significantly interacted with 
the cyp1a expression, with higher cyp1a expression in fish oil fed fish. The increased 
Cyp1a-mediated metabolism in fish oil fed fish versus vegetable oil fed fish could 
explain the lower intestinal BaP concentrations in the distal intestine in fish fed a fish 
oil-based diet. Indeed, when cyp1a expression was not increased in the pyloric caeca 
after BaP exposure fish oil resulted in increased BaP concentrations. Previous studies 
have shown that BaP metabolism by intestinal cytochrome P450 activity can also be 
induced by fatty acids levels and in particular by PUFAs [230]. When rats were fed a 
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cod liver oil diet that is rich in PUFAs, BaP metabolism by the intestinal cytochrome 
P450 system [80] and epoxide hydrolase activity of BaP [79] were both increased 
compared to BaP metabolism in rats fed a reference corn oil diet rich in saturated 
and mono-unsaturated fatty acids. As no differences were seen in the control group 
of this experiment between fish fed a fish oil-based diet or a vegetable oil-based 
diet, this could indicate that PUFAs have an additional stimulating effect on cyp1a 
expression in the presence of BaP [81].
In addition to the effects of dietary fat, other contaminants than BaP could also have 
induced the intestinal cytochrome P450 system in the fish oil fed fish. Earlier studies 
have shown that cyp1a expression is increased when multiple cyp1a inducers were 
introduced in combination with BaP, such as polyhalogenated aromatic hydrocarbons 
(PHAHs), dioxin-like polychlorinated biphenyls (PCBs) and polychlorinated dibenzo-
p-dioxins and furans (PCDD/F) [185, 190]. Fish oil is well known to contain elevated 
levels of dioxins and dioxin like-PCBs with an aryl hydrocarbon receptor affinity that 
induce Cyp1a activity [15]. In the present trial, the sum of dioxin and dioxin-like PCBs 
was 2.7 pg WHO2005-Toxic Equivalence Quotient (TEQ) ∙ g-1 for the fish oil-based diets 
and 0.43 pg WHO2005-TEQ ∙ g-1 for the vegetable oil-based diets. However, long-term 
trials with Atlantic salmon fed diets containing similar levels of dioxins and dioxin-like 
PCBs (2.31 pg WHO2005-TEQ ∙ g-1) or decontaminated feeds (0.54 pg WHO2005-TEQ ∙ g-1) 
showed no significant differences in hepatic cyp1a expression [15]. The stimulating 
effects on BaP metabolism by the cytochrome P450 in combination with higher 
levels of PUFA’s and the background level of dioxin-like components in fish oil-based 
feed could explain the significantly higher cyp1a expression in the distal intestine in 
salmons fed a fish oil-based diet compared to salmon fed the same level of spiked 
BaP in a vegetable oil-based feed. Fish oil induced metabolism is likely to reduce 
distal BaP intestinal concentrations by increasing the transfer into the systemic 
circulation or/and excretion to the intestinal lumen via cellular efflux transporters 
[217].
Conclusions
Dynamics and distinctions between uptake and metabolism are complex integrated 
processes, which make it difficult to distinguish dynamics in the present in vivo 
experiment. Nonetheless, this experiment shows that fish oil increases BaP and PHE 
concentrations in the pyloric caeca and proximal intestine respectively, compared to 
vegetable oil-based feed. This is probably due to a lower solubility of PAHs in micelles 
that consist of shorter vegetable oil fatty acid chains lengths and have a lower 
degree of unsaturated bonds compared to fish oil fatty acids. In addition, it has to be 
44
2
Intestinal uptake and tissue distribution of BaP and PH
E
taken into account that replacement of fish oil with vegetable oil is likely to increase 
feed PAH levels and so increase their relative intestinal accumulation. Conversely, 
vegetable oil increased BaP concentrations in the distal intestine compared to fish 
oil-based feed, which is most likely due to a lower degree of BaP metabolism in 
vegetable oil fed fish. In the intestinal part with no BaP induced metabolism, (i.e., 
pyloric caeca), BaP behaved as PHE with elevated levels when fish were fed fish oils 
compared to vegetable oils. 
The partial replacement of fish oils by vegetable oils in aquafeeds increase PAH 
concentrations in feed to farmed salmon. This study showed that fish oil could 
lead to an increased intestinal delivery and transfer of PAHs. In addition, vegetable 
oils could increase the intestinal transfer time by decreasing Cyp1a-mediated 
metabolism causing a decreased PAH metabolism. Further long-term feeding trials 
have to investigate the effects of aquafeed oil blends on the intestinal PAHs uptake 
and metabolism.    
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Chapter 3
The polycyclic aromatic hydrocarbons benzo[a]pyrene and 
phenanthrene inhibit intestinal lipase activity in rainbow trout 
(Oncorhynchus mykiss)
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Abstract
Elevated levels of polycyclic aromatic hydrocarbons (PAHs) are detected in 
aquafeeds where fish oils are (partially) replaced by vegetable oils. The highly 
lipophilic PAHs solubilize readily in oil droplets and micelles in the intestinal 
lumen that can affect enzymatic lipid digestion by altering lipase activity. 
We therefore investigated the effect of two PAHs, benzo[a]pyrene (BaP) and 
phenanthrene (PHE), on bile salt-activated lipase (BAL) activity in desalted luminal 
extracts of the proximal intestine of rainbow trout (Oncorhynchus mykiss) using 
the triacylglycerides rapeseed oil and fish oil as substrates. 
The hydrolysis of rapeseed oil and fish oil measured at a calculated substrate 
concentration of 2.2 mM, increased linearly up to 30 min at 15 °C. Substrate 
dependency under initial velocity conditions was described by simple Michaelis-
Menten kinetics with a Km value of 1.2 mM for rapeseed and fish oil. Rapeseed oil 
hydrolysis was inhibited by 1 nM BaP and 10 nM PHE. The hydrolysis of fish oil was 
only inhibited by 10 µM BaP. The in vitro lipase activity data were corroborated by 
TLC/HPLC analysis of the reaction products, showing that in the presence of BaP 
and PHE, 46-80% less free fatty acids (FFA) were hydrolyzed from rapeseed and 
fish oil triacylglycerides. 
The presence of low concentrations of BaP and PHE decreased rapeseed oil 
hydrolysis by BAL whereas fish oil hydrolysis was not affected. The replacement 
of fish oil by rapeseed oil in aquafeeds introduces PAHs that could affect lipid 
digestion.
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Introduction
Traditionally, marine fish oils and fishmeal have been used as main fish ingredients 
in aquafeeds. However, the rapidly growing aquaculture sector cannot continue 
to rely on the limited supply of fish ingredients. Hence, fish oil and fishmeal in 
aquafeeds are more and more replaced with ingredients from plant origin [59, 158, 
199]. The inclusion of vegetable ingredients in aquafeeds, however, introduced 
polycyclic aromatic hydrocarbon (PAH) congeners, including benzo[a]pyrene 
(BaP) and phenanthrene (PHE) in Atlantic salmon (Salmo salar) tissue [13, 14, 16]. 
PAHs are ubiquitous lipophilic organic contaminants composed of two or more 
fused aromatic rings. These contaminants are mostly formed due to incomplete 
combustion or pyrolysis of organic matter [134]. In aquafeeds, PAHs are formed 
by thermal processing of oil-containing seeds and grains during toasting or gas 
drying [135, 157, 202]. The diet contributes substantially to PAH exposure with 
cereals, vegetable fats and oils being the principal culprits [157]. Concern about 
these contaminants has been due to the carcinogenic, mutagenic/genotoxic and 
other toxic effects induced by PAHs [52].
After oral ingestion, the lipophilic nature of PAHs promotes their solubilization 
in oil droplets and mixed micelles in the intestinal lumen [97, 104, 160] where 
it can potentially interfere with lipase activity and lipid digestion. Luminal entry 
of emulsified lipids stimulates the exocrine pancreas and gall bladder to secrete 
digestive lipases and bile juice, respectively, in the intestinal lumen [147, 205]. In 
many teleost species, the exocrine pancreas is distributed diffusely around the 
gastrointestinal tract and secretes its enzymes into the lumen of the pyloric caeca 
and/or proximal intestine [5]. Biliary components (e.g., bile salts and cholesterol) 
spontaneously form mixed micelles with free fatty acids (FFA) and, to a lesser 
extent, with mono-, di- and triacylglycerides [5, 156, 224, 231]. 
Two key lipolytic enzymes are secreted by the exocrine pancreas in mammals, 
viz. bile salt-activated lipase (BAL) and pancreatic lipase [223]. Lipases hydrolyze 
ester bonds in triacylglycerides, phospholipids, cholesterylesters and fat-soluble 
vitamins. In mammals, pancreatic lipase is the most important digestive lipase. In 
fish, however, BAL is considered to be the most important digestive lipase [22, 23, 
71, 147, 170, 197, 205]. BAL has a broad substrate specificity, is highly dependent 
on bile salts to be catalytically active and is more efficient in hydrolyzing 
polyunsaturated fatty acids (PUFAs), which are abundant in the diet of marine 
and freshwater fish [35, 70, 223]. 
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The lipid composition of micelles can affect the solubility of PAHs. Indeed, PAHs 
have a higher solubility in micelles composed of unsaturated long-chain fatty 
acids compared to saturated short-chain fatty acids [44, 110] whereas solubility 
in micelles composed of long-chain triacylglycerides is often low [160]. Fish 
oil is an important source of n-3 unsaturated long-chain fatty acids such as 
eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) 
[12, 182]. Rapeseed oil is mainly used as a substitute for fish oils and contains 
high levels of oleic acid (ca. 60%; 18:1n-9) and moderate levels of linoleic acid 
(ca. 20%; 18:2n-6) and saturated short-chain fatty acids (Table 3.1). The different 
lipid compositions of rapeseed oil and fish oil are thus likely to affect PAH levels in 
micelles and, hence, influence lipase activity.
The objective of the present study was to investigate the effects of BaP and PHE 
on the lipolytic activity of lipase in rainbow trout (Oncorhynchus mykiss) using 
rapeseed oil and fish oil as substrates. 
Materials and Methods
Animals
Rainbow trout (Oncorhynchus mykiss) with a body weight of 429 ± 78 g (mean ± SD) 
were obtained from a commercial hatchery ‘Keijzersberg’ in Blitterswijck, the 
Netherlands. Fish were kept at 15.0  ±  0.5 °C in an indoor recirculating system 
containing 575 L (input of 1 L fresh tap water per min) of biofiltered and UV-
treated Nijmegen tap water. Trout were fed a commercial fish feed (Optiline trout, 
3.0 mm, Skretting, Utah, USA) with an automated feeder at 9.30 and 16.30 hour at 
a ration of 2% of the estimated body weight per day.
Previous studies showed that six hours post-feeding feed was mainly located 
in the proximal intestine in Atlantic salmon weighing 200  g [41]. Therefore, to 
ensure access to intestinal luminal contents, rainbow trout were anaesthetized 
six hours post-feeding in 0.1% (v/v) 2-phenoxyethanol (Sigma, St. Louis, USA) and 
euthanized by spinal transection caudal of the opercula. Experimental design 
obeyed Dutch legislation and was approved by the ethical review committee of 
Radboud University (RU-DEC 2012-315). 
Preparation of BAL extracts
As the exocrine pancreas is made up of diffuse tissue in between the pyloric 
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caeca, the best way to collect pancreatic enzymes such as BAL is by collection of 
luminal contents. The peritoneal cavity was opened and the proximal intestine, 
defined as the section directly posterior of the pyloric caeca to the beginning 
of the distal intestine, recognized by its darker appearance and annulo-spiral 
septa, was dissected and placed in a Petri dish on ice. All subsequent steps were 
performed at 0 - 4 °C. Visceral fat was removed, the proximal intestine was opened 
longitudinally and the luminal contents were gently extruded and suspended in 
four volumes (w/v) ice-cold 100 mM phosphate buffer containing 2.5% aprotinin 
and 0.1 mM PMSF, pH 7.5. All chemicals were purchased from Sigma-Aldrich Co, 
St Louis, U.S.A. unless mentioned otherwise. Samples were centrifuged at 10000 g 
for 10 min at 4  °C. The lipid layer was aspirated from the surface of the supernatant 
after which the supernatant was collected and designated as crude BAL extract. 
Crude BAL extracts were desalted overnight at 4 °C by dialysis (Tube-O-Dialyzer, 
MWCO 4000 Da, G-Biosciences St Louis, U.S.A.) against 100 mM phosphate 
buffer to remove endogenous bile salts. Protein concentrations of the desalted 
BAL extracts were measured by spectrophotometry with a Coomassie Brilliant 
Olive oil 1 Fish oil 2 Rapeseed oil 2
14:0 0.3 6.7 0.4
16:0 9.7 11.7 5.7
18:0 3.2 1.0 1.7
Sum saturates 13.7 20.4 9.1
16:1n-7 0.7 8.0 0.6
18:1n-7 1.5 3.4 3.2
18:1n-9 73.9 11.2 53.6
20:1n-9 0.7 17.1 2.1
22:1n-11 0.7 13.3 1.0
Sum monoenes 77.5 57.1 61.1
18:2n-6 5.9 3.5 19.5
20:2n-6 - 0.2 -
20:4n-6 - 0.3 -
Sum n-6 5.9 4.1 19.5
18:3n-3 0.5 1.1 8.6
18:4n-3 - 2.8 0.2
20:4n-3 - 0.4 -
20:5n-3 0.3 5.9 0.7
22:5n-3 - 0.4 -
22:6n-3 0.6 4.6 1.0
Sum n-3 1.4 15.8 10.6
Table 3.1: Fatty acid composition (area percentage of total fatty acids) of various diets containing 
100% of the different oil sources. Table was adapted from 1 Bell et al. (1999) and 2 Torstensen et al. 
(2004).
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Blue reagent kit (Bio-Rad, München, Germany) using bovine serum albumin as a 
reference, and diluted to 1.0 mg protein ∙ mL-1 unless mentioned otherwise.
Validation of the modified titrimetric assay 
Lipase activity was assessed with a modified titrimetric assay [78] by measuring 
the decline in pH following lipid hydrolysis. Lipase activity can be assessed in a 
volumetric assay as described by Gotthilf (1974), in which the fatty acids liberated 
from the triacylglyceride substrate are titrated with NaOH. To prevent dilution of 
substrate and enzyme concentrations in the incubate by the addition of NaOH 
titrant, the initial decrease in pH of the incubate was measured with a sensitive 
pH electrode (GK2401C Radiometer Analytical, Villeurbanne Cedex, France) 
connected to a pH meter (CG-842 Schott Geräte GmbH, Mainz, Germany). 
All assay media were mechanically stirred, pre-warmed for 10 min and maintained 
at the designated temperature. The modified titrimetric assay was validated 
with a substrate emulsion containing 11% (final assay concentration: 35 mM) 
commercially available olive oil and 89% gum Arabic (10% w/v) that was added 
to assay medium containing 30 mM sodium taurocholate and 32 mM NaCl. Olive 
oil is a generally used substrate to measure lipase activity and known for its high 
levels of monounsaturated fatty acids and deficiency in n-3 unsaturated long-
chain fatty acids [83]. The assay medium was completed with substrate emulsion, 
assay medium and dH2O (3:3:2.9 v/v). The medium was adjusted to exactly pH  9.0 
with 0.1 or 0.01 M NaOH and maintained at pH 9.0 for 8 min to stabilize gum 
Arabic. After 8 min, porcine pancreatin (4 x United States Pharmacopeia (U.S.P.) 
specifications; 8.0 units lipase ∙ mg pancreatin-1), dissolved in 300 µL assay medium 
was added as a source of lipase. The pH was readjusted to 8.0 with NaOH, the 
volume was adjusted with dH2O to 9.3 mL and the change in pH was measured. 
Samples were measured in triplicate, measured pH values were recalculated to a 
H+ concentration, corrected for non-enzymatic fatty acid formation by subtracting 
measurements on heat-inactivated samples (boiled for 10  min at 100 °C) and 
normalized for the total assay volume and protein content of the incubate. The 
recalculated H+ activity was interpreted to be equivalent to one released proton 
(H+) per liberated FFA by lipase [78]. The liberation of FFA by lipase activity was 
expressed as pmol FFA per min per mg protein. 
The time course of lipase activity by porcine pancreatin with 35  mM olive oil 
as substrate is well described by a single first-order exponential rate equation 
(Fig. 3.1A). Data points converged well on a linearization of the single exponential, 
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indicative of one active component in pancreatin lipase activity. Olive oil 
hydrolysis was linear up to 40 µg pancreatin ∙ mL-1 (Fig. 3.1B). All further validation 
experiments were performed with 6.5 µg pancreatin ∙ mL-1. Linearity of olive oil 
hydrolysis was observed at pHs 7.5, 8 and 8.5 up to 10 min (Fig. 3.1C), hence we 
chose an incubation time of 2 min to measure initial hydrolysis rates in all further 
experiments with porcine pancreatin. Optimal pH for porcine pancreatic lipase was 
7.5 (Fig. 3.1D). However, as the time course was no longer linear at pH 7.0, pH 8.0 
was chosen for all further experiments to allow a wider pH range over which pH 
could decrease. Optimal lipase activity was observed around 40 °C (Fig. 3.1E). The 
initial hydrolysis rate with olive oil was best described by a substrate inhibition 
model with a substrate inhibition constant (Ki) of 5.7 mM olive oil (Fig. 3.1F). Pre-
incubation of porcine pancreatin for one hour with 10 nM of the lipase inhibitor 
orlistat decreased olive oil hydrolysis by 40%.
Trout intestinal lipase activity
Lipase activity was assayed as previously described with some small modifications. 
Briefly, all media were cooled to 15 °C and maintained at this temperature during 
the assay as this resembles the ambient temperature of our laboratory stock and 
that of feral rainbow trout (11-18 °C). A volume of 0.1 mL substrate emulsion 
containing 11% (final assay concentration: 2.2 mM) olive oil, fish feed graded 
rapeseed oil (Emmelev AS, Denmark) or fish oil (Norsildmel, Norway) and 89% gum 
Arabic was added to 4.4 mL assay medium (final concentration: 20 mM sodium 
taurocholate and 32 mM NaCl). Assay conditions were 100 µg desalted BAL extracts 
of Oncorhynchus mykiss and 20 mM bile salt (taurocholate) [22]. The solution was 
adjusted to exactly pH 9.0 and after 8 min 100 µL (1 mg protein ∙ mL-1) desalted BAL 
extract was added. The pH was readjusted with NaOH, the volume was adjusted to 
5.0 mL with dH2O and the decline in pH was measured. The assay with desalted BAL 
extracts was optimized for time and substrate dependency with olive oil, rapeseed 
oil and fish oil. Initial hydrolysis rates were measured in a 30 min incubation time 
unless mentioned otherwise. Under these assay conditions less than 1% of the 
substrate was hydrolyzed. Olive oil was used as substrate to validate lipase activity 
in BAL extracts. The time course of lipase activity in desalted BAL extracts with 
2.2 mM olive oil was well described by a single first-order exponential rate equation 
and the logarithmic transformed data points converged well on a linearization of 
the single exponential. The calculated rate constant and limit were 0.015 min-1 and 
1352 pmol ∙ mg protein-1, respectively. Substrate dependency at t = 30 min showed 
characteristic single-site Michaelis-Menten kinetics with calculated Michaelis 
constant (Km) value of 0.5 mM and a Vmax of 11.8 pmol ∙ mg protein-1 ∙ min-1.
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Lipase activity in the presence of PAHs
Stock solutions of 100 mM BaP and PHE were prepared in acetone (propan-2-one). 
A preliminary test confirmed that a final assay concentration of 0.1% acetone had 
no effect on lipid hydrolysis in desalted BAL extracts of the proximal intestine of 
Oncorhynchus mykiss (data not shown). Due to their non-polar, lipophilic nature, 
PAHs adsorb strongly to labware surfaces. Previous studies have shown that 
untreated glass vials had the highest recovery and lowest adsorption of PAHs [42]; 
therefore glass vials were used for all experiments. The substrate emulsion was 
pre-incubated for 2 min with BaP or PHE prior to addition to the assay medium. 
The effect of BaP and PHE on rapeseed and fish oil hydrolysis was assessed at the 
established Km values of the oil substrates (i.e., 1.2 mM). Final assay conditions 
were: 100 µg BAL extract, 1.2 mM rapeseed or fish oil, pH 8.0 at 15 °C and measured 
at t = 30 min at initial rate. At t = 30 a sample of 1 mL was immediately frozen in 
liquid nitrogen and stored at −80 °C for lipid class analysis. 
Lipid class analysis
Lipids were extracted from the samples by adding 750 µL of a chloroform–
methanol mixture (2:1 v/v) to 60 µL of the assay medium after which the solution 
was vortexed. Then, 250 µL chloroform and 250 µL ddH2O were added and again 
vortexed thoroughly [20]. The samples were then filtered on a vacuum block 
in 10 mL reservoirs with a paper filter. The reservoirs are rinsed twice with a 
chloroform:methanol mix (2:1 v/v). The filtered samples were collected and dried 
in a RapidVap (Labconco, MO, USA). Lipid class composition was determined 
using high-performance thin layer chromatography analysis as described by 
[87].  Briefly, samples were re-suspended in chloroform to an approximate lipid 
Figure 3.1: Optimization of the pH-drop assay with olive oil as substrate and porcine pancreatin 
as lipase source. A) Time course of lipase activity with 36 mM olive oil as substrate, 25 µg porcine 
pancreatin ∙ mL-1 at pH 9.0. Data were fitted to a single exponential equation with a calculated 
limit and a rate constant of 2567 pmol FFA ∙ mg protein-1 and k = 0.044 min-1, respectively. 
The inset shows linearization of the single exponential equation, indicative of a single site 
substrate. B) Effect of increasing porcine pancreatin concentrations ranging from 4 to 40 µg 
pancreatin ∙ mL-1 at t = 5 min. C) Effect of pH on enzyme activity. D) Lipase activity at pH values 
from 6 to 11. E) Temperature dependence at temperature values from 10 to 60 °C. F) Substrate 
dependent hydrolysis. The kinetic parameters derived from this curve are: maximum hydrolysis 
rate Vmax is 3402 pmol FFA ∙ mg protein-1 ∙ min-1, Km is 22.4 mM olive oil and a substrate inhibition 
constant (Ki) of 5.7 mM olive oil. G) Inhibition of lipase activity with 2.4 mM olive oil by Orlistat. 
Orlistat significantly decreased olive oil hydrolysis by 40% (ANOVA with Dunnett’s multiple 
comparison test). Points represent experimental data (mean ± SEM; n = 3 and n = 5 for the 
orlistat experiment). Due to the small sample size (n = 3) and the relatively large standard errors 
no sensible 95% CIs could be calculated.
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concentration of 0.1 mg ∙ mL-1 based on the weight of the dried sample. To silica 
plates (20 x 10 cm), 1 µL chloroform was applied 1 cm from the bottom and polar 
lipids were separated in methyl acetate:isopropanol:chloroform: methanol and 
0.25% (w/v) aqueous KCl (25:25:25:10:9, v/v). After drying the TLC plates, neutral 
lipids were separated in isohexane:diethyl ether:acetic acid (80:20:1.5, v/v). Lipid 
classes were visualized by charring at 160 °C for 15 min after spraying with 3% 
copper acetate (w/v) in 8% phosphoric acid (v/v) and identified by comparison 
with commercially available standards. Lipid classes were quantified by scanning 
densitometry (CAMAG TLC Scanner 3) and calculated using an integrator (WinCATS-
Planar Chromatography manager, Version 1.2.0). Mono- and diacylglycerides were 
below the limit of quantification (< 0.1 mg ∙ g sample-1), hence all data are given as 
triacylglycerides or FFA (as area percentage of total lipid content).
Analysis and statistics
The molarities of olive oil, rapeseed oil and fish oil were calculated based on the 
molecular weight of the most abundant FFA covalently bound to glycerol per oil. 
The density of olive oil, rapeseed oil and fish oil was calculated from the weights of 
50 mL oil that were 0.911, 0.914 and 0.918 kg ∙ L-1, respectively. The most prevalent 
FFA (i.e., oleic acid) esterified to glycerol in olive oil gave an average triacylglyceride 
molecular weight of 885.4 g ∙ mol-1. The average triacylglyceride molecular weight 
in rapeseed and fish oil was 882.8 and 903.5 g ∙ mol-1, respectively. With the 
average molecular weights and density, the molarity of olive oil, rapeseed oil and 
fish oil was calculated to be 1.03, 1.04 and 1.02 M, respectively. 
Enzyme kinetic data were analyzed using weighted non-linear regression 
procedures in the statistical programming language R (version 3.3.1) [162] where 
the Gauss-Newton algorithm for least squares estimation of parameters was 
employed. For each data point the SEM was used as an explicit weighting value. 
A Kolmogorov-Smirnov normality test revealed that data points in all groups 
followed a normal distribution. Time courses were fitted to a single first-order rate 
equation:
where p represents the liberated FFA (pmol FFA ∙ mg protein-1) by lipase, Limit 
(pmol ∙ mg protein-1) represents the uptake at time (t) approaching ∞, and k is a 
first-order rate constant (min-1). The FFA liberated by lipase was log-transformed 
to check for a systematic deviation from a single first-order rate equation by:
[1]
[2]
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Initial hydrolysis rates approaching t = 0 min were calculated from the slope of the 
tangents of the time course by solving dp/dt at t = 0 min. 
Initial hydrolysis rates of lipase activity were fitted to a simple Michaelis-Menten 
equation:
where v0 is enzyme initial rate (pmol FFA ∙ mg protein-1 ∙ min-1), [S] is the substrate 
concentration (mM), Vmax is the maximum rate (pmol ∙ mg protein-1), and Km is 
the Michaelis constant (mM). When a simple Michaelis-Menten equation did 
not describe the data adequately, a substrate inhibition function containing the 
Michaelis-Menten equation plus an inhibition constant (Ki; mM) was used [38]. 
Calculated model parameters were compared using Akaike’s information criterion 
(AIC) and the best fitting (ANOVA, p ≤ 0.05) and the most parsimonious model 
was chosen. Statistical significance was therefore evaluated with a one-way 
ANOVA followed by Bonferroni’s or Dunnett’s multiple comparison test, where 
appropriate. Results were considered statistically significant when p < 0.05 (two-
tailed) and indicated with; * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
Results
Addition of 20 mM bile salt (taurocholate) to desalted BAL extracts from luminal 
trout contents significantly increased lipid hydrolysis by 300% compared to crude 
and desalted BAL extracts (ANOVA; p < 0.001). Heat inactivated samples had no 
hydrolytic activity (Table 3.2).
[3]
Table 3.2: The effects of bile salt (taurocholate) on the hydrolysis of olive oil (pmol FFA ∙ mg protein-1 ∙ 
min-1) in crude and desalted BAL extracts from the proximal intestine of rainbow trout. Measurements 
were corrected for rising acidity by subtracting control incubations (heat inactivated samples). 
Mean values ± SD; n = 5. Different superscript letters indicate significant differences (Student’s t-test 
with Bonferroni’s post-hoc test; p < 0.001). 
BAL extract Bile salt FFA release (pmol FFA ∙ mg protein-1 ∙ min-1)
Average SEM
Control 20 mM 0.2 ± 0.1
Crude - 2.5 ± 0.5 a
Desalted 0 mM 3.7 ± 0.5 a
Desalted 20 mM 15.5 ± 1.5 b
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Substrate dependency at initial hydrolysis rates showed characteristic single-
site Michaelis-Menten kinetics for rapeseed and fish oil (Fig. 3.3). The calculated 
Michaelis constant (Km) value was 1.2 mM for rapeseed as well as for fish oil. 
Proceeding from these observations, a concentration of 1.2 mM rapeseed and fish 
oil was chosen to assess the effects of BaP and PHE on lipase activity. 
Both PAHs inhibited the hydrolysis of rapeseed oil where BaP was 10-fold more 
potent than PHE (Fig. 3.4). Rapeseed oil hydrolysis had significantly decreased by 
40% in the presence of 0.001 µM BaP(p < 0.01) and by 55% with 0.01 µM PHE 
(p < 0.01) compared to the control incubation (0 µM BaP or PHE). Interestingly, only 
the highest BaP concentration significantly inhibited fish oil hydrolysis by 50% 
(p < 0.05). Unfortunately, since BaP has a low solubility in an aqueous environment, 
the effect of BaP on lipase activity with concentrations higher than 10 µM could 
not be measured.
The time course of rapeseed and fish oil hydrolysis by BAL extracts proceeded linearly 
up to 30 min (Fig. 3.2A). The hydrolysis of rapeseed and fish oil is well described by a 
single first-order exponential rate equation (Fig. 3.2B) with calculated rate constants 
of 0.01 and 0.008  min-1, respectively. The calculated limit for lipid hydrolysis at a 
substrate concentration of 2.2 mM was practically similar for rapeseed and fish oil 
(i.e., 918 and 1186 pmol FFA ∙ mg protein-1). The initial hydrolysis rates calculated 
at t = 0 min were 9.2 and 9.0 pmol FFA ∙ min-1 ∙ mg protein-1 for rapeseed and fish 
oil, respectively. Data points converged on a linearization of the single exponential, 
indicative of a single substrate site reflecting a single lipase entity. 
Figure 3.2: Time course of rapeseed oil (open symbols) and fish oil (closed symbols) hydrolysis by 
BAL extracts of the proximal intestine of rainbow trout (n = 5, mean ± SEM). Time kinetics are well 
described by a single exponential equation. Calculated parameters for rapeseed oil hydrolysis 
were: Limit = 918 pmol ∙ mg protein-1 (95% CI [842, 994]), k = 0.010 min-1 [0.008, 0.011] and for 
fish oil hydrolysis: Limit = 1186 pmol ∙ mg protein-1 [1106, 1265], k = 0.008 min-1 [0.007, 0.009]. B) 
Linear logarithmic transformation, indicative of one active component in lipid hydrolysis. 
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TLC/HPLC analyses of the reaction products corroborate the in vitro lipase activity 
data. Without PAHs, approximately 85% of the total lipid content consisted of FFA 
after rapeseed and fish oil hydrolysis (Table 3.3). TLC/HPLC analyses showed that 
the hydrolysis of rapeseed as well as fish oil was inhibited by 0.001 µM BaP and 
0.01 µM PHE whereas the hydrolysis of fish oil measured with the in vitro lipase 
assay was only significantly inhibited by 10 µM BaP. In the presence of 0.001 µM 
BaP, 50% of the lipid content consisted of triacylglycerides and FFA after fish oil 
hydrolysis. Rapeseed oil hydrolysis was inhibited by 80% by 0.001 µM BaP as only 
17% FFA were liberated by lipase activity. Similar to BaP, 0.01 µM PHE inhibited 
FFA liberation from triacylglycerides in rapeseed and fish oil by 55%.
Figure 3.3: Substrate dependence of 
lipase activity measured at initial rate in 
BAL extracts of the proximal intestine 
of rainbow trout (n = 5, mean ± SEM). 
The hydrolysis of rapeseed and fish oil 
are described by Michaelis-Menten 
kinetics. Calculated values for rapeseed oil 
hydrolysis were Km = 1.2 mM (95% CI [0.5, 
1.9]) and Vmax = 8.4 pmol ∙ mg protein-1 [7.3, 
9.5]. Calculated values for fish oil hydrolysis 
were Km = 1.2 mM [0.6, 1.7] and Vmax = 11.1 
pmol ∙ mg protein-1 [9.4, 12.8]. 
Figure 3.4: Hydrolysis of rapeseed oil (open symbols) and fish oil (closed symbols) in the presence 
of BaP (A) and PHE (B) by desalted BAL extracts of the proximal intestine of rainbow trout (n = 6, 
mean ± SEM). Experimental incubations are compared to the control incubation (0 µM PAHs) 
with an ANOVA with Dunnett’s multiple comparison test. 
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Discussion
The lipophilic PAHs, BaP and PHE inhibit rapeseed oil hydrolysis by BAL in rainbow 
trout. This effect depends on the substrate’s oil composition, as the hydrolysis of 
fish oil was largely insensitive to PAHs compared to rapeseed oil. The established 
inhibitory concentrations of BaP and PHE are in the range of 0.3 to 2 µg · L-1, and are 
comparable with detected BaP and PHE concentrations of 1.0 and 17 µg · kg-1 in 
aquafeeds [14]. Therefore, we speculate that the occurrence of PAHs in aquafeeds 
by partial replacement of fish ingredients by vegetable ingredients could decrease 
lipid digestion in vivo. This could result in decreased intestinal fatty acid uptake 
and have a negative impact on organismal energy metabolism.
This study provides support for the notion that BAL is the prominent lipase 
in rainbow trout as the addition of bile salts (i.e., taurocholate) considerably 
increased lipase activity in desalted BAL extracts [89, 123, 223]. Linearization of 
the data points of the single exponential from rapeseed and fish oil hydrolysis 
illustrated a single catalytic component in the BAL extracts, reflecting a single 
lipase entity. This indicates that there was no contamination by other lipases (e.g., 
bacterial lipases) than BAL. In Atlantic salmon, rainbow trout and Atlantic cod 
(Gadus morhua) bile salts also stimulated lipase activity [22, 71, 117, 203]. BAL is 
able to hydrolyze water-soluble lipid substrates composed of short-chain fatty 
acids. However, BAL requires activation by bile salts to hydrolyze mono-, di- and 
triacylglycerides, cholesteryl esters, phospholipids, lysophospholipids, ceramides 
and fat-soluble vitamins [90, 132, 223]. It is presumed that bile salts interact with 
two sites on BAL’s tertiary structure to activate the protein. One site protects BAL 
from proteolysis and promotes binding to the surface of lipid emulsions while the 
other site causes a conformational change after bile salt binding that exposes the 
active site of the enzyme [90, 109, 132]. Crude luminal extracts prepared 6 hours 
post-feeding displayed similar lipase activities as desalted extracts without bile 
salts. The capability of BAL to hydrolyze short-chain fatty acids without bile salts 
might explain the low lipase activity in the desalted extracts [90, 223].
Table 3.3: Lipid class composition (area percentage of total lipid content) of triacylglycerides and 
FFA after rapeseed and fish oil hydrolysis in the presence of 0.001 µM BaP and 0.01 µM PHE by 
desalted BAL extracts of the proximal intestine of rainbow trout (n = 2, mean ± SD).
Rapeseed oil Fish oil
0 µM PAH 1 nM BaP 10 nM PHE 0 µM PAH 1 nM BaP 10 nM PHE
Triacylglycerides (%) 16 ± 5 83 ± 6 65 ± 6 8 ± 2 50 ± 5 56 ± 1
FFA (%) 85 ± 5 17 ± 6 35 ± 6 92 ± 2 50 ± 5 44 ± 1
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To validate whether the initial decrease in pH of the incubate coincides with an 
increased FFA concentration, TLC/HPLC was used to quantitatively measure FFA 
liberation from triacylglycerides. The TLC/HPLC analysis confirms the yield of FFA 
following the incubation of a lipid substrate with a BAL extract and the inhibitory 
effect of BaP and PHE on rapeseed oil hydrolysis. The data also showed inhibition of 
fish oil hydrolysis by both PAHs, an effect that was not detected with the in vitro pH 
assay. We have to note that TLC/HPLC measures the total lipid content, including 
the 6-12% FFA already present in native fish oil before hydrolysis, whereas the in 
vitro pH assay measures the decline in pH resulting from FFA newly liberated from 
the lipid substrate. Since the BAL extracts were prepared in a phosphate buffer, 
some hydronium ions will be buffered and not detected with the pH electrode. 
These technicalities likely result in some overestimation of the TLC/HPLC outcome 
that might explain the different results obtained from TLC/HPLC and the in vitro 
pH assay.
Dietary lipids and their digestion products, such as FFA, interact with lipophilic 
contaminants in their intestinal uptake and luminal transfer [41, 44, 49, 77, 110, 
221, 222]. When PAHs enter the gastrointestinal tract, micelles can facilitate 
luminal transfer across the unstirred water layer towards the brush border 
membrane of enterocytes [44, 110]. The solubility of lipophilic contaminants is 
higher in micelles composed of unsaturated long-chain fatty acids compared to 
saturated short-chain fatty acids [44, 110]. Fish oil contains more PUFAs that have 
longer fatty acid chains and a higher degree of unsaturated bonds than rapeseed 
oil (Table 3.1). This fact coincides well with the more potent inhibition of rapeseed 
oil hydrolysis by both PAHs. Since micelles composed of rapeseed oil have a 
lower partitioning of PAHs compared to fish oil-composed micelles, more PAHs 
would be freely available to inhibit lipase activity. The relative resistance of fish 
oil hydrolysis to PAHs is likely due to the increased partitioning of PAHs in fish oil-
composed micelles leaving less PAHs free to directly interact with lipases.
Triacylglyceride hydrolysis in the intestinal lumen is necessary as intact 
triacylglycerides cannot cross the intestinal brush border membrane [68, 69]. 
Double knock-out C57BL/6 mice lacking pancreatic lipase and BAL displayed a 40% 
reduction in dietary triacylglyceride absorption compared with wild type C57BL/6 
mice under high fat/high cholesterol dietary conditions [69]. The inhibition of 
lipase activity by BaP and PHE also results in a functional lipase deficiency, and 
would likely reduce lipid digestion leading to higher luminal lipid contents as 
triacylglycerides cannot cross the intestinal brush border membrane. In a lipid-
rich diet less lipophilic compounds are absorbed by the intestinal epithelium, 
62
probably because higher luminal lipid contents reduce their bioavailability [42, 
103]. Oral administration of PCBs and chlorobenzenes in goldfish (Carassius auratus) 
or PCB 136 in female C57BL/6 mice decreased intestinal uptake of these lipophilic 
contaminants with increased dietary lipid content [77, 103]. Furthermore, increasing 
the lipid content of a diet with a mixture of non-absorbable long-chain fatty acid 
bonded by ester links to sucrose (Olestra) also increased fecal excretion of lipophilic 
compounds [67, 96, 136, 139]. Although both BaP and PHE are absorbed along the 
entire teleost intestinal tract into the systemic circulation following gavage [6, 41, 
189], transmembrane uptake of BaP, in intestinal brush border membrane vesicle 
preparations of rainbow trout, decreases in the presence of high EPA and oleic acid 
concentrations [42]. Therefore, the inhibited hydrolysis of rapeseed oil by BaP and 
PHE could aid in decreasing intestinal PAH uptake from vegetable-based aquafeeds 
as a decreased lipid digestion elevates luminal lipid contents. In a previous study, 
we have observed that a vegetable (rapeseed) oil-based diet decreased intestinal 
BaP and PHE concentrations in vivo in Atlantic salmon compared to a fish oil-based 
diet [41]. This decrease in intestinal PAH uptake might be an effect initiated by the 
more potent inhibition of rapeseed oil hydrolysis by BaP and PHE. Since a decreased 
lipase activity could reduce intestinal lipid absorption and therefore maintain high 
luminal lipid contents, this could lead to a decreased PAH bioavailability [42, 69, 
103]. In contrast, BaP and PHE did not inhibit fish oil hydrolysis. Therefore, luminal 
lipid contents shall decrease following lipid digestion and intestinal FFA uptake, 
which increases intestinal PAH uptake [42].
Conclusion 
This study has shown that BaP and PHE inhibit rapeseed oil hydrolysis in vitro. 
Substitution of fish oils by vegetable oils in aquaculture increases aquafeed 
levels of BaP and PHE. Therefore, the inclusion of vegetable oils could result in 
a decreased lipase digestion and subsequently a decreased intestinal fatty acid 
uptake which ultimately could negatively impact organismal energy metabolism. 
In vegetable-based aquafeeds more PAHs would be freely available to inhibit 
lipase activity as PAHs have a lower solubility in micelles that consist of shorter 
vegetable oil fatty acid chains lengths and have a lower degree of unsaturated 
bonds compared to fish oil fatty acids. Contrary, micelles composed of fish oil 
have a higher PAH solubility and decrease PAH partitioning in the intestinal 
lumen, leaving less PAHs free to directly interact with lipases and maintain lipase 
activity. Therefore, the fatty acid and lipid composition of an alternative aquafeed 
is an important determinant for lipid digestion and should be a considered in the 
development of novel sustainable aquafeeds. 
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Chapter 4
Uptake of benzo[a]pyrene, but not of phenanthrene, is 
inhibited by fatty acids in intestinal brush border membrane 
vesicles of rainbow trout (Oncorhynchus mykiss)
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Abstract
Partial replacement of fish ingredients with vegetable ingredients has elevated 
levels of polycyclic aromatic hydrocarbons (PAHs) in Atlantic salmon reared on 
these feeds. PAH uptake in the intestinal tract is postulated to occur in association 
with lipid absorption and could well be affected by fatty acid composition. 
We therefore investigated the effects of a fish oil and vegetable oil fatty acid, 
eicosapentaenoic acid (EPA; 20:5n-3) and oleic acid (18:1n-9) respectively, on the 
uptake of benzo[a]pyrene (BaP) and phenanthrene (PHE) across the intestinal 
brush border membrane in the salmonid species rainbow trout (Oncorhynchus 
mykiss). 
BaP and PHE were solubilized in micelles composed of either EPA or oleic acid 
and administrated to isolated brush border membrane vesicles (BBMV) derived 
from the pyloric caeca, proximal intestine and distal intestine. In the absence 
of free fatty acids (FFA), transmembrane uptake of BaP and PHE was 2-7 times 
lower than the fraction associated to or in the membrane. In the presence of 
FFA, transmembrane BaP uptake had decreased by 80 and 40% at the highest 
EPA and oleic acid concentration, respectively, whereas PHE uptake was virtually 
unaffected. In the presence of BaP, but not PHE, transmembrane EPA uptake in 
BBMV had decreased. 
This study obtained evidence for PAH-dependent interactions with FFA uptake. 
In conclusion, intestinal BaP uptake is reduced by luminal FFA contents whereas 
PHE uptake is not. A large fraction of the administrated BaP and PHE remains 
associated with the cellular membrane of enterocytes and may interfere with 
uptake of nutrients. 
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Introduction
The steadily growing aquaculture industry has resulted in an increased pressure 
on limited available aquafeed ingredients, viz. fish oils and fishmeal [24, 59, 199]. 
The requirement of sustainable aquafeeds in aquaculture has led to the partial 
replacement of fish ingredients by vegetable ingredients. As of 2013, the diet of 
cultured Atlantic salmon (Salmo salar) consists of less than 30% of fish ingredients 
while approximately 56% is composed of vegetable ingredients [232]. Rapeseed 
oil is mainly used as a substitute for fish oils, but small amounts of palm oil and 
soybean oil are also used [198]. Rapeseed oil contains ca. 60% oleic acid (18:1n-9) 
and ca. 20% linoleic acid (18:2n-6), whereas fish oil is rich in n-3 long-chain 
polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA; 20:5n-3) 
and docosahexaenoic acid (DHA; 22:6n-3). 
With the introduction of vegetable oils into aquafeeds, elevated levels of 
lipophilic contaminants were detected that have not been associated in Atlantic 
salmon farming before [13, 16]. Vegetable oil obtained from oil producing 
seeds and grains contained polycyclic aromatic hydrocarbons (PAHs), which are 
mostly formed due to the incomplete combustion of organic matter by so-called 
toasting or gas drying [135, 157, 202]. As a consequence, the use of vegetable 
oil in aquafeeds introduces PAH congeners, including benzo[a]pyrene (BaP) 
and phenanthrene (PHE), in Atlantic salmon reared on these diets [14]. PAHs are 
ubiquitous lipophilic non-persistent organic compounds that are potentially 
toxic [16]. BaP consists of five fused benzene rings, is highly lipophilic (octanol/
water partition coefficient, log Kow = 6.3) while PHE has three fused benzene rings 
and is less lipophilic (log Kow = 4.5).
The first barrier for dietary PAH uptake is the mucosa of the intestinal tract. 
Although the exact mechanisms have not been elucidated yet, intestinal 
transport and uptake of lipophilic organic compounds such as PAHs have been 
suggested to occur in association with fat absorption [47, 48, 77, 104, 221]. A lipid-
dependent uptake mechanism is suggested in which lipophilic compounds are 
absorbed from the intestinal tract with lipids during digestion and membrane 
transport [222]. Emulsified lipids are hydrolyzed by digestive lipases to yield free 
fatty acids (FFA), monoacylglycerides and, after complete digestion, glycerol [5, 
147, 205]. 
Biliary components (e.g., bile salts and cholesterol) together with FFA, and, to lesser 
degrees, mono-, di- and triacylglycerides form micelles (hereafter referred to as 
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micelles) [5, 156, 224, 231]. These micelles can enhance absorption of lipophilic 
compounds in enterocytes by facilitating transport of e.g., monoacylglycerides, 
FFA, fat-soluble vitamins and lipophilic compounds across the unstirred water 
layer which is positioned directly adjacent to the brush border membrane 
of enterocytes [44, 48, 104, 221, 222]. Despite the low solubility of lipids and 
lipophilic compounds in an aqueous environment, micelles greatly increase their 
aqueous concentrations [156]. Solubility of lipophilic compounds depends on 
the lipid composition of micelles [44, 110]. Besides micelle-mediated transport 
of lipophilic compounds, bile salts also facilitate the transport of PAHs across the 
unstirred water layer to the brush border membrane in the absence of lipids [226]. 
The transfer of PAHs from micelles might occur via a vesicular-mediated uptake 
process or via direct absorption following a collisional mechanism. Once micelles 
arrive at the brush border membrane, monoacylglycerides, FFA and lipophilic 
xenobiotics are released and can then be absorbed across the apical membrane 
of enterocytes [160].
 
The interactions of lipids with the uptake of lipophilic compounds has led to 
the suggestion that increased lipid consumption affects the bioavailability of 
PAHs [77]. In previous in vivo studies, a fish oil-based diet increased intestinal 
delivery and transfer of PAHs to the systemic circulation [41]. The objective of the 
present study was to investigate whether the uptake of PAHs at the first step of 
intestinal uptake in rainbow trout, at the apical brush border membrane of the 
enterocyte, is affected by two different fatty acids, i.e., EPA and oleic acid, from fish 
and vegetable origin, respectively. To reliably measure the first step of intestinal 
uptake it is necessary to isolate the apical brush border membrane in a purified 
homogenous preparation. 
Materials and Methods
Animals
Rainbow trout (Oncorhynchus mykiss) weighing 200 to 600 g were obtained from 
a commercial hatchery (Keijzersberg, Blitterswijck, the Netherlands) and kept in 
an indoor recirculating system with a tank volume of 575 L. Water was aerated, 
biofiltered and UV-treated with an input of 1 L fresh tap water per min. Water 
temperature was kept at 15.0 ± 0.5 °C (mean ± S.D.). Trout were fed a commercial 
fish feed (Optiline trout, 3.0 mm, Skretting, Utah, USA) with an automatic feeder at 
9.30 and 16.30 h at a ration of 2% of the estimated body weight per day. Rainbow 
trout were sacrificed in the morning by a single blow to the head one hour pre-
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feeding. Experimental design followed Dutch legislation and was approved by 
the local ethical review committee (RU-DEC 2012-315). 
Isolation of intestinal brush border membrane vesicles
Collection and isolation of brush border membrane vesicles (BBMV) was based 
on protocols described by Pelletier et al. (1986), Klaren et al. (1993) and Glover et 
al. (2003). Following euthanasia, the peritoneal cavity of two rainbow trout was 
opened and the intestinal tract was removed and placed on a Petri dish on ice. 
All subsequent steps were performed at 0-4 °C. Visceral fat was removed and the 
intestinal tract was divided in three sections; the pyloric caeca, proximal intestine 
and distal intestine. The proximal intestine was defined as the section directly caudal 
from the pyloric caeca to the beginning of the distal intestine, which is recognized 
by its larger diameter, darker appearance and annulo-spiral septa. All intestinal parts 
were flushed with ice-cold saline containing 150 mM NaCl, 1 mM dithiothreitol 
(DTT), 0.5  mM ethylene glycol tetraacetic acid (EGTA) and 10 mM HEPES/Tris at 
pH 7.4. All chemicals were purchased from Sigma-Aldrich Co, St Louis, USA, unless 
stated otherwise. Thirty caeca of the pyloric caeca, the proximal intestine and distal 
intestine were cut open lengthwise and rinsed with the same saline and blotted on 
tissue paper to remove excess fluid and mucus. The mucosa (< 2.0 g wet weight) 
of each intestinal segment from both fish was scraped off its underlying muscle 
layers with the aid of two glass microscope slides and pooled into one preparation. 
Scrapings were disrupted in a glass Dounce homogenizer by 25 strokes of a loosely 
fitting pestle (type A) in 35  mL homogenization buffer. Scrapings of the pyloric 
caeca and proximal intestine were disrupted in a buffer containing 50 mM mannitol, 
2 mM EGTA, 0.5 mM Mg2SO4, 0.1 mM phenylmethanesulfonyl-fluoride (PMSF), and 
10 mM HEPES/Tris at pH 7.4. Scrapings of the distal intestine were disrupted in 
a buffer containing 320  mM sucrose, 0.5 mM Mg2SO4, 0.1 mM PMSF and 10 mM 
HEPES/Tris at pH 7.4. The homogenates were centrifuged (Sorvall® RC 26 Plus 
centrifuge, SS-34 rotor) for 15 min at 1400 x g (K factor = 25708). The resulting pellet 
consisted of a white ‘fluffy’ top layer and sometimes with a firm brownish bottom 
layer. The white ‘fluffy’ top layer was aspirated and suspended in 30 mL of a buffer, 
containing 320 mM sucrose and 10 mM HEPES/Tris at pH 7.4. This suspension was 
again homogenized in a glass Dounce homogenizer by 25 strokes of a tightly fitting 
pestle (type B) after which solid MgCl2 was added to a final concentration of 10 mM. 
The homogenate was mildly inverted once and slowly shaken for 15 min. The 
suspension was centrifuged for 10 min at 20200 x g (K factor = 1779), the supernatant 
was collected and again centrifuged for 20 min at 43500 x g (K factor = 826). The 
pellet containing the brush border membranes was resuspended by 30 passages 
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through a 23-G needle in 200-300 µL assay buffer (150 mM KCl and 10 mM HEPES/
Tris at pH 7.4). Occasionally, the pellet of the proximal intestine sedimented as a thin 
layer along the length of the centrifugal tube. In this case the scattered pellet was 
resuspended and centrifuged for 20 min at 43500 x g to obtain a compact pellet. 
The total isolation procedure lasted ca. 3.5 hours and experiments started within 
one hour after isolation.
Characterization of brush border membrane vesicle preparations
Protein concentrations of the membrane preparations were measured by 
spectrophotometry with a Coomassie Brilliant Blue reagent kit (Bio-Rad, München, 
Germany) using bovine serum albumin as a standard. Marker enzymes used to 
characterize the membrane preparations were alkaline phosphatase (EC 3.1.3.1) 
[63] and maltase (EC  3.2.1.20) [40] for brush border membranes, Na+/K+-ATPase 
(EC  3.6.1.3) [63] for basolateral membranes, and succinate dehydrogenase (SDH, 
EC  1.3.99.1) [63] and β-D-glucuronidase (EC  3.2.1.31) [62] for mitochondrial 
and lysosomal contamination, respectively. Membrane preparations were pre-
incubated with 0.4 mg saponin  ∙ mg protein-1 for 5 min at 37 °C to permeabilize 
BBMV and unmask latent enzyme activity. 
Data on enrichment and recovery of marker enzymes of the three intestinal 
preparations are presented in Table 4.1. Our preparations are enriched in BBMV 
as evidenced by purification in maltase and enrichment factors of 11, 9 and 6 for 
alkaline phosphatase in BBMV derived from the pyloric caeca, proximal and distal 
intestine, respectively. Membranes were not contaminated with mitochondria and 
only slightly with lysosomes. Contamination of basolateral membranes could not be 
determined as Na+/K+-ATPase activity was not detectable in the initial homogenate 
and membrane preparation. The enrichment and recovery of the marker enzymes 
correspond to those of other studies using rainbow trout and tilapia [73, 105, 152]. 
To determine the membrane orientation of vesicles, alkaline phosphatase activity in 
untreated preparations was compared to activity in saponin-treated preparations. 
The proportion of correctly orientated vesicles (i.e., right-side-out) was calculated 
as the ratio of alkaline phosphatase activity in permeabilized to untreated brush 
border membrane preparations. This analysis revealed 95.1 ± 1.9%, 99.8 ± 0.3% and 
86.6 ± 6.1% right-side-out orientated vesicles (n = 3) in the pyloric caeca, proximal 
and distal intestinal preparations, respectively. These high percentages of resealed 
right-side-out vesicles are consistent with observations in other intestinal BBMV 
isolated from other fish species [73, 105]. 
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Measurement of intravesicular space 
Intravesicular space was determined according to Flik et al. (1990). BBMV were 
diluted to 0.3 mg protein ∙ mL-1 in mannitol buffer containing 150 mM NaCl, 
100 µM D-mannitol labeled with 100 kBq  ∙  mL-1 D-[1-14C]-mannitol (1.85 MBq, 
Table 4.1: Enrichment and relative recoveries of marker enzyme activities in membrane preparations 
of three intestinal segments, the pyloric caeca, proximal intestine and distal intestine (mean ± 
SEM) Na+/K+-ATPase activities were not detected (N.D.) in the initial homogenate or brush border 
membrane preparation.
Pyloric caeca
Marker enzyme Enrichment a Recovery b (%) n
Alkaline phospathase 11.6 ± 1.1 6.7 ± 0.9 19
Maltase 5.7 ± 0.6 2.6 ± 0.2 8
Na+/K+-ATPase N.D.
Succinate dehydrogenase 0.9 ± 0.4 0.4 ± 0.1 4
β-D-Glucuronidase 2.2 ± 0.9 0.9 ± 0.3 5
Protein - 0.6 ± 0.1 19
Proximal intestine
Marker enzyme Enrichment a Recovery b (%) n
Alkaline phospathase 9.5 ± 1.5 7.4 ± 1.1 20
Maltase 10.5 ± 2.6 3.3 ± 0.9 7
Na+/K+-ATPase N.D.
Succinate dehydrogenase 1.1 ± 0.5 0.2 ± 0.1 4
β-D-Glucuronidase 2.9 ± 0.6 1.2 ± 0.3 5
Protein - 1.1 ± 0.2 20
Distal intestine
Marker enzyme Enrichment a Recovery b (%) n
Alkaline phospathase 6.4 ± 0.7 4.8 ± 0.9 20
Maltase 8.4 ± 2.8 3.9 ± 1.5 7
Na+/K+-ATPase N.D.
Succinate dehydrogenase 1.1 ± 0.2 0.6 ± 0.1 4
β-D-Glucuronidase 2.0 ± 0.2 1.2 ± 0.3 5
Protein - 0.8 ± 0.1 20
a. Enrichment of membrane preparations was calculated as the ratio of the specific activities in the 
BBMV preparations to the initial homogenate. 
b. Recovery was calculated as the percentage of the total activity (specific activity * total protein) in 
the BBMV preparations to the initial homogenate. 
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PerkinElmer Inc, Massachusetts, USA) and 10 mM HEPES/Tris at pH 7.4 and 
pre-incubated for 30  min at 16 °C. Samples were quenched in 1 mL ice-cold 
stop buffer (150 mM NaCl, 2 mM D-mannitol and 10 mM HEPES/Tris at pH 7.4), 
and then filtered over an 80  kPa vacuum filtration manifold (Merck Millipore 
Corporation, Darmstadt, Germany) using glass microfiber filters with a pore size of 
0.7 µm (VWR International, Amsterdam, the Netherlands). The filters were rinsed 
three times with 2.5 mL ice-cold stop buffer (150 mM NaCl, 100 µM D-mannitol) 
transferred to 6-mL polyethylene vials (PerkinElmer Inc, Massachusetts, USA) and 
dissolved in 4 mL liquid scintillation cocktail (Optiphase Hisafe 3TM, PerkinElmer 
Inc, Massachusetts, USA). For every assay three 15-µL aliquots were withdrawn 
to determine the specific activity (dpm · mol-1) of the radiotracer. Radioactivity 
(dpm) was measured in 3H and 14C channels in a liquid scintillation counter (Tri-
Carb® 2900TR, PerkinElmer Inc, Massachusetts, USA). Radioactivity count rates 
were divided by the specific activity of the radiotracer and normalized for the 
protein content of the incubate; uptake was expressed as mol substrate per mg 
membrane protein. All samples were measured in duplicate and corrected by 
subtracting blank values (no BBMV present in the incubate). 
The intravesicular space, calculated from the equilibrium mannitol content after 
120 min (16 °C), was calculated to be 1.0 ± 0.3 µL  ∙ mg protein-1 (mean ± SEM, 
n = 4) in the pyloric caecal membrane preparations, 3.3 ± 0.8 µL ∙ mg protein-1 
in the proximal intestinal and 1.9 ± 0.9 µL ∙ mg protein-1 in the distal intestine 
membrane preparations, respectively.
Uptake and membrane association of PAHs with fatty acids
Stock solutions of 2 mM EPA or oleic acid were prepared fresh daily in assay 
buffer (10 mM sodium taurocholate, 150 mM KCl and 10 mM HEPES/Tris at 
pH 7.4). Micelles were formed by sonication in a water bath for 20 min [151]. 
BBMV were diluted to 0.3 mg  protein  ∙  mL-1 in assay buffer, to which 1 µM 
[7-14C]BaP (26.6 mCi ∙ mmol-1; American Radiolabeled Chemicals, St Louis, USA) or 
1 µM [9-14C]PHE (52 mCi ∙ mmol-1; Larodan Fine Chemicals AB, Malmö, Sweden) and 
0, 10, 100 or 1000 µM unlabeled fatty acid (EPA or oleic acid) was added. Similar 
radioactivity concentrations of [3H]EPA (100 mCi ∙ mmol-1; Campro scientific, 
Berlin, Germany) or [9,10-3H]oleic acid (60 Ci ∙ mmol-1; Campro scientific, Berlin, 
Germany) were added to the designated experiments as BaP or PHE. PAH uptake 
could not be measured without the addition of bile salts as PAHs have a very 
low solubility in an aqueous environment without a detergent. Incubations were 
carried out at 16 °C, as this resembles the ambient temperature of our laboratory 
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stock and that of feral rainbow trout (11-18 °C) [74, 75]. All assay buffers were pre-
cooled 30 min before incubation. 
Pilot experiments showed that PAHs and FFA associated very quickly, within 
seconds, with the BBMV in the incubate. Incubating at 0 °C did not resolve this. 
We therefore chose to measure transmembrane substrate uptake as the amount 
of substrate released from BBMV following perturbation of the vesicular space 
by detergent treatment. Transmembrane uptake in BBMV was assessed by 
disruption of the vesicular membrane with saponin, releasing PAH and FFA from 
the intravesicular space. BBMV were loaded with PAHs and FFA for 30 min and 
sampled, after which saponin was added. Five min later the substrate content 
of the BBMV was again sampled. The difference in radioactivity is the amount 
of substrate released from an intravesicular space and is interpreted to reflect 
transmembrane uptake. Samples (100 µL) were measured in duplicate at 0, 30 
and 35 min. Blank incubations were carried out with water as a substitution for 
BBMV. Samples (75 µL) were filtered, rinsed three times with 2.5 mL ice-cold stop 
buffer (150 mM KCl and 10 mM HEPES/Tris at pH 7.4), dissolved in 4 mL liquid 
scintillation cocktail (Ultima Gold FTM, PerkinElmer Inc, Massachusetts, USA) and 
counted as described above. 
Disturbance of the osmotic space and temperature dependence
To detect the most suitable membrane disrupting agent, pyloric caeca BBMV 
were incubated with assay buffer (10 mM sodium taurocholate, 150 mM KCl, 
100 µM D-mannitol labeled with 100 kBq  ∙  mL-1 D-[1-14C]-mannitol and 10 mM 
HEPES/Tris at pH 7.4) for 125 min at 0, 16 and 37 °C. After 120 min, the samples 
were incubated with either 0.4 mg saponin  ∙ mg protein-1 or 0.1% Triton X-100 
and allowed to incubate for 5 min to permeabilize the BBMV. Saponin induced 
the release of mannitol from the intravesicular space (Fig. S4.1), whereas Triton 
X-100 permeabilized the BBMV to such an extent that no membrane protein 
was retained by the glass microfibers filters as assessed by a Coomassie Brilliant 
Blue protein staining (data not shown). Therefore, saponin was chosen as the 
membrane-disrupting agent in our experiment. In the intravesicular space of 
BBMV, 150 pmol mannitol ∙ mg protein-1 was absorbed at 0 and 16 °C after 120 min, 
whereas no uptake was detected at 37 °C (Fig. 4.1). A similar uptake of mannitol 
was observed at 0 and 16 °C in studies with BBMV of rainbow trout [73]. Therefore, 
16 °C was used for all experiments. 
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Passive adsorption and manipulation of PAHs
Due to their non-polar, lipophilic nature, PAHs adsorb strongly to labware surfaces. In 
a preliminary test the adsorption of PAHs to polystyrene, polypropylene, glass vials 
and glass vials etched with hydrofluoric acid or silanized with dichloromethylsilane 
were assessed. One µM [7-14C]BaP or 1 µM [9-14C]PHE was dissolved in assay buffer, 
incubated for 60 min at 16 °C and sampled at 0, 30 and 60 min. Samples (100 µL) 
were added to 6-mL polyethylene vials containing 4 mL liquid scintillation cocktail 
(Ultima Gold FTM, PerkinElmer Inc, Massachusetts, USA). All vials and pipette tips 
used were washed 3 times with 100 µL methanol to rinse off PAHs. Radioactivity 
count rates were divided by the specific activity of the radiotracer to calculate total 
radionuclide adsorption (mol) to the vials and pipette tips. Our measurements 
showed that untreated glass vials had the highest recovery and lowest adsorption 
of PAHs (data not shown), therefore glass vials were used for all experiments.
Statistics 
The effects of different concentrations of EPA and oleic acid on transmembrane 
uptake and membrane partitioning of PAHs in BBMV from different intestinal 
segments were analyzed using multilevel linear models in the statistical 
programming language R (version 3.2.3) [162]. In brief, fixed and random intercept 
models predicting the relative PAH or FFA concentration from the intercept were 
created for each section of the intestine. The models produced were compared to 
each other using log likelihood tests and the best fitting (ANOVA, p < 0.05) and most 
parsimonious model was chosen for further analyses in which the concentration 
and type of fatty acid were added as predictors. Statistical significance was 
accepted at p < 0.05. A comprehensive overview of all models created and all 
Figure 4.1: Mannitol uptake (pmol ∙ mg 
protein-1) on the left y-axis and 
intravesicular space (µL ∙ mg protein-1) 
on the right y-axis in brush border 
membrane vesicles (BBMV) of the 
pyloric caeca. BBMV were incubated 
at 0, 16, and 37 °C for 120 min and 
an additional 5 min incubation with 
saponin to disrupt the vesicular 
membrane and release of mannitol. 
Bars represent experimental data 
(mean values ± SEM; n = 6 for 0, 16 °C 
and n = 4 for 37 °C).
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parameters determined is presented in the supplementary information (Table 
S4.1 – S4.6). Data were checked for homogeneity of variance by D’Agostino–
Pearson normality test. A Student’s t-test was performed to analyze differences in 
the total PAH content of BBMV without FFA. Duplicate measurements were found 
to be stable as they differed by 16.4 ± 0.9% (mean ± SEM). Due to inter-sample 
heterogeneity  (138.7 ± 33.9%) data were not pooled. 
Results
Table 4.2 shows that the total BaP content of BBMV was 3-5 times higher (p < 0.001) 
in every intestinal segment compared to the total PHE content. In the absence of 
FFA, 12-42% of the total BaP and PHE content was released from the intravesicular 
space after perturbation of the intestinal brush border membrane with saponin, 
indicating uptake of BaP and PHE across the membrane. A large fraction remained 
associated to or in the saponin-treated membrane and was 2-7 times greater than 
the fraction released from the intravesicular space. 
BaP as well as PHE, solubilized in micelles, were absorbed across the intestinal 
brush border membrane into the intravesicular space (Fig. 4.2). Transmembrane 
BaP uptake had significantly decreased (p ≤ 0.015) by 80 and 40% at the highest 
EPA and oleic acid concentration, respectively, compared to BaP uptake in the 
absence of FFA (Fig. 4.2A-C). In the distal intestinal preparations, EPA was 3.5 times 
more potent than oleic acid in inhibiting transmembrane BaP uptake (p < 0.040). 
This pattern was observed in all three intestinal preparations, although not 
Table 4.2: Total benzo[a]pyrene (BaP) and phenanthrene (PHE) content in brush border membrane 
vesicles derived from the pyloric caeca, proximal intestine and distal intestine (mean ± SEM; n = 16). 
Vesicles were incubated with 1 µM BaP or PHE in the absence of eicosapentaenoic acid (EPA) and 
oleic acid. The fractions of BaP and PHE that were released from the intravesicular space upon 
membrane perturbation with saponin, and the fractions that remained associated to, or in, the 
brush border membrane after detergent treatment are given in percentages.
BaP Pyloric caeca Proximal intestine Distal intestine
Total BaP (nmol ∙ mg protein-1) 0.57 ± 0.05 1.00 ± 0.05 0.54 ± 0.06
Intravesicular space (%) 32 ± 4 18 ± 3 42 ± 5
Membrane-associated (%) 68 ± 4 82 ± 3 58 ± 5
PHE Pyloric caeca Proximal intestine Distal intestine
Total PHE (nmol ∙ mg protein-1) 0.14 ± 0.03 0.29 ± 0.03 0.09 ± 0.03
Intravesicular space (%) 12 ± 4 14 ± 5 28 ± 7
Membrane-associated (%) 88 ± 4 86 ± 5 72 ± 7
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Figure 4.2: Trans-membrane uptake of 1  µM benzo[a]pyrene (BaP) and phenanthrene (PHE) 
(nmol ∙ mg protein-1) as measured by detergent treatment of brush border membrane vesicles, 
isolated from the pyloric caeca (A, D), proximal intestine (B, E) and distal intestine (C, F). BaP and 
PHE were administered solubilized in micelles composed of 10 mM bile salts + 0, 10, 100 and 
1000 µM eicosapentaenoic acid (EPA; closed symbols, solid lines) or oleic acid (open symbols, 
dashed lines), as indicated on the x-axes. The top panels (A-C) represent BaP uptake, the bottom 
panels (D-F) PHE uptake (mean values ± SEM; n = 8). 
statistically significant in the pyloric caeca (p = 0.23) and proximal intestine 
(p = 0.28). In contrast to BaP uptake, transmembrane PHE uptake was unaffected 
by oleic acid (Fig. 4.2D-F) and PHE uptake solubilized in EPA micelles was virtually 
undetectable. All regression model parameters for transmembrane BaP/PHE 
uptake and effects of FFA are presented in the supplementary information (Table 
S4.1 – S4.6).
Similarly to the PAHs, EPA and oleic acid were absorbed across the intestinal 
border membrane into the intravesicular space of BBMV (Fig. 4.3). In the presence 
of BaP, transmembrane EPA uptake was significantly lower when 1000 µM EPA 
was administrated to the BBMV compared to 1000 µM oleic acid in all intestinal 
segments (Fig. 4.3A-C; p ≤ 0.011). The decreased EPA uptake coincides with 
the decreased transmembrane BaP uptake. Interestingly, in the presence of 
PHE, transmembrane uptake of EPA and oleic acid increased concentration-
dependently in the pyloric caeca and proximal intestine, with an overall higher 
uptake of oleic acid (Fig. 4.3D-E; p < 0.001). In contrast to transmembrane uptake 
of oleic acid, EPA uptake did not increase dose-dependently in the distal intestine 
(Fig.  4.3F). The increased transmembrane uptake of EPA and oleic acid had no 
effect on transmembrane PHE uptake. 
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Figure 4.3: Transmembrane uptake of eicosapentaenoic acid (EPA) and oleic acid (nmol ∙ mg 
protein-1) as measured by detergent treatment of brush border membrane vesicles (BBMV), 
isolated from the pyloric caeca (A, D), proximal intestine (B, E) and distal intestine (C, F) in the 
presence of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE). EPA and oleic acid were 
administered in the form of micelles composed of 10 mM bile salts and 10, 100 or 1000 µM EPA 
(closed symbols, solid lines) or oleic acid (open symbols, dashed lines). The top panels (A-C) 
represent free fatty acid uptake in the presence of BaP, the bottom panels (D-F) in the presence 
of PHE (mean values ± SEM; n = 8).
Figure 4.4: Partitioning of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE) (nmol ∙ mg 
protein-1) to or in the brush border membrane after detergent treatment of brush border 
membrane vesicles, isolated from the pyloric caeca (A, D), proximal intestine (B, E) and distal 
intestine (C, F). BaP and PHE were administered solubilized in micelles composed of 10 mM bile 
salts and 10, 100 or 1000 µM eicosapentaenoic acid (EPA; closed symbols, solid lines) or oleic 
acid (open symbols, dashed lines), as indicated on the x-axes. The top panels (A-C) represent 
BaP partitioning, the bottom panels (D-F) PHE partitioning (mean values ± SEM; n  =  8). 
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As opposed to transmembrane BaP uptake, the partitioning of BaP in or to 
the membrane was practically unaffected by FFA (Fig. 4.4A-C). Only oleic acid 
significantly decreased the membrane-associated BaP by 40% (p = 0.001) when 
1000 µM oleic acid was administrated to BBMV derived from the proximal 
intestine. The partitioning of PHE in or to the membrane was unaffected by FFA 
(Fig. 4.4D-F), as it was for transmembrane PHE uptake. 
Discussion
Prominent differences were seen between transmembrane uptake of BaP and PHE 
across the intestinal brush border membrane of rainbow trout. In the presence of 
FFA, transmembrane BaP uptake decreased but not that of PHE. Bile salts aid in 
the uptake of PAHs along the intestinal tract. Similar results were seen for channel 
catfish (Ictalurus punctatus) intestine where BaP uptake had decreased when 
solubilized in micelles composed of triacylglycerides and FFA compared to when 
only bile salts were present [226]. Unfortunately, the uptake of PAHs without the 
addition of bile salts could not be measured as PAHs have a very low solubility in 
an aqueous environment without a detergent. 
The transmembrane PHE uptake was 4-fold lower compared to BaP. As PHE is less 
lipophilic (log Kow 4.5 vs. 6.31) and has a smaller molecular size than BaP, differences 
can be expected in PAH uptake across the intestinal brush border membrane into 
the intravesicular space of BBMV. In a number of different vertebrate species, 
including fish, it has been reported that dietary uptake is less efficient for extreme 
lipophilic compounds [47, 76, 104]. Diffusion through the unstirred water layer 
would be a rate-limiting step for high-Kow compounds whereas diffusion through 
the phospholipid bilayer is rate-limiting for low-Kow compounds [104]. In our 
brush border membrane preparation, however, the unstirred water layer is most 
likely lost during the isolation procedure [61]. This would remove the rate-limiting 
step for BaP transport and could have led to the higher transmembrane uptake 
of BaP compared to PHE. In contrast to BaP, the less lipophilic PHE does not seem 
to leave the apical phospholipid bilayer of BBMV after associating to or into it. 
Phospholipids that form the bilayer structure of cell membranes are favorable 
sites for partitioning of lipophilic organic compounds such as PAHs [120, 161] and 
could affect the membrane fluidity and ultimately lead to abnormal enterocyte 
and gut architecture [233]. Besides partitioning to the brush border membrane, 
multiple in vivo studies have shown that following intragastric administration, 
BaP as well as PHE are absorbed along the entire teleost intestinal tract into the 
systemic circulation [6, 41, 189]. In contrast to the present BBMV model system, 
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other studies with intact CaCo-2 enterocytes showed a higher transcellular 
uptake of PHE compared to BaP [32, 33] which emphasizes the role of intestinal 
drug metabolism by the cytochrome P450 family (Cyps) on intestinal transport of 
different dietary PAH congeners [41]. In the present BMMV model, drug metabolism 
could only have a minor effect on PAH uptake, as Cyps are mainly located on the 
membrane of the endoplasmic reticulum and the inner mitochondrial membrane 
of cells [45, 174] that are removed during the isolation of BBMV. 
EPA and oleic acid, administered as micelles, decreased transmembrane BaP 
uptake in BBMV in all sections of the intestinal tract. In analogy, a high-fat diet 
decreased intestinal uptake of orally administrated lipophilic compounds (PCBs 
and chlorobenzenes) in goldfish (Carassius auratus) and PCB 136 in adipose tissue 
of female C57BL/6 mice [77, 103]. Subsequently, fecal excretion of PCB 136 had 
increased in female mice in the highest fat diet [103]. Increasing the lipid content 
of a diet with a mixture of non-absorbable long-chain fatty acid bonded by ester 
links to sucrose (Olestra) also increased fecal excretion of lipophilic compounds 
[67, 96, 136, 139]. In a lipid-rich diet, less lipophilic compounds are absorbed 
via the intestinal tract, probably because a higher luminal fat content reduces 
bioavailability of lipophilic compounds. The reduced bioavailability of lipophilic 
compounds with increasing fat content coincides with the more potent inhibition 
of BaP uptake when administrated in micelles composed of EPA compared to 
oleic acid. Because transmembrane uptake of EPA was considerably lower than 
that of oleic acid in BBMV, a higher ambient EPA concentration and thus higher 
lipid content can reduce BaP bioavailability and uptake [103].
In contrast to this study, in primary hepatocytes of Atlantic salmon EPA uptake 
was significantly higher than oleic acid uptake [235]. However, when primary 
hepatocytes were pre-incubated with phloretin, EPA uptake was significantly 
more inhibited than oleic acid uptake (80 vs. 30% inhibition compared to control 
uptake). Phloretin inhibits the Na+/glucose co-transporter and has shown to 
partially inhibit fatty acid uptake in different model systems [125, 167, 235]. 
This suggests that FFA uptake is driven by passive diffusion as well as via a 
transmembrane transporter dependent on a Na+ gradient and that EPA uptake 
is more dependent on membrane-bound protein mediated uptake than oleic 
acid [235]. In this brush border membrane model FFA are translocated across the 
membrane alike PAH and the observed interactions likely occur at the level of 
transmembrane uptake. Transmembrane uptake of FFA and PAHs in the present 
study is most likely driven by passive diffusion, as no external chemical energy 
source (i.e., ATP) or electrochemical or osmotic gradient was provided. Therefore, 
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the significantly lower transmembrane EPA uptake could be due to the higher 
protein-mediated uptake of EPA compared to oleic acid.
Micelle-mediated uptake is thought to enhance the absorption of lipophilic 
compounds in enterocytes by facilitating movement across the unstirred water 
layer towards the brush border membrane of enterocytes [44, 48, 104, 221, 222]. 
Once lipophilic compounds arrive at the brush border membrane, possible 
mechanisms for transmembrane uptake encompass passive diffusion, carrier 
mediated (facilitated) passive transport and/or (primary or secondary) active 
transport. Gobas et al. (1993) postulated that passive diffusion is the principal 
transmembrane uptake route when dietary uptake rates and absorption 
efficiencies of lipophilic compounds decrease with increasing lipid content in 
consumed food. Conversely, if an increased lipid content results in a higher uptake 
and absorption efficiencies of lipophilic contaminants then transmembrane 
uptake would be mainly facilitated by micelles [77, 104]. The fugacity theory, which 
states that lipophilic compounds flow occurs from a high fugacity compartment 
to a low fugacity compartment, was used to explain transmembrane uptake of 
lipophilic compounds [77, 104]. These authors hypothesized that the decreased 
uptake of lipophilic compounds by dietary fat is driven by passive diffusion 
because lipid absorption concentrates lipophilic compounds in the intestinal 
lumen and creates a lipid-generated fugacity gradient from the gut lumen towards 
the gastro-intestinal tract for lipophilic compounds [77]. The present study 
showed that the presence of micelles did not facilitate transmembrane uptake 
of PAHs. However, the absence of micelle-mediated uptake across brush border 
membranes can also be explained by the absence of the unstirred water layer, 
in isolated membrane preparations, as discussed above. The notion of intestinal 
uptake of PAHs in association with fat uptake and aided by a lipid-generated 
fugacity gradient was supported by a Caco-2 in vitro digestion study where BaP 
bound to skimmed milk resulted in a two-fold higher BaP uptake than in a similar 
in vitro study with equivalent amounts of BaP bound to soil [220, 221]. Vasiluk et 
al. (2008) hypothesized that BaP was absorbed via passive diffusion, as the uptake 
of BaP and its transfer across Caco-2 monolayers were similar regardless whether 
BaP was added to the apical or basolateral side. 
Uptake of PAHs across the brush border membrane of enterocytes is one of the 
side effects of the inclusion of vegetable oils in aquafeeds. After ingestion, fatty 
acids and PAHs disperse after lipid hydrolysis in the intestinal lumen into micelles. 
Micelles composed of fish oil result in an increased intestinal delivery and transfer 
of PAHs to the systemic circulation in vivo compared to vegetable oil-composed 
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micelles [41]. The present study shows that, in vitro, a high-lipid diet decreased 
PAH uptake across the intestinal brush border membrane. Other in vitro studies 
with Caco-2 cells showed substantially different results than our brush border 
membrane model. For instance, the higher transcellular uptake of PHE compared 
to BaP was not observed in the present study. This difference is attributed to the 
important role of intestinal metabolism with a faster metabolism of BaP compared 
to PHE. The absence of the unstirred water layer removed the rate-limiting step 
for BaP transport and illustrated that transmembrane uptake is less efficient for 
smaller ‘less’ lipophilic contaminants like PHE. This brush border membrane model 
emphasizes PAH-dependent interactions with FFA that take place at the first step 
of (passive) intestinal uptake.
Conclusion
We conclude that FFA and lipophilic PAHs interact in transmembrane uptake 
across the apical membrane of the enterocyte. Moreover, of the two FFA 
investigated, the fish oil derived fatty acid EPA is more potent than the vegetable-
based fatty acid oleic acid in inhibiting BaP uptake. However, fish oil should not be 
supplemented to vegetable-based aquafeeds to reduce uptake of contaminants, 
as this would not enhance the development of sustainable aquafeeds. The fatty 
acid and lipid composition of an alternative aquafeed is an important determinant 
of PAH bioavailability and should be a considered in the development of novel 
sustainable aquafeeds. Furthermore, this study has also shown that PAHs not only 
translocate across, but for the largest part passively partition in the membrane. 
The physiological aspects of this membrane-associated fraction of lipophilic PAHs 
should be considered, as it is likely to disturb plasma membrane function and that 
of integral membrane proteins. 
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Chapter 5
Transepithelial transfer of phenanthrene, but not of benzo[a]pyrene, 
is inhibited by fatty acids in the proximal intestine of 
rainbow trout (Oncorhynchus mykiss)
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Abstract
The inclusion of vegetable oils in aquafeeds introduces contaminating polycyclic 
aromatic hydrocarbons (PAHs) in Atlantic salmon (Salmo salar). Since lipophilic 
PAHs solubilize in micelles composed of lipids, bile salts and fatty acids, dietary 
lipid composition could alter intestinal transepithelial PAH transfer. To study the 
uptake and transepithelial transfer of PAHs and the effects of fatty acids, two 
labeled PAHs, viz. 14C-benzo[a]pyrene (BaP) or 14C-phenanthrene (PHE), were 
solubilized in micelles composed of tritiated fatty acids derived from fish oil or 
vegetable oil: 3H-eicosapentaenoic acid (EPA; 20:5n−3) or 3H-oleic acid (18:1n−9), 
respectively. PAHs, solubilized in micelles, were administrated to the mucosal side 
of intestinal segments of rainbow trout (Oncorhynchus mykiss) mounted in Ussing 
chambers for measurement of transepithelial transfer.
In the absence of EPA and oleic acid, PHE accumulation was two times higher 
than BaP in the mucosal and serosal layers of both proximal and distal intestine. 
Administration of PHE in micelles composed of oleic acid resulted in a 50% lower 
accumulation of PHE in the mucosal layers of the proximal intestine compared 
to EPA-composed micelles. Accumulation of EPA and oleic acid in the proximal 
intestinal mucosa correlated negatively with the transepithelial transfer of these 
fatty acids across the proximal intestinal epithelium. Transepithelial PHE transfer 
across the proximal intestine was reduced when co-exposed with micelles, with a 
lower reduction in co-exposure with EPA micelles compared to oleic acid micelles 
(30% and 80% lower transepithelial transfer, respectively), whereas BaP was not 
transferred across the intestine.
We conclude that the lipid composition of a vegetable oil-based aquafeed is an 
important determinant of PAH bioavailability. Therefore, lipid composition should 
be an important consideration in choosing vegetable oils as alternatives for fish 
oil in aquafeeds.
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Introduction
Fishmeal and fish oil in aquafeeds for marine carnivorous fish are partially 
substituted by ingredients such as vegetable meal and vegetable oil and 
already extensively used in aquaculture [65, 198, 199, 214, 232]. The use of 
vegetable oils, however, alters the lipid profile of aquafeeds and introduces 
lipophilic contaminants such as polycyclic aromatic hydrocarbons (PAHs). The 
polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA; 20:5n-3) and 
docosahexaenoic acid (DHA; 22:6n-3) are important sources of dietary lipids in 
fish oils. Rapeseed oil is mainly used as a substitute for fish oils [198] and is rich in 
oleic acid (18:1n-9) and linoleic acid (18:2n-6) which are fatty acids with shorter 
hydrocarbon tails and fewer carbon-carbon double bonds than EPA and DHA. 
PAHs are lipophilic organic contaminants that are introduced in vegetable- based 
aquafeeds by replacement of marine ingredients with plant feed ingredients, in 
particular vegetable oils [14]. PAHs are mostly formed by incomplete combustion 
of organic matter during toasting and/or gas drying of oil-producing seeds and 
grains [43, 135, 202]. Atlantic salmon (Salmo salar) reared on vegetable-based 
aquafeeds had substantially increased levels of the PAHs benzo[a]pyrene (BaP) 
and phenanthrene (PHE) in the fillet [14]. BaP and PHE differ in their potential 
toxicological and physico-chemical properties. BaP is highly lipophilic (octanol/
water partition coefficient, log Kow = 6.31) and an agonist of the aryl hydrocarbon 
receptor that induces cytochrome P4501A (cyp1a) mRNA expression and 
metabolism [112, 113]. PHE is less lipophilic than BaP (log Kow = 4.5) and is not 
an aryl hydrocarbon receptor agonist [19] and is consequently less extensively 
metabolized than BaP [32]. The introduction of PAHs in aquafeeds raises concerns 
as to their potential toxic effects for fish and consumers [52].
After ingestion, the mucosa of the intestinal tract is the first barrier for uptake of 
dietary PAH. Intestinal uptake of lipophilic contaminants such as PAHs has been 
suggested to follow lipid absorption [47, 48, 77, 104]. Throughout lipid digestion, 
absorption and assimilation, Vetter et al. (1985) observed that BaP remained 
strongly associated with lipids and their hydrolysis products and was eventually 
detected in enterocytic lipid droplets.
Emulsified lipids are hydrolyzed by digestive lipases in the intestinal lumen to 
yield free fatty acids (FFA). Together with bile salts, FFA form self-aggregating 
spheres called mixed micelles (hereafter referred to as micelles) [5, 156, 224, 
231]. Micelles can enhance intestinal absorption of lipophilic compounds by 
facilitating luminal transport of, e.g., monoacylglyceride, FFA, fat-soluble vitamins 
and lipophilic compounds across the unstirred water layer towards the apical 
brush border membrane of enterocytes [44, 48, 104, 160].
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The lipid composition of micelles is an important component in intestinal delivery 
and transfer of lipophilic contaminants. Fish oil-based diets contain more PUFAs 
such as EPA and DHA that have longer fatty acid chains and a higher degree 
of unsaturated bonds which increase PAH solubility in micelles compared to 
vegetable-based diets [44, 110]. Indeed, in previous studies it was observed that 
a fish oil-based diet increased the intestinal uptake of BaP and PHE compared to 
a vegetable oil-based diet in Atlantic salmon [41]. Micelles act as a vector ferrying 
monoacylglycerides, FFA, cholesterol, fat-soluble vitamins and even lipophilic 
contaminants across the unstirred water layer towards enterocytes. The acidic 
microclimate of the unstirred water layer promotes micelle dissociation. Following 
dissociation, the micellar content is released, including lipophilic compounds 
such as PAHs, which can then be absorbed by enterocytes [145, 179]. Alternatively, 
micelles are absorbed by enterocytes via a vesicle-mediated uptake process or are 
directly absorbed following a collisional mechanism [160]. Overall, the chemical 
composition of lipids and their constituting fatty acids greatly determine the 
solubility of PAHs in micelles and their interaction with intestinal membranes. 
Dietary lipids per se constitute a sink for lipophilic contaminants in the intestinal 
lumen, and their bioavailability is suggested to decrease with increasing lipid 
consumption [77]. Indeed, decreased trans-membrane BaP uptake with increased 
presence of EPA and oleic acid FFA was observed in intestinal brush border 
membrane vesicle preparations of rainbow trout (Oncorhynchus mykiss) [42]. 
This is a first study to detect possible interactions between PAHs and FFA during 
transepithelial transfer in intact intestinal epithelia. To this end, we measured 
the transfer of 14C-labelled BaP and PHE solubilized in micelles composed of two 
different tritiated fatty acids from fish (EPA) and vegetable (oleic acid) origin, 
across intact, metabolically active intestinal segments of rainbow trout mounted 
in Ussing chambers.
Materials and Methods
Animals
Rainbow trout (Oncorhynchus mykiss) with an average body weight of 540 ± 225 g 
(mean ± SD) were obtained from a commercial hatchery ‘Keijzersberg’ in Blitterswijck, 
the Netherlands. Fish were kept at 15.0 ± 0.5 °C in an indoor recirculating system 
with a total volume of 575 L. Water was aerated, biofiltered and UV-treated with an 
input of 1 L fresh tapwater per min. Trout were fed a commercial fish feed (Optiline 
trout, 3.0 mm, Skretting, Utah, USA) with an automated feeder at 9.30 and 16.30 h 
at a ration of 2% of the estimated body weight per day. 
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Rainbow trout were sacrificed in the morning by a single blow to the head one 
hour post-feeding. To ensure that animals were in a postprandial state, animals 
in which no chymus was detected in the intestinal lumen were excluded from 
experimentation. Experimental design obeyed Dutch legislation and was approved 
by the local ethical review committee (RU-DEC 2012-315).
Preparation of intestinal segments for Ussing chamber experiments
Following euthanasia, the peritoneal cavity was opened and the intestinal tract, 
from directly caudal of the most posterior pyloric caeca to the anus, was dissected 
and placed on a Petri dish on ice. For each experiment either the proximal or distal 
intestine from one fish was chosen, using a random number generator, to mount 
in one of the four Ussing chambers in our laboratory. The proximal intestine was 
defined as the section caudal from the pyloric caeca to the beginning of the 
distal intestine, which is recognized by its larger diameter, darker appearance and 
annulo-spiral septa. The preparation and mount of intestinal segments for Ussing 
chamber measurements were performed according to Sundell et al. (2003). In 
brief, the intestine was dissected, opened lengthwise along a mesenteric border 
and rinsed in ice-cold Ringer solution (140 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 
15 mM NaHCO3, 1 mM KH2PO4, 0.8 mM MgSO4, 10 mM glucose, 10 mM glutamate 
and 5 mM HEPES buffer at pH 7.4), saturated for 10 min with 99.7% air and 0.3% 
CO2. Remaining fat was removed from the serosal muscle layer while immersed 
in ice-cold Ringer solution using forceps and a dissecting microscope. From 
the anterior and posterior side of an intestinal segment, 0.5 cm was removed 
to be certain that there was no interference from adjacent intestinal regions. 
Each intestinal segment was randomly divided in five sections. Four of the five 
sections were placed in tissue holders with an aperture of 0.5 cm2 (type P2305; 
Physiologic Instruments, San Diego, CA, U.S.A.). The fifth section was not exposed 
to labeled compounds and was used to correct for background radioactivity. 
The tissue holders were randomly placed in modified Ussing chambers (type 
P2300; Physiologic Instruments), to avoid bias of electrogenic parameters. The 
mucosal and serosal half-cells were filled with 2.5 mL pre-gassed Ringer solution. 
The four Ussing chambers were mounted in water-jacketed chamber holders 
(type EM-CSYS-4; Physiologic Instruments, San Diego, CA, U.S.A.) connected to a 
thermostatic water bath maintained at 16 °C. Mixing and oxygenation was done 
by gassing the half-chambers with a 99.7/0.3% air:CO2 mixture. 
Intestinal preparations were exposed to different lipophilic solutions as described 
by Oxley et al. (2007). Briefly, after an initial 45 min stabilization period, the Ringer 
solution of the mucosal half-chamber was withdrawn simultaneously with that 
of the serosal half-chamber to avoid hydrostatic pressure differences across the 
preparation. The mucosal half-chamber was refreshed with fresh mannitol Ringer 
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solution, devoid of glucose and Mg2+ and Ca2+ ions to avoid FFA precipitation [100, 
234]. 1.5 mM CaCl2 and 0.8 mM MgSO4 were replaced isosmotically by 2.3 mM   
NaCl, 10 mM glucose was replaced by 10 mM mannitol to maintain osmolarity 
of the original Ringer solution. Ringer solution of the serosal half-chamber was 
refreshed with fresh Ringer solution containing glucose. After this, the tissues 
were allowed to equilibrate for 15 to 30 min.
Electrophysiology
Intestinal viability was assessed by continuous measurement of transepithelial 
potential (TEP), transepithelial resistance (TER), and short circuit current (SCC) of 
the intestinal epithelium. In short, TER mainly reflects the paracellular permeability 
to ions. SCC equals the sum of active transports that are electrogenic (i.e., carrying 
charged substrates) in the apical and basolateral membranes of the enterocytes. 
The TEP reflects the electrochemical gradient across the epithelium [192]. 
A pair of current (Ag-wire coated with Cl) and voltage (Ag/AgCl pellet) electrodes, 
connected via 3 M KCl agar bridges to an amplifier (model VCC MC6, Physiologic 
Instruments), recorded differences under voltage-clamp conditions at 0 mV. At 
20-s intervals, two 5-mV pulses in opposite direction were passed across the 
intestinal segment. The currents were measured and the TER was calculated using 
Ohm’s law.
The measurements were logged on a personal computer using a data acquisition 
system (DataQ DI-400, Physiological Instruments) and Acquire & Analyze software 
(version 2.3, Physiological Instruments). Electrical parameters were measured 
every 20 s. Potential differences between Ag/AgCl electrodes and the resistance 
originating from the electrode/agar bridge and the Ringer solution were 
corrected by determining these parameters in the chambers without mounted 
intestinal epithelium. All tissues were allowed to equilibrate for 45 min before the 
start of the experiment. Electrophysiological measurements were averaged per 
20-s window, amounting to 15 data points per 5-min period. Tissue viability was 
checked by continuous monitoring of SCC and TER. 
Experimental treatments
Stock solutions of 2 mM oleic acid or EPA were prepared freshly daily in mannitol-
Ringer buffer containing 20 mM sodium taurocholate. Micelles were formed 
by sonication in a water bath for 20 min [151]. Experimental Ringer solutions 
were prepared by diluting the stock solution containing EPA or oleic acid with 
mannitol-Ringer solution to concentrations of 0, 20, 200 and 2000 µM unlabeled 
fatty acid. Radiolabeled BaP or PHE were added to concentrations of 2 µM 
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[7-14C]BaP (American Radiolabeled Chemicals, St Louis, USA) or 2 µM [9-14C]PHE 
(Larodan Fine Chemicals AB, Malmö, Sweden). Tritiated fatty acids served as 
radiotracers for EPA and oleic acid (Campro Scientific GmbH, Berlin, Germany). 
The radioactive concentrations in the experiments were 10 and 20 kBq ∙ mL-1 for 
BaP and PHE, respectively, with similar radioactive concentrations of tritiated EPA 
and oleic acid. 
After the second equilibration period, 2.5 mL of the Ringer solution of the mucosal 
and serosal half-chamber was removed. The experiment started at t = 60 min by 
adding 2.5 mL of the experimental Ringer solution to the mucosal half-chamber 
to obtain a final concentration in the Ussing chambers of 1 µM [9-14C]PHE or [7-14C]
BaP and 0, 10, 100 or 1000 µM fatty acid (EPA or oleic acid). 
The serosal chamber received 2.5 mL Ringer solution (containing glucose) only. 
Duplicate 250-µl samples were taken at t = 60 min from the mucosal and serosal 
half-chamber every 30 min for a total period of 180 min. Sample volumes were 
replaced by the same volume of experimental Ringer solution and serosal Ringer, 
respectively. Ringer samples were taken from each half-chamber before the 
experiment started to correct for background radioactivity. 
Control incubations (without PAHs and FFA) were carried out as described above, 
with the exception that at the start of the experiment 2.5 mL mannitol Ringer 
solution was added.
Samples taken from the half-chambers were directly transferred to 6-mL 
polyethylene vials (PerkinElmer Inc., Massachusetts, USA) and dissolved in 4 mL 
liquid scintillation cocktail (Optiphase Hisafe 3TM, PerkinElmer Inc., Massachusetts, 
USA). For every assay three 15-µL aliquots from every experimental concentration 
were withdrawn to determine the specific activity (dpm · mol-1) of the radiotracer. 
Radioactivity (dpm) was measured in 3H and 14C channels in a liquid scintillation 
counter (Tri-Carb® 2900TR, PerkinElmer Inc., Massachusetts, USA). Radioactivity 
count rate was divided by the specific activity of the radiotracer and normalized 
for the volume of the sample and aperture of the intestinal segment. The flux of 
the tracee in a chamber was presented as mol per cm2. All half-cell samples were 
measured in duplicate and corrected by subtracting blank values. 
Apparent permeability of a substrate, expressed in cm · min-1, under steady-state 
conditions substrate was calculated using the equation: 
where dQ/dT is the appearance rate (mol · min-1) in the serosal half-cell of the 
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Ussing chamber, A is the area of intestinal surface (cm2) exposed in the chamber 
and Co (mol · cm-3) is the initial concentration in the mucosal half-cell (with the 
assumptions that the concentration in the mucosal half-chamber remains 
constant, and that the concentration in the serosal half-chamber is virtually zero 
as compared to the mucosal half-chamber). 
Tissue accumulation of PAHs and fatty acids
After termination of the experiment, the intestinal segment was removed from 
the Ussing chamber and the mucosal layers were separated from the serosal 
layers (tunica muscularis and tunica serosa) with the aid of glass microscope 
slides. The mucosal and serosal layers were weighed separately, transferred to 
6-mL polyethylene vials (PerkinElmer Inc, Massachusetts, U.S.A.) and dissolved 
overnight in 1 mL solubilizer (Solvable, PerkinElmer Inc, Massachusetts, U.S.A.) at 
37 °C. Samples of 250-µL of the dissolved tissue were placed in 6-mL polyethylene 
vials, 4 mL liquid scintillation cocktail (Ultima Gold, PerkinElmer Inc, Massachusetts, 
U.S.A.) was added and radioactivity was determined as described above. All tissue 
samples were measured in duplicate and corrected by subtracting blank values 
(unexposed tissue of the same intestinal segment). Tissue level was expressed as 
pmol substrate per g tissue (wet weight).
Statistical analysis
Statistical analyses were performed using the statistical programming language R 
(version 3.2.3) [162]. Data were checked for homogeneity of variance by a 
D’Agostino–Pearson normality test. The data sets that did not show homogeneity 
of variance were log-transformed. The log-transformed data were then subjected 
to appropriate analysis of variance. PAH concentrations in the mucosal and serosal 
layers in the absence of FFA were assessed with two-way ANOVA to analyze the 
effects of the two factors “intestinal layers” (consisting of two levels: mucosal 
layer and serosal layer) and “PAH” (levels: BaP and PHE). PHE fluxes in the proximal 
intestine were assessed with a two-way ANOVA to analyze the effects of the two 
factors “FFA” (EPA and oleic acid) and “FFA concentration” (0, 10, 100 and 1000 µM). 
Results were considered statistically significant when p < 0.05 (two-tailed). 
The effects of EPA and oleic acid on PAH accumulation in the mucosal and serosal 
layers of the proximal and distal intestine and electrophysiology were analyzed 
using multilevel linear models. In brief, fixed and random intercept models 
predicting the relative PAH or FFA concentration from the intercept were created 
for each intestine. Calculated model parameters were compared using Akaike’s 
information criterion (AIC), and the best fitting (ANOVA, p < 0.05) and the most 
parsimonious model was chosen for further analyses in which time, concentration 
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or type of fatty acid were added as predictors. Statistical significance was accepted 
at p < 0.05. A comprehensive overview of all models created and of all parameters 
determined is presented in the supplementary information (Tables S5.1 – S5.12).
Results
Intestinal PAH accumulation
In the absence of FFA, PHE concentrations in the mucosal and serosal layers 
of the proximal intestine were two times higher (p < 0.001) than those of BaP 
(Fig. 5.1A). The concentrations of BaP and PHE were 10 times higher (p < 0.001) in 
the mucosal layers of the proximal intestine compared to the serosal layers. In the 
mucosal and serosal layers of the distal intestine, PHE had a 1.7 fold higher total 
accumulation (p = 0.016) than BaP (Fig. 5.1B). The BaP and PHE concentrations 
were two and four times higher, respectively (p < 0.001) in the mucosal layers of 
the distal intestine than in the serosal layers (Fig. 5.1B).  
BaP and PHE, solubilized in micelles, accumulated in the mucosal and serosal layers 
of the proximal (Fig. 5.2) and distal intestine (Fig. 5.3). The accumulation of BaP in 
the mucosal and serosal layers of both intestinal segments was unaffected by EPA 
and oleic acid. In contrast to BaP, PHE accumulation was 50% lower in the mucosal 
layers of the proximal intestine when administrated via 1000 µM oleic acid-micelles 
(p < 0.001) compared to EPA-composed micelles (Fig. 5.2C). The accumulation of 
PHE in the serosal layers of the proximal intestine was unaffected by EPA (Fig. 5.2D) 
but virtually undetectable when PHE was administrated in micelles composed of 
Figure 5.1: Benzo[a]pyrene (BaP) and phenanthrene (PHE) accumulation in the mucosal and 
serosal layers of the proximal (A) and distal intestine (B). Intestinal segments were incubated 
with 1 µM BaP or PHE in the absence of eicosapentaenoic acid (EPA) and oleic acid. Significant 
differences are indicated below each graph; n.s. = not significant. Bars represent experimental 
data (mean values ± SD; n = 16). 
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oleic acid (p < 0.001). PHE accumulation in the mucosal and serosal layers of the 
distal intestine was unaffected by increasing FFA concentrations (Fig. 5.3A-B). All 
regression model parameters for BaP/PHE accumulation and effects of FFA are 
presented in the supplementary information (Tables S5.1 – S5.2).
Tissue accumulation and transepithelial transfer of fatty acids
In the mucosal and serosal layers of the proximal and distal intestine, a concentration-
dependent increase of EPA and oleic acid accumulation was observed (p < 0.001; 
Fig. 5.4). Oleic acid accumulated 7.5 and 4.5 times higher in the mucosal layers 
of the proximal and distal intestine, respectively, than EPA (p ≤ 0.002). The lower 
accumulation of EPA compared to oleic acid correlated significantly (R2 > 0.74; 
p < 0.001) with the 2 - 4 times higher transfer of EPA across both intestinal segments 
compared to oleic acid in the presence of BaP and PHE, respectively (Fig. 5.4). The 
apparent permeability of EPA under steady state conditions was 2 and 1.6  times 
higher than that of oleic acid (p  <  0.05) in the proximal and distal intestine, 
respectively, and did not differ between BaP or PHE presence (Table 5.1).
Figure 5.2: Accumulation of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE) in the mucosal 
and serosal layers of the proximal intestine. BaP and PHE were administered to the mucosal half-
chamber solubilized in micelles composed of 10 mM bile salts without and with 10, 100 and 
1000 µM eicosapentaenoic acid (EPA; closed symbols, solid lines) or oleic acid (open symbols, 
dashed lines), as indicated on the x-axes. The top panels (A–B) represent BaP accumulation, the 
bottom panels (C-D) PHE accumulation (mean values ± SD; n = 8). 
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Figure 5.3: Accumulation of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE) in the mucosal 
and serosal layers of the distal intestine. BaP and PHE were administered to the mucosal half-
chamber solubilized in micelles composed of 10 mM bile salts without and with 10, 100 and 
1000 µM eicosapentaenoic acid (EPA; closed symbols, solid lines) or oleic acid (open symbols, 
dashed lines), as indicated on the x-axes. The top panels (A–B) represent BaP accumulation, the 
bottom panels (C-D) PHE accumulation (mean values ± SD; n = 8). 
Figure 5.4: Correlation between the accumulation and transepithelial transfer at t = 180 min of 
eicosapentaenoic acid (EPA) and oleic acid in the presence of 1 µM benzo[a]pyrene (BaP; A) and 
phenanthrene (PHE; B) in the mucosal layers of the proximal intestine (n = 8). EPA and oleic acid 
were administered to the mucosal half-chamber solubilized in micelles composed of 10 mM 
bile salts with 10, 100 and 1000 µM EPA (closed symbols) or oleic acid (open symbols). The solid 
line is the best linear fit and dotted lines represent the 95% confidence intervals. 
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Figure 5.5: Transepithelial transfer of 
phenanthrene (PHE) in the proximal 
intestinal after 180 min exposure. 
PHE was administered to the mucosal 
half-chamber solubilized in micelles 
composed of 10 mM bile salts 
without and with 10, 100 and 1000 
µM eicosapentaenoic acid (EPA) or 
oleic acid. Significant differences 
are indicated below each graph; 
n.s. = not significant. Bars represent 
experimental data (mean values ± SD; 
n = 8).
Transepithelial PAH transfer
PHE was transferred across the proximal intestine whereas BaP was not. EPA 
as well as oleic acid decreased unidirectional PHE fluxes across the proximal 
intestine (Fig. 5.5; p = 0.003). The PHE flux decreased by 40% when co-exposed 
with the highest EPA concentration. When PHE was administrated in oleic acid 
micelles, the PHE fluxes were decreased by 45-65% compared to PHE uptake in 
the absence of FFA. In the distal intestine, BaP and PHE were not transferred across 
the intestinal segment (data not shown). The presence of FFA had no effect on the 
transepithelial transfer on any of the PAHs in the distal intestine. 
Electrophysiology
The effect of BaP and PHE on the electrical properties of the intestinal epithelium 
was assessed over the 240 min incubation period by concomitant measurement 
of TEP, SCC and TER in the proximal and distal intestine (Fig. S5.1 – S5.4). The 
intestinal segments of the proximal and distal intestine displayed stable TEP, SCC 
and TER values after mucosal administration of BaP and PHE, indicating good 
viability. Linear regression modeling revealed increased, i.e., less negative, TEP 
and SCC values in the proximal intestine when PHE was administrated in micelles 
Table 5.1. Apparent permeability of EPA and oleic acid (10-6 cm ∙ min-1) in the proximal and distal 
intestine in the presence of 1 µM BaP or PHE (mean ± SD; n = 8). Lower case letters indicate significant 
differences of apparent permeability between EPA and oleic acid per intestinal segment (p < 0.05).
                                         EPA (10-6 cm ∙ min-1) Oleic acid (10-6 cm ∙ min-1)
BaP PHE BaP PHE
Proximal intestine 0.44 a ± 0.01 0.46 a  ± 0.03 0.24 b ± 0.02 0.19 b ± 0.02
Distal intestine 0.24 a ± 0.05 0.22  a  ± 0.06 0.13 b ± 0.02 0.16 b ± 0.03
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composed of 1000 µM EPA or oleic acid. FFA concentrations had no effect on the 
stability of TEP, TER and SCC after PAH exposure in the distal intestine.
Discussion
Of the two PAHs investigated PHE was transferred across the proximal intestine 
whereas BaP was not. PHE and BaP both accumulated in mucosal as well as serosal 
layers of the proximal and distal intestine, with an overall higher accumulation 
of PHE than BaP. In the presence of FFA, transepithelial PHE transfer decreased 
in the proximal intestine while BaP was not transferred across the intestine. 
The transepithelial transfer of PHE but not of BaP might be explained by its 
less extensive metabolism and subsequently faster transfer across the proximal 
intestine while BaP is metabolized and its metabolites bind to intestinal cellular 
macromolecules [41]. Although both PAHs accumulated in the distal intestine, 
BaP and PHE were not transferred across these sections of the intestine. 
Intestinal PAH accumulation and transepithelial transfer
Accumulation of PHE was 2-fold higher in the proximal and distal intestine 
compared to BaP. Dietary uptake is less efficient for extreme lipophilic compounds 
(log Kow > 6.3) in a number of different vertebrate species, including fish [47, 
76, 104]. Diffusion of high-Kow compounds through the unstirred water layer 
is believed to be a rate-limiting step while diffusion through the phospholipid 
bilayer is considered to be rate-limiting for low-Kow compounds [104]. Indeed, the 
unstirred water layer, adjacent to the brush border membrane of enterocytes, 
creates an absorption barrier that increases with molecule lipophilicity [49]. The 
transmembrane uptake of BaP was higher than PHE in vitro in intestinal brush 
border membrane vesicles of rainbow trout that lacked an unstirred water layer 
[42]. In contrast, PHE had a higher absorption than BaP in intact intestinal epithelia 
that contained an unstirred water layer (present study). The higher lipophilicity 
(log Kow) of BaP compared to PHE (log Kow 6.31 vs. 4.5) can well explain the lower 
accumulation of BaP compared to PHE in the intestinal mucosa. In support, PHE 
concentrations were higher compared to that of BaP in intact intestinal Caco-2 
cells [33, 34]. CaCo-2 cells are cellular monolayers from colonic origin that exhibit 
a typical enterocytic differentiation characterized by a polarization of the cell 
layer with the presence of tight junctions, apical brush border membranes with 
their associated enzymes and epithelial electrical properties [111, 169] that 
display transmembrane uptake of PAHs. Therefore, the in vitro PAH accumulation 
in intestinal segments of rainbow trout and intestinal Caco-2 cells most likely 
resembles PAH uptake in vivo. Additionally, transmembrane uptake in isolated 
brush border membrane vesicles of rainbow trout illustrate membrane effects 
that already take place at the first step of intestinal transmembrane uptake.
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The accumulation of PAH measured in the mucosal and serosal layers is the sum 
of the intracellular and plasma membrane-associated fractions. The largest PAH 
fraction is most likely passively partitioned in the membrane [42]. Accumulation 
of BaP and PHE in the serosal layers of the proximal and distal intestine is evidence 
that both PAHs are transferred across the tunica mucosa (consisting of the mucosal 
epithelium and lamina propria) towards the circular and longitudinal muscle layers 
of the tunica muscularis [229]. The continuous blood circulation of the lamina 
propria, which transports absorbed intestinal nutrients to peripheral organs, is 
absence in Ussing chamber experiments. In Atlantic salmon, BaP and PHE were 
both transported across the intestinal epithelium into the systemic circulation 
and distributed to peripheral organs [41]. Therefore, the in vitro accumulation of 
BaP and PHE in the serosal layers of the proximal and distal intestine would in vivo 
most likely have entered the systemic circulation. 
In contrast to PHE, BaP was not transferred across the epithelium in any of 
the intestinal segments during the 180 min incubation. Since BaP is an aryl 
hydrocarbon receptor agonist it induces its own metabolism by Cyp1a [18, 19]. 
Intestinal CaCo-2 cells have been shown to express CYP1A and CYP3A that can 
metabolize xenobiotics [111]. When BaP was incubated with intestinal Caco-2 
cells, it was more extensively metabolized than pyrene and PHE and transferred to 
a lesser extent across CaCo-2 cell monolayers (Cavret and Feidt, 2005). Therefore, 
the transepithelial transfer of PHE but not of BaP might be explained by the 
less extensive PHE metabolism and subsequently higher transfer of the native 
compound across the proximal intestine while, in contrast, BaP is metabolized and 
binds to intestinal cellular macromolecules [41]. Although PHE does not stimulate 
its own biotransformation, PHE is metabolized in marine fish such as European 
flounder (Platichthys flesus), Atlantic salmon and rainbow trout [41, 187]. 
When PAHs are metabolized by Cyp450s, intestinal enterocytes extrude the 
metabolites into the intestinal lumen [28, 33]. Excretion is most likely facilitated by 
ATP-binding cassette (ABC) proteins that excrete highly hydrophobic compounds 
into the gastrointestinal tract as native, non-metabolized xenobiotics or water-
soluble conjugates. Waterborne exposure of BaP resulted in an up-regulation of 
abcc2 (multidrug resistance-associated protein 2) mRNA expression in the gills and 
an increase in abcg2 mRNA expression in the liver and proximal intestine of tilapia 
(Oreochromis niloticus) [39]. The ABCG2 transporter is indeed involved in the efflux 
of BaP conjugates in Caco-2 cells [50]. Therefore, the absence of transepithelial 
BaP transfer, in contrast to PHE, could also have been caused by Cyp1a-mediated 
BaP metabolism following efflux of BaP metabolites to the mucosal half-cell (i.e., 
intestinal lumen). 
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FFA effects on intestinal PAH uptake and transepithelial transfer
PHE accumulation in the mucosal layers of the proximal intestine was lower when 
PHE was administrated to the mucosal side of the intestine solubilized in micelles 
composed of 1000 µM oleic acid compared to micelles composed of the same 
concentration EPA. In Atlantic salmon, a vegetable oil-based fish feed (i.e., rich in 
oleic acid) also decreased intestinal PHE concentrations in the proximal intestine 
compared to a fish oil-based fish feed [41]. The lipophilic core of micelles provides 
a more suitable hydrophobic environment for lipophilic compounds than the 
aqueous intestinal lumen [48]. However, the composition of micelles can affect 
intestinal delivery and transfer of lipophilic compounds [44]. Micelles composed 
of shorter fatty acid chain-lengths and a lower degree of unsaturated bonds have 
a decreased PAH solubility [44, 110]. In the present study, the lower hydrocarbon 
chain length and degree of saturation of oleic acid compared to EPA might explain 
why oleic acid but not EPA reduced intestinal PHE accumulation in the mucosal 
layer of the proximal intestine at high concentrations.
In fish, lipids are absorbed along the entire intestinal tract but predominantly 
in the proximal region and, when present, in the pyloric caeca [100, 108, 205]. 
The higher mucosal accumulation of oleic acid compared to EPA coincides with 
previous in vitro studies performed with isolated enterocytes of rainbow trout 
[150, 155]. It has been postulated that an increased intestinal lipid accumulation 
reduces lipid transport across the basolateral membrane and consequently 
reduces the absorption of lipids across the brush border membrane [5]. Indeed, 
the 2 - 4 times lower transepithelial transfer of oleic acid compared to EPA strongly 
correlates with the higher FFA accumulation in the proximal and distal intestine. 
In addition, the apparent permeability of oleic acid was also lower than EPA in 
the proximal as distal intestine (Fig. 5.4). The apparent digestibility of saturated 
and long-chain monounsaturated fatty acids in vivo by fish is generally lower 
compared to PUFAs [4, 66, 181, 208]. In this study, the total FFA absorption (i.e., 
FFA accumulation + transepithelial FFA transfer) was also higher for EPA than 
oleic acid that reflects in vivo digestibility studies. Therefore, the degree of lipid 
accumulation in enterocytes varies with the concentration and type of dietary 
oil composition and could reduce lipid absorption across the brush border 
membrane of enterocytes [5]. 
EPA and oleic acid, administrated as micelles, decreased transepithelial PHE 
transfer in the proximal intestine. If an increased intestinal lipid accumulation 
decreases lipid transport across the basolateral membrane, this could also affect 
the transepithelial transfer of lipophilic PAH across the intestine. Indeed, our study 
showed that an increased intestinal lipid accumulation reduced PHE transfer 
across the proximal intestine. In addition, lipid accumulation in enterocytes is not 
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only affected by lipid concentration but also by a lipid’s chemical properties, that 
differ between the sources from which lipids are obtained. In gilthead seabream 
(Sparus aurata) and Atlantic salmon, intracellular lipid accumulation increased 
dose-dependently in fish fed vegetable oils while this was observed to a much 
lesser degree in fish fed fish oils as sole dietary lipid source [30, 148, 149]. Likewise, 
the higher dose-dependent accumulation of oleic acid than that of EPA in the 
mucosal layers of the proximal intestine coincides with the increased inhibition of 
transepithelial PHE transfer of 60% by oleic acid whereas EPA only inhibited PHE 
transfer by the highest concentration by 40%. 
A high-lipid diet decreased intestinal uptake of orally administrated lipophilic 
compounds (PCBs and chlorobenzenes) in goldfish (Carassius auratus) [77]. 
In female C57BL/6 mice, higher dietary lipids decreased PCB 136, which 
subsequently increased the fecal excretion of lipophilic compounds [103]. 
Furthermore, transmembrane uptake of BaP had decreased in intestinal brush 
border membrane vesicle preparations of rainbow trout in the presence of high 
EPA and oleic acid concentrations [42]. Lipophilic compounds are absorbed less 
by the intestinal epithelium in a high lipid diet probably because higher luminal 
lipid contents reduce their bioavailability [42, 103]. Gobas et al. (1993) postulated 
that passive diffusion is the principal uptake route when dietary uptake rates and 
absorption efficiencies of lipophilic compounds decrease with increasing dietary 
lipid content. Conversely, if an increased lipid content results in higher uptake 
and absorption efficiencies of lipophilic contaminants then transepithelial uptake 
would be mainly facilitated by micelles [77, 104]. In a previous study with brush 
border membrane vesicles, the absence of micelle-mediated uptake across brush 
border membranes was postulated to be caused by the absence of the unstirred 
water layer [42]. However, intestinal segments used in this study constitute intact 
epithelia that still have an unstirred water layer. Therefore, since transmembrane 
[42] as well as transepithelial PAH transfer decreased with increasing FFA 
concentrations passive diffusion and/or carrier mediated (facilitated) passive 
transport could be the main uptake mechanism for lipophilic PAHs. Another 
possibility is that PHE and FFA used in this study compete for the same specific 
binding site of a transport protein in the proximal intestine, as increasing FFA 
concentrations decreased PHE accumulation as well as transepithelial PHE transfer. 
Interestingly, PHE was not transferred across the distal intestine but was transferred 
across the proximal intestine. In general, the distal intestine of salmonids has a 
higher TER and lower apparent permeability of paracellular marker molecules 
compared to the proximal intestine [100, 191, 193]. The inverse of the TER, the 
conductivity, is regarded to reflect paracellular permeability, i.e., conductance 
across tight junctions [192]. The absence of transepithelial PHE transfer across 
the distal intestine could indicate that the proximal intestine, but not the distal 
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intestine, expresses a membrane PHE transport protein. Alternatively, besides a 
transcellular route [42] , PHE might be transferred via a second transport route 
(e.g., paracellular) across the intestine. 
FFA decrease TEP and SCC values in the presence of PHE
Micelles composed of EPA or oleic acid decreased an active transport mechanism 
in the proximal intestine in the presence of PHE, but only at the highest FFA 
concentration (1000 µM), as evidenced by significant interaction effects on 
TEP (EPA and oleic acid) and SCC (oleic acid only) (Tables S7 - S8). The observed 
decrease in TEP was accompanied by a decrease in SCC. A lowered TEP reflects 
a decreased ability of the epithelium to maintain an electrochemical gradient. 
Factors increasing the total paracellular permeability across the intestinal 
epithelium, reflected in TER, are predicted to decrease TEP [191, 194]. However, 
since TER showed no changes over time after PHE incubation this suggests that 
the decrease in TEP is caused not by increased paracellular leakage of charged 
molecules but mainly by disturbance in ion-transporting mechanisms [194]. The 
decreased TEP and SCC coincide with the results of Oxley et al., (2007) where an 
experimental incubation of 1 mM unsaturated fatty acids decreased TEP and SCC 
values in saltwater-adapted Atlantic salmon. In vitro studies have shown that 
n-3 and n-6 unsaturated fatty acids of 18  and 20 carbon chain-lengths inhibit 
Na+/K+-ATPase activity [128, 195]. Therefore, the observed decrease in SCC and 
TEP could be due to an inhibition of the Na+/K+-ATPases activity by unsaturated 
fatty acids and a collapse of a transmembrane Na+-gradient that drives sodium-
coupled cotransport and exchange. Under normal physiological conditions 
intracellular FFA bind to lipoproteins, therefore, it is unlikely that these lipids 
are physiological regulators of Na+/K+-ATPase [126] and why only the highest 
incubation concentration decreased intestinal electrogenic properties. 
Conclusion
This study has shown that fatty acids decrease the PHE accumulation and 
transepithelial PHE fluxes. The inhibitory effects of FFA were on established BaP 
and PHE concentrations of 1.3 and 0.9 μg ·  L-1, respectively, and are comparable 
with detected BaP and PHE concentrations of 1.0 and 17 μg · kg-1 in aquafeeds 
[14]. Micelles composed of oleic acid decreased PHE accumulation in the proximal 
intestine compared to EPA micelles. This is probably due to a lower solubility 
of PAHs in micelles that consist of shorter vegetable oil derived fatty acid chain 
lengths that have a lower degree of unsaturated bonds compared to fish oil fatty 
acids. Partial replacement of fish oil with vegetable oil is likely to increase aquafeed 
PAH levels and so increase their intestinal exposure. In addition, the inclusion of 
vegetable oil fatty acids could lead to higher intestinal accumulation of fatty acids 
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and possibly a decreased flux of vegetable oils to the systemic circulation that could, 
ultimately, negatively impact organismal energy metabolism. Since increasing 
concentrations of EPA and oleic acid decreased transepithelial PHE transfer in the 
proximal intestine the lipid composition and content of alternative aquafeeds are 
important determinants of PAH bioavailability and should be a consideration in the 
development of novel sustainable aquafeeds.
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Nutrient-contaminant interactions on intestinal uptake 
The steadily and rapidly growing aquaculture increases pressure on the limited 
supply of marine aquafeed ingredients. The increased use of vegetable feed 
ingredients to replace fish oil and fishmeal that are traditionally used in aquafeeds 
introduces new challenges in the development of novel, alternative aquafeeds.
One particular challenge is that substitution of fishmeal and oil with vegetable 
ingredients leads to increased levels of contaminating polycyclic aromatic 
hydrocarbons (PAHs) in aquafeeds. Nutrients such as tocopherols, flavonoids 
and fatty acids are well known to interact with contaminants such as PAHs 
and pesticides [131, 138, 222]. The intestine is the site where nutrients and 
contaminants are absorbed from the aquafeed diet and is also the primary site 
where nutrient-toxicant interactions take place. These interactions constituted 
the main research theme of this thesis.
We wished to generate fundamental knowledge on nutrient-toxicant interactions, 
in particular those between lipids (and its digestion products) and two typical 
lipophilic PAH contaminants: benzo[a]-pyrene (BaP) and phenanthrene (PHE). We 
approached this by first performing an in vivo pulse-chase study to investigate 
the metabolic fate and peripheral distribution of BaP and PHE. We then employed 
several in vitro models to gain further insights in the interactions between dietary 
lipids, their hydrolysis products and BaP and PHE at the level of enzymatic lipid 
hydrolysis, intestinal membrane transport and intestinal transepithelial uptake. 
The main findings of the research presented in this thesis are:
-  BaP and PHE, administered via the diet, are transported from the intestinal 
lumen across the intestinal wall into the systemic circulation. Intestinal 
uptake of PAHs and the distribution to peripheral organs were stimulated 
by dietary fish oil compared to a vegetable oil (Chapter 2). 
-  Exposure to BaP induces intestinal and hepatic cyp1a expression. This 
can explain the detection of BaP metabolites that appear to be bound 
to cellular proteins and/or DNA. PHE did not induce cyp1a expression 
(Chapter 2).
-  BaP and PHE inhibited lipase activity in vitro which effect was dependent 
on the type of substrate, i.e., rapeseed oil or fish oil (Chapter 3).
-  BaP and PHE avidly associated with or in the enterocyte’s apical membrane 
in a purified membrane preparation. The presence of free fatty acids 
(FFA) inhibited transmembrane BaP uptake across the intestinal apical 
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membrane whereas PHE uptake was not affected. (Chapter 4).
-  A study using Ussing chambers revealed that BaP and PHE accumulated 
in the mucosal and serosal layers of intact intestinal epithelium. FFA 
inhibited transepithelial PHE fluxes in vitro across the proximal intestine. 
BaP did not cross the intestinal epithelium at all (Chapter 5). 
PAH distribution is dependent on intestinal barrier functions
Dietary BaP and PHE are both transported across the intestinal epithelium into 
the systemic circulation and are distributed to various peripheral organs in vivo 
in a number of different teleost species [6, 41, 91, 106, 172, 186]. Both PAHs were 
detected in the mucosa of the pyloric caeca and proximal intestine 6-12 hours 
post-feeding in Atlantic salmon (Salmo salar) (Chapter 2). The resolution of our 
whole-body autoradiographs was not sufficient to detect the exact location 
where BaP and PHE resided in the intestinal mucosa. However, in brush border 
membrane vesicles the largest fraction of BaP and PHE passively partitioned in 
the membrane’s lipid bilayer rather than translocate across the membrane into 
the vesicle’s lumen (Chapter 4). Indeed, phospholipids that form the bilayer 
structure of cell membranes are preferential sites for the partitioning of lipophilic 
contaminants such as PAHs [120, 161]. Lipophilic contaminants can affect 
membrane fluidity and ultimately disturb plasma membrane integrity and the 
function of integral membrane proteins [233]. We predict that the largest fraction 
of dietary PAHs shall initially partition in the apical brush border membrane of 
enterocytes where they may interfere with nutrient uptake. 
Differences in the intestinal uptake of high and low-Kow PAH congeners seem to be 
dependent on the presence of an unstirred water layer. The unstirred water layer, 
adjacent to the brush border membrane of enterocytes, creates an absorption 
barrier which permeability decreases with increasing molecule lipophilicity 
[49]. It is postulated that diffusion through the unstirred water layer is a rate-
limiting step for high-Kow compounds (e.g., BaP) whereas diffusion through the 
phospholipid bilayer is rate-limiting for low-Kow compounds (e.g., PHE) [104]. This 
notion is supported by our observations of a higher absorption of BaP than PHE 
in intestinal brush border membrane vesicles that lack an unstirred water layer in 
vitro, and of a higher absorption of PHE than BaP in intact intestinal epithelia that 
do contain an unstirred water layer (Chapter 4 & 5). 
The intestine is the first barrier for dietary PAH uptake and plays an important role 
in PAH metabolism [129]. Because BaP is an aryl hydrocarbon receptor agonist 
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that induces cyp1a expression, an enzyme that is involved in phase I xenobiotic 
metabolism, BaP is more extensively metabolized compared to PHE [21, 33, 112, 
113]. Cyp1a-mediated metabolism of BaP can result in toxic intermediates that 
are very reactive and can bind to cellular proteins and/or DNA leading to cellular 
damage [130, 146, 219]. Intestinal CaCo-2 cells have been shown to express 
CYP1A and CYP3A that can metabolize xenobiotics [111]. When intestinal Caco-2 
cells were exposed to BaP and PHE, BaP was more extensively metabolized 
than PHE and transferred to a lesser extent across CaCo-2 cell monolayers [33]. 
Conversely, while PHE was transferred across an intact epithelium of the proximal 
and distal intestine of rainbow trout (Oncorhynchus mykiss) mounted in Ussing 
chambers, BaP was not (Chapter 5). Similarly, BaP was not detected in peripheral 
organs three hours post-feeding in Atlantic salmon while in the same time period 
low PHE concentrations were already detected in the liver (Chapter 2). The more 
extensive peripheral distribution of PHE compared to BaP can thus be explained 
by the less extensive metabolism of PHE and subsequently faster transfer of the 
native compound across the proximal intestine. In contrast, BaP is metabolized by 
Cyp1a to derivatives that can bind to cellular proteins and/or DNA. Hence, less BaP 
is transferred into the systemic circulation [91, 172]. The activities of intracellular 
xenobiotic-metabolizing enzymes are an important determinant of the transfer 
of PAHs from the intestine and subsequent distribution to peripheral organs.
Aquafeeds contain PAH mixtures [14]. Therefore, dietary PAHs mixtures with 
compounds such as PHE, that do not induce cyp1a mRNA levels, could be 
metabolized at an increased rate by the presence of BaP-induced Cyp1a levels. 
Pre-exposure of rat hepatocytes of rat and human with the Cyp1a inducer 
2,3,7,8-tetrachlorodibenzo-p-dioxin resulted in an increased BaP metabolism 
[190]. Although PHE does not stimulate its own biotransformation, metabolites 
were detected in the bile which illustrated that PHE is metabolized in Atlantic 
salmon (Chapter 2). The stimulating effect on PAH metabolism by Cyp1a inducers 
is likely to reduce intestinal PAH concentrations by increasing PAH transfer into 
the systemic circulation or/and excretion to the intestinal lumen via cellular efflux 
transporters [217].
Lipase inhibition by PAHs is dependent on the diet’s lipid composition
Dietary lipids affect the intestinal uptake of lipophilic compounds [44, 48, 110, 
222]. Indeed, in Atlantic salmon, a vegetable (rapeseed) oil-based diet decreased 
intestinal and peripheral distribution of BaP and PHE in vivo compared to a fish 
oil-based diet (Chapter 2). When ingested, the lipophilic nature of PAHs promotes 
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their solubilization in oil droplets and micelles in the intestinal lumen [97, 104, 
160]. The lipid composition of micelles is an important determinant of the 
intestinal delivery of lipophilic contaminants [44, 110]. The solubility of lipophilic 
compounds is higher in micelles composed of long-chain fatty acids with a higher 
degree of unsaturated bonds than in micelles composed of more saturated 
shorter-chain fatty acids [44, 110]. Fish oil-based diets contain more C20 and C22 
polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA; 20:5n-3) 
and docosahexaenoic acid (DHA; 22:6n-3). Hence, the solubility of PAHs in fish oil-
composed micelles can be predicted to be higher than in vegetable oil-composed 
micelles rich in monoene shorter-chain fatty acids such as oleic acid (18:1n-9). 
The dependence of PAH solubility on micelle composition can explain why PHE 
accumulation in the proximal intestine of rainbow trout in vitro was lower when 
co-exposed with micelles composed of oleic acid compared to EPA (Chapter 5). 
The shorter hydrocarbon chain length and lower degree of saturation of oleic acid 
compared to EPA explains why a diet based on the vegetable-derived oleic acid 
reduced the accumulation of PHE in the proximal intestine in vivo as well as in 
vitro (Chapter 2 & 5). This suggests that by manipulation of the lipid content and 
composition of an aquafeed the intestinal uptake of PAHs can be modulated.
BaP and PHE potently inhibited the hydrolysis of rapeseed oil by rainbow trout 
intestinal lipase in vitro, whereas fish oil hydrolysis was largely insensitive to 
inhibition (Chapter 3). Dietary rapeseed oil can thus be expected to reside intact 
in the intestinal lumen for a longer period of time than fish oil. Indeed, partial 
substitution of fish oil by crude palm oil resulted in a significantly higher excretion 
of undigested triacylglycerides via the faeces in rainbow trout [144]. This effect, 
combined with the higher affinity of PAHs to partition in fish oil-composed micelles 
can result in lower luminal concentrations of PAHs to inhibit lipase activity. 
The lipid composition of aquafeeds not only provides the substrate and, hence, the 
catalytic activity of lipases per se, but also affects the potency of lipase inhibitors. 
Lipase activity had decreased in yellowtail kingfish (Seriola lalandi) fed a rapeseed/
canola oil diet while it was not affected in gilthead seabream (Sparus aurata) and 
European sea bass (Dicentrarchus labrax) fed a vegetable oil blend diet containing 
rapeseed, linseed and palm oil [25, 31, 173]. These vegetable oil blend diets had a 
higher lipid content of long-chain fatty acids with a higher degree of unsaturated 
bonds such as EPA, DHA and α-linolenic acid (18:3n-3) and less monoene shorter-
chain fatty acids such as oleic acid compared to the rapeseed/canola oil diet 
[25, 31, 173]. These results illustrate that, in general, lipase activity is inhibited in 
aquafeeds rich in monoene short-chain fatty acids. Our studies, however, show 
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that the reduced lipase activity of vegetable oil-based diets could also be caused 
by luminal presence of PAHs (i.e., BaP and PHE) that inhibit enzymatic rapeseed oil 
hydrolysis (Chapter 3). Therefore, the occurrence of PAHs in aquafeeds by partial 
replacement of fish ingredients by vegetable ingredients could possibly decrease 
lipid digestion in vivo and negatively impact organismal energy metabolism. 
To minimize the inhibitory effects of PAHs on lipase activity, aquafeed manufacturers 
could include vegetable oils rich in PUFA and with lower levels of monoene fatty 
acids. This would exclude rapeseed oil, currently one of the most used oils in 
aquafeeds, as sole oil source of dietary lipid because rapeseed oil contains high 
levels of monoene fatty acids such as oleic (40%). Linseed oil, for example, contains 
higher levels of the PUFA α-linolenic acid (40%) and has lower levels of oleic (15%) 
than rapeseed oil [10, 9, 66]. A 55:30:15-mixture of rapeseed, palm, and linseed 
oil, respectively, can be used as an adequate replacement to partially replace fish 
oil as it has no detrimental effects on fish growth, but will establish a dietary lipid 
profile of saturated, monoene and n-3 PUFA that is similar to fish oil [168, 211]. 
If adjustments in vegetable oil composition of aquafeeds are beneficial for fish 
growth and they counteract the inhibitory effect of PAHs on lipase, it might be a 
potential solution to decrease intestinal PAH uptake. 
Lipids in the diet modulate intestinal PAH transfer 
In a lipid-rich diet, less lipophilic compounds are absorbed by the intestinal 
epithelium [77, 103]. Indeed, transmembrane uptake of BaP in intestinal brush 
border membrane vesicle preparations of rainbow trout decreased when co-
exposed with increasing concentrations of micelles composed of EPA or oleic 
acid (Chapter 4). Increasing concentrations of EPA and oleic acid, administrated as 
micelles, also decreased the unidirectional PHE flux across the proximal intestine 
of rainbow trout in vitro, which effect was more prominent with oleic acid than 
with EPA (Chapter 5). The higher intracellular accumulation of oleic acid compared 
to EPA in the proximal intestine coincides with a reduced transepithelial transfer of 
oleic acid compared to EPA (Chapter 5). Lipophilic compounds, such as tocopherol 
and astaxanthin, follow lipoprotein transport pathways [36, 118, 163]. Fat-soluble 
nutrients possibly follow lipid-associated transport pathways across the intestine 
as well. An increased lipid accumulation in enterocytes decreases transport of 
lipids and lipophilic nutrients across the basolateral membrane [5]. Therefore, we 
hypothesize that an increased intracellular lipid accumulation in enterocytes also 
reduces the transport of lipophilic compounds across the basolateral membrane. 
The reduced transepithelial PHE transfer across the proximal intestine seems to be 
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related to an increased intracellular lipid accumulation and was more prominent 
in combination with oleic acid that accumulated to a higher degree than EPA 
(Chapter 5). This suggests that the intestinal transfer of PAHs can be modulated 
by manipulation of the lipid content and composition of an aquafeed.
Complete fish oil substitution by vegetable oil decreases PAH uptake
 
Marine ingredients are substituted with plant ingredients and already extensively 
applied in commercial salmon feeds. However, in particular aquafeeds that are 
composed of fish oil combined with vegetable oil seem to have detrimental 
effects on PAH uptake. The inclusion of vegetable oils in aquafeeds introduces 
PAHs into the feeds, but specifically the presence of fish oils rich in long-chain 
unsaturated fatty acids increase luminal transfer, intestinal uptake and peripheral 
distribution of PAHs in salmonids. Therefore, the replacement of fish oil in these 
alternative aquafeeds seems warranted.
In aquafeeds, fish oil is mainly included because it provides the dietary 
requirements for n-3 PUFAs that are essential for optimal growth and health of 
farmed fish and consumers [198, 214]. The composition of marine carnivorous 
fish feeds has changed considerably during the last 30 years. In 1990, 90% of 
the global aquaculture feed ingredients was of marine origin while nowadays 
only 30% of the ingredients is composed of marine ingredients which contain 
approximately 8% EPA + DHA combined [184, 201, 232]. Recently, it has been 
shown that low concentrations (5% of the total fatty acid content) of the n-3 fatty 
acids EPA and DHA in aquafeeds did not seem to affect production performance 
of Atlantic salmon during a seawater production cycle [184].
All vertebrate species, including fish, have a minimal dietary requirement for 
both n-6 and n-3 PUFAs. The biologically active forms of essential fatty acids are 
generally the C20 and C22 metabolites of linoleic acid (18:2n-6) and α-linolenic 
acid [12, 72, 198, 214]. In vivo, de novo synthesis of fatty acids takes place by the 
addition or removal of 2-C acetyl units and the synthesis of an unsaturated bond 
in a fatty acid hydrocarbon chain [72]. However, vertebrates lack Δ-12 and Δ-15 
desaturases to form de novo linoleic acid and α-linolenic acid, hence, these fatty 
acids are essential and must be provided by the diet [72, 205, 214]. Elongation 
and further desaturation of α-linolenic can successively result in the synthesis of 
EPA and DHA [72, 205]. Atlantic salmon have specific requirements of EPA + DHA 
combined (more than 2.7% of the total fatty acids content, provided in 1:1 ratio) 
for optimal long-term growth in seawater [168, 183, 184]. These aquafeeds also 
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contained 11-12% α-linolenic acid, which can be converted to EPA and DHA by 
Atlantic salmon [72, 168, 205]. When EPA + DHA concentrations in aquafeeds can 
be decreased from 8% to 2.7%, the low inclusion of fish oils necessary for optimal 
growth will likely have beneficial effects on PAH uptake as a reduction in fish oils 
could decrease PAH accumulation and subsequently PAH toxicity. 
Rainbow trout and Atlantic salmon both showed no reduction in growth when 
fed aquafeeds where fish oil was completely substituted by vegetable oils [12, 
171]. However, these diets contained fish meal as the main protein source. Fish 
meal also contains phospholipids rich in EPA and DHA, resulting in dietary levels 
of EPA + DHA at 3% and above [168]. Complete substitution of fish oils by linseed 
oils decreased n-3 PUFA levels in fish fillets but Atlantic salmon fed on linseed 
oil-based diets had increased desaturase mRNA levels in hepatocytes, implicating 
an increased capacity to convert α-linolenic acid into EPA and DHA [204]. 
Vegetable oils rich in α-linolenic such as linseed oil are best used in aquafeeds 
to decrease intestinal PAH uptake. However, since linseed oil contains high PUFA 
levels, intestinal transfer of PAHs by PUFA-composed micelles could still elevate 
the intestinal PAH uptake and hence mimic the detrimental effects of fish oils. It 
seems, therefore, that a vegetable oil blend with a lipid composition that contains 
sufficient n-3-PUFA levels, to reduce the inhibitory PAH effects on lipase activity, 
and shorter saturated, monoene fatty acids to decrease intestinal PAH uptake is 
most appropriate in aquafeeds. 
Production processes of vegetable oils can decrease PAH levels in aquafeeds
Vegetable oils used in aquafeeds are mainly contaminated by environmental 
pollution of the vegetable raw material and by thermal feed processing like toasting 
and gas drying [134, 157]. Drying of oil-containing seeds with combustion gases 
(using oil, diesel or propane fuel) tremendously increases PAH levels in vegetable 
oils [43]. The drying technique had no effect on heavy PAH concentrations such 
as BaP, but Dennis et al. (1991) showed that air drying (electrically heated or 
unheated) of rapeseeds gave lower levels of the PAHs fluoranthene, pyrene and 
chrysene compared to drying with combustion gases. A transition to cleaner 
drying techniques could already improve the quality of aquafeed ingredients 
considerably.
The inclusion of crude vegetable oils in aquafeeds has increased the dietary 
concentration of 13 potentially genotoxic and carcinogenic PAH congeners 10-fold. 
In addition, concentrations of the non-genotoxic and/or non-carcinogenic PAHs 
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fluoranthene (FA), naphthalene (NA), anthracene (AN) and PHE had increased 
4-fold [14]. The European Union has set an upper limit for BaP of 2 µg ∙ kg-1 in oils 
and fats intended for human consumption and 10 µg ∙ kg-1 for the sum of BaP, 
benzo[a]anthracene, benzo[b]fluoranthene and chrysene [56, 57]. However, no 
upper limit currently exists for PAH concentrations in feed ingredients of animal 
feeds while BaP and PHE concentrations in vegetable-based aquafeeds are 1.0 µg 
and 17.0 µg ∙ kg-1, respectively [14]. 
When Atlantic salmon was reared on a crude vegetable oil-based diet, fillets 
contained 0.3 µg ∙ kg-1 BaP and 3.2 µg ∙ kg-1 PHE. Although fillet concentrations of 
BaP were 7-fold lower than the EU upper limit for human consumption, prominent 
in vitro effects were detected, e.g., lipase inhibition by low concentrations of 
BaP and PHE. Refining processes, such as treatment with active carbon and/or 
deodorization, have been known to drastically reduce PAH levels in vegetable oils 
[43, 133, 202]. Deodorization processes are most effective in the removal of the 
most volatile light PAHs, whereas bleaching by activated carbon is more efficient 
in removing heavy PAHs [37, 135, 202]. Refining of vegetable oils decreased the 
content of light and heavy PAHs by 70-80% and 30-80%, respectively [43, 202]. 
Therefore, the introduction of refining processes during aquafeed production 
could greatly reduce PAH levels, but, unfortunately, not completely remove 
PAHs from aquafeeds [16]. The most known toxic effect of BaP is the formation 
of tumors due to the carcinogenic or mutagenic/genotoxic properties. Therefore, 
refining processes should be focused more on removing BaP from aquafeeds than 
the non-carcinogenic PHE. Since vegetable oils used for human consumption 
are refined to reduce the concentrations of potentially hazardous lipophilic 
compounds (such as PAHs) it could be commercially feasible to process vegetable 
oils in such a way that they do not introduce toxic PAH levels in aquafeeds. 
Conclusion and future perspectives
In this thesis we used several in vitro and in vivo models to investigate interactions 
between lipids, their hydrolysis products and PAHs at the level of enzymatic lipid 
hydrolysis, intestinal membrane transport, intestinal transepithelial uptake and 
peripheral distribution. With the partial inclusion of vegetable oils, aquafeed 
manufacturers will have to consider the effects of fish oil and rapeseed oil on 
the uptake of high as well as low-Kow PAH congeners. We have clearly shown that 
interactions are dependent upon type of oil, lipid content, fatty acid composition 
and PAH congener. Prominent effects on lipid digestion and intestinal uptake 
by PAHs in concentrations that are below EU upper limits were detected in vitro, 
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and these could very well negatively impact organismal energy metabolism. To 
decrease PAH uptake in salmonids, the most realistic and commercially feasible 
solution for the aquaculture industry is refining of vegetable oils to decrease PAH 
levels in aquafeeds. Also, the lipid composition and content of an aquafeed is an 
important determinant for PAH bioavailability and should be considered in the 
development of novel aquafeeds.  
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Kinetic change over time of BaP per organ (ng BaP ∙ g-1 organ)
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Stomach
Intercept 1613 1162 2065 217 23 7.44 < 0.001
Time 0.196 -420 -1045 204 300 23 -1.40 0.176
Pyloric 
caeca
Intercept -2258 -6419 1904 1988 23 -1.14 0.270
Time 0.001 1819 498 3140 631 23 2.88 0.010
Time2 0.040 -87 -172 -1.7 41 23 -2.14 0.046
Vegetable feed -1515 -2959 -70 690 23 -2.19 0.041
Proximal 
intestine
Intercept -1937 -6058 2185 1976 23 -0.98 0.339
Time 0.001 1096 606 1585 235 23 4.67 < 0.001
Vegetable feed 2159 -1438 5755 1724 23 1.25 0.225
Chapter 2
Table S2.1: PCR efficiencies for each gene per organ. Genes that were not determined for 
transcriptional levels are indicated with ND
PCR efficiency
Gene Pyloric caeca Proximal intestine Distal intestine Liver
arp 1.83 2.07 ND ND
elf1α 2.01 1.96 1.85 2.07
β-actin ND 2.09 2.20 2.21
rpl13 1.96 2.08 1.95 1.87
cyp1a1 1.95 2.02 1.98 2.19
cyp2m ND ND ND 2.12
cyp3a27 1.92 2.00 1.94 2.13
gstp 2.00 2.01 2.10 2.05
ugt 1.90 2.14 2.14 2.07
abcb1 2.00 2.33 2.30 1.86
abcc2 1.95 2.17 2.16 2.13
abcg2 1.91 2.08 2.23 1.84
fabp1 1.96 1.93 1.98 ND
fadsd5 2.00 2.29 2.29 2.04
Table S2.2: Regression models fitted to the predicted benzo[a]pyrene (BaP) concentration following 
the effect of vegetable oil-based feed on the organ concentrations. Fish oil-based feed is the 
reference level with value 0. MC is the p value for the model criteria (ANOVA, p < 0.05), b is the 
estimate for the ‘Intercept’, slope for ‘Time’ and ‘Time2’, and the coefficient for ‘vegetable feed’ of the 
regression models. Lower and Higher Cl: 95% confidence intervals, SE: associated standard errors; 
df: degrees of freedom, Within each model, p-values give significant differences among slopes. 
Linear model: y = intercept  + (btime ∙ Time) + bVegetable feed. polynominal model:  y = intercept + (btime ∙ 
Time) + (bTime2 ∙ Time2) + bVegetable feed,  where the intercept is the initial BaP organ concentration (ng 
BaP ∙ g-1 organ) at three hours.
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Table S2.2 continued
Kinetic change over time of BaP per organ (ng BaP ∙ g-1 organ)
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Proximal 
intestine
Intercept -1937 -6058 2185 1976 23 -0.98 0.339
Time 0.001 1096 606 1585 235 23 4.67 < 0.001
Vegetable feed 2159 -1438 5755 1724 23 1.25 0.225
Distal  
intestine
Intercept -1528 -2636 -421 531 23 -2.88 0.009
Time 0.001 307 176 439 63 23 4.87 < 0.001
Vegetable feed 1039 72 2006 463 23 2.24 0.037
Liver
Intercept 163 -179 506 164 23 1.00 0.331
Time 0.001 -50 -159 59 52 23 -0.97 0.346
Time2 0.012 8.4 1.4 15 3.3 23 2.52 0.021
Vegetable feed -52 -171 67 57 23 -0.92 0.368
Bile
Intercept -4821 -8228 -1414 1633 23 -2.95 0.008
Time 0.001 1102 697 1506 194 23 5.68 < 0.001
Vegetable feed 1290 -1683 4264 1425 23 0.91 0.376
Blood
Intercept -0.08 -0.30 0.14 0.11 23 -0.75 0.461
Time 0.001 0.07 0.05 0.10 0.012 23 5.76 < 0.001
Vegetable feed -0.01 -0.20 0.18 0.09 23 -0.14 0.893
Gills
Intercept -76 -623 470 261 23 -0.29 0.773
Time 0.272 129 -45 302 83 23 1.55 0.137
Time2 0.074 -9.2 -20 2.0 5.3 23 -1.73 0.100
Vegetable feed -117 -307 73 91 23 -1.29 0.212
Head Kidney
Intercept 33 3.4 62 14 23 2.32 0.031
Vegetable feed 0.200 25 -15 66 20 23 1.29 0.211
Kidey
Intercept -31 -49 -13 8.8 22 -3.54 0.002
Time 0.002 9.6 7.4 12 1.1 22 9.10 < 0.001
Vegetable feed 3.5 -13 20 7.7 22 0.45 0.657
Spleen
Intercept 16 -8.6 41 12 22 1.37 0.187
Time 0.002 5.7 2.8 8.7 1.4 22 4.08 0.001
Vegetable feed -31 -53 -9.2 11 22 -2.96 0.008
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Table S2.3: Regression models fitted to the predicted phenanthrene (PHE) concentration following 
the effect of vegetable oil-based feed on the organ concentrations. Fish oil-based feed is the 
reference level with value 0. MC is the p value for the model criteria (ANOVA, p < 0.05), b is the 
estimate for the ‘Intercept’, slope for ‘Time’ and ‘Time2’, and the coefficient for ‘vegetable feed’ of the 
regression models. Lower and Higher Cl: 95% confidence intervals, SE: associated standard errors; 
df: degrees of freedom, Within each model, p-values give significant differences among slopes. 
Linear model: y = intercept  + (btime ∙ Time) + bVegetable feed. polynominal model:  y = intercept + (btime ∙ 
Time) + (bTime2 ∙ Time2) + bVegetable feed,  where the intercept is the initial BaP organ concentration (ng 
PHE ∙ g-1 organ) at three hours.
Kinetic change over time of PHE per organ (ng PHE ∙ g-1 organ)
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Stomach
Intercept 1140 815 1466 155 22 7.33 < 0.001
Time 0.001 -78 -113 -42 17 22 -4.55 < 0.001
Vegetable feed -31 -303 240 130 22 -0.24 0.811
Pyloric 
caeca
Intercept -1054 -2197 90 542 21 -1.94 0.069
Time 0.442 803 446 1159 169 21 4.75 < 0.001
Time2 0.001 -50 -73 -27 11 21 -4.62 < 0.001
Vegetable feed 367 -16 750 182 21 2.02 0.059
Proximal 
intestine
Intercept 660 -16 1336 322 21 2.05 0.055
Time 0.038 85 8.2 162 37 21 2.32 0.032
Vegetable feed -586 -1163 -8.7 275 21 -2.13 0.047
Distal inte-
stine
Intercept 144 -58 347 97 22 1.50 0.152
Time 0.001 -25 -89 38 30 22 -0.84 0.411
Time2 0.045 3.7 -0.36 7.7 1.9 22 1.91 0.072
Vegetable feed -7.6 -74 59 32 22 -0.24 0.813
Liver
Intercept -808 -1312 -304 240 22 -3.37 0.003
Time 0.252 406 248 563 75 22 5.42 < 0.001
Time2 0.001 -25 -35 -15 4.8 22 -5.24 < 0.001
Vegetable feed 30 -135 195 78 22 0.38 0.706
Bile
Intercept -15650 -28574 -2725 6152 21 -2.54 0.020
Time 0.001 3106 1667 4545 685 21 4.53 < 0.001
Vegetable feed 6422 -4359 17202 5131 21 1.25 0.227
Blood
Intercept -0.54 -1.1 0.055 0.28 21 -1.92 0.072
Time 0.001 0.29 0.11 0.48 0.087 21 3.33 0.004
Time2 0.018 -0.013 -0.025 -0.0013 0.0056 21 -2.34 0.032
Vegetable feed -0.15 -0.34 0.045 0.091 21 -1.61 0.125
Gills
Intercept 113 34 192 38 22 2.97 0.008
Vegetable feed -6.8 -119 105 54 22 -0.13 0.901
Head Kidney
Intercept 53 -31 138 41 22 1.31 0.205
Vegetable feed 78 -42 198 57 22 1.36 0.191
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Table S2.3 continued
Kinetic change over time of PHE per organ (ng BaP ∙ g-1 organ)
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Kidey
Intercept 16 -19 51 16.7 22 0.94 0.361
Time 0.001 8.0 4.2 12 1.8 22 4.37 < 0.001
Vegetable feed -7.9 -37 21 14.0 22 -0.57 0.577
Spleen
Intercept 10 -13.7 34 11 21 0.88 0.388
Time 0.004 3.8 1.1 6.4 1.3 21 3.01 0.008
Vegetable feed -14 -34 5.9 9.4 21 -1.47 0.159
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Transmembrane uptake of PHE (nmol ∙ mg protein-1) with increasing concentrations of FFA
Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Intercept  0.005 -0.016 0.025 0.011 60 0.45 0.654
FFA concentration 0.282 1.2∙10-5 -9.9∙10-6 3.3∙10-5 1.1∙10-5 60 1.06 0.297
Oleic acid 0.003 0.050 0.019 0.081 0.015 60 3.38 0.005
Proximal 
intestine
Intercept  0.014 -0.031 0.060 0.023 60 0.62 0.541
FFA concentration 0.902 -3.3∙10-6 -5.7∙10-5 5.0∙10-5 2.7∙10-5 60 -0.12 0.905
Oleic acid 0.006 0.097 0.029 0.164 0.032 60 3.02 0.010
Distal  
intestine
Intercept  0.005 -0.013 0.023 0.009 60 0.50 0.617
FFA concentration 0.282 1.5∙10-5 -1.2∙10-5 4.2∙10-5 1.4∙10-5 60 1.07 0.292
Oleic acid 0.009 0.041 0.013 0.069 0.013 60 3.07 0.009
Transmembrane uptake of BaP (nmol ∙ mg protein-1) with increasing concentrations of FFA
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Intercept  0.164 0.126 0.203 0.019 59 8.58 < 0.001
FFA concentration 0.008 -1.0∙10-4 -1.8∙10-4 -2.6∙10-5 3.8∙10-5 59 -2.69 0.009
Proximal 
intestine
Intercept  0.136 0.102 0.171 0.017 59 7.96z < 0.001
FFA concentration 0.013 -8.8∙10-5 -1.6∙10-4 -1.8∙10-5 3.5∙10-5 59 -2.51 0.015
Intercept  0.244 0.196 0.291 0.024 58 10.33 < 0.001
Distal  
intestine
FFA concentration 0.005 -2.0∙10-4 -2.9∙10-4 -1.1∙10-4 4.6∙10-5 58 -4.28 < 0.001
Oleic acid 0.001 -0.124 -0.192 -0.055 0.034 58 -3.63 < 0.001
Interaction 0.032 1.5∙10-4 7.1∙10-6 2.9∙10-4 7.0∙10-5 58 2.11 0.040
Chapter 4
Table S4.1: Regression models fitted to the predicted transmembrane benzo[a]pyrene (BaP) and 
phenanthrene (PHE) uptake in brush border membrane vesicles following the effect of increasing 
concentrations of eicosapentaenoic acid (EPA) and oleic acid. EPA is the reference level with value 0. 
Model criterion (MC) is the p-value for the model criteria and only used when significant (ANOVA; p < 
0.05), b is the estimate for the ‘Intercept’, slope for ‘free fatty acid (FFA) concentration’ and ‘Interaction 
(FFA concentration * Oleic acid)’ and the coefficient for ‘Oleic acid’ of the regression models. Lower 
and Higher Cl: 95% confidence intervals, SE: associated standard errors, df: degrees of freedom and 
t-value. Within each model, p-values give significant differences among slopes. Linear model: y = 
Intercept + (bFFA concentration ∙ FFA concentration) + (binteraction ∙ FFA concentration) + Oleic acid, where the 
intercept is the BaP or PHE concentration (nmol ∙ mg protein-1) in the intravesicular space of BBMV 
at 0 µM FFA.
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Transmembrane BaP (nmol ∙ mg protein-1) uptake with increasing concentrations of EPA or oleic acid
Organ FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Oleic 
acid Intercept  0.119 0.076 0.161 0.021 28 5.76 < 0.001
Intercept  0.251 0.185 0.317 0.032 31 7.79 < 0.001
EPA FFA concentra-tion 0.011 -1.9∙10
-3 -3.2∙10-3 -6.9∙10-4 6.0∙10-4 31 -3.19 < 0.001
FFA  concentra-
tion2 0.004 1.7∙10
-6 5.3∙10-7 2.9∙10-6 5.8∙10-7 31 2.96 0.006
Proximal 
intestine
Oleic 
acid Intercept  0.095 0.060 0.130 0.017 28 5.59 < 0.001
Intercept  0.218 0.160 0.276 0.028 31 7.68 < 0.001
EPA FFA concentra-tion 0.009 -1.8∙10
-3 -2.9∙10-3 -6.9∙10-4 5.4∙10-4 31 -3.33 0.003
FFA concentra-
tion2 0.003 1.6∙10
-6 5.4∙10-7 2.7∙10-6 5.3∙10-7 31 3.07 0.005
Distal 
intestine
Oleic 
acid Intercept  0.055 0.030 0.080 0.012 27 4.48 < 0.001
EPA
Intercept  0.244 0.185 0.302 0.029 31 8.51 < 0.001
FFA concentra-
tion 0.001 -2.0∙10
-4 -3.1∙10-4 -8.3∙10-5 5.6∙10-5 31 -3.52 0.001
Transmembrane PHE (nmol ∙ mg protein-1) uptake with increasing concentrations of EPA or oleic acid
Organ FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Oleic 
acid Intercept  0.058 0.034 0.081 0.011 28 5.05 < 0.001
EPA
Intercept  0.006 0.002 0.009 0.002 32 3.35 0.002
FFA concen-
tration 0.021 8.0∙10
-6 1.0∙10-6 1.5∙10-5 3.4∙10-6 32 2.34 0.026
Proximal 
intestine
Oleic 
acid Intercept  0.110 0.056 0.165 0.027 28 4.15 < 0.001
EPA Intercept  0.013 0.004 0.022 0.004 32 3.03 0.005
Distal 
intestine
Oleic 
acid Intercept  0.055 0.030 0.080 0.012 28 4.48 < 0.001
EPA Intercept  0.004 0.002 0.006 0.001 32 4.59 < 0.001
Table S4.2: Regression models fitted to the predicted change of transmembrane benzo[a]pyrene 
(BaP) and phenanthrene (PHE) uptake in brush border membrane vesicles (BBMV) following the effect 
of increasing concentrations of free fatty acids (FFA) i.e., oleic acid or eicosapentaenoic acid (EPA). 
Model criterion (MC) is the p-value for the model criteria and only used when significant (ANOVA; p < 
0.05), b is the estimate for the Intercept and the slope for ‘FFA concentration’ and ‘FFA concentration2’ 
of the regression models. Lower and Higher Cl: 95% confidence intervals, SE: associated standard 
errors, df: degrees of freedom and t-value. Within each model, p-values give significant differences 
among slopes. Linear model: y = Intercept + (bFFA concentration ∙ FFA concentration), polynomial model: 
y = Intercept + (bFFA concentration ∙ FFA concentration) + (bFFA concentration2 ∙ FFA concentration2) where the 
intercept is the BaP or PHE concentration (nmol ∙ mg protein-1) in the intravesicular space of BBMV 
at 0 µM FFAs.
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Table S4.3: Regression models fitted to the predicted transmembrane free fatty acids (FFA) i.e., 
oleic acid or eicosapentaenoic acid (EPA); Ln(nmol ∙ mg protein-1 + 1)) uptake in brush border 
membrane vesicles (BBMV) in the presence of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE). 
EPA is the reference level with value 0. Model criterion (MC) is the p-value for the model criteria 
(ANOVA; p < 0.05), b is the estimate for the ‘Intercept’, slope for ‘FFA concentration’ and ‘Interaction 
(FFA concentration * Oleic acid)’ and the coefficient for ‘Oleic acid’ of the regression models. Lower 
and Higher Cl: 95% confidence intervals, SE: associated standard errors, df: degrees of freedom and 
t-value. Within each model, p-values give significant differences among slopes. Linear model: y = 
Intercept + (bFFA concentration ∙ FFA concentration) + (binteraction ∙ FFA concentration) + Oleic acid, where the 
intercept is the FFA uptake (Ln(nmol ∙ mg protein-1 +1)) in the osmotic space of BBMV at 10 µM FFAs.
Transmembrane uptake of FFA (Ln(nmol ∙ mg protein-1+ 1)) in the presence of BaP
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Intercept  0.349 0.081 0.618 0.133 45 2.63 0.012
FFA concentration 0.014 2.1∙10-5 -4.4∙10-4 4.8∙10-4 2.3∙10-4 45 0.09 0.928
Oleic acid 0.620 -0.256 -0.648 0.137 0.194 45 -1.32 0.196
Interaction 0.007 9.0∙10-4 2.2∙10-4 1.6∙10-3 3.4∙10-4 45 2.68 0.011
Proximal 
intestine
Intercept  0.162 -0.097 0.420 w0.128 45 1.26 0.214
FFA concentration < 0.001 3.6∙10-4 -8.3∙10-5 8.1∙10-4 2.2∙10-4 45 1.64 0.108
Oleic acid 0.041 -0.142 -0.521 0.236 0.187 45 -0.76 0.452
Interaction < 0.001 1.3∙10-3 6.6∙10-4 2.0∙10-3 3.2∙10-4 45 4.05 < 0.001
Distal 
intestine
Intercept  0.160 -0.058 0.377 0.107 39 1.49 0.146
FFA concentration < 0.001 1.4∙10-4 -2.8∙10-4 5.7∙10-4 2.1∙10-4 39 0.69 0.495
Oleic acid 0.219 -0.102 -0.411 0.207 0.152 39 -0.67 0.508
Interaction 0.004 8.2∙10-4 2.4∙10-4 1.4∙10-3 2.9∙10-4 39 2.88 0.007
Transmembrane uptake of FFA (Ln(nmol ∙ mg protein-1+ 1)) in the presence of PHE
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Intercept  0.125 -0.117 0.367 0.120 45 1.04 0.305
FFA concentration < 0.001 1.1∙10-3 7.4∙10-4 1.4∙10-3 1.7∙10-4 45 6.40 < 0.001
Oleic acid 0.023 0.339 0.036 0.643 0.150 45 2.26 0.029
Proximal 
intestine
Intercept  0.090 -0.191 0.371 0.139 45 0.65 0.522
FFA concentration < 0.001 8.1∙10-4 4.2∙10-4 1.2∙10-3 1.9∙10-4 45 4.17 < 0.001
Oleic acid 0.036 0.362 0.010 0.714 0.174 45 2.08 0.044
Distal 
intestine
Intercept  0.139 -0.096 0.374 0.116 45 1.19 0.240
FFA concentration 0.002 1.9∙10-4 -2.1∙10-4 6.0∙10-4 2.0∙10-4 45 0.96 0.343
Oleic acid < 0.001 0.252 -0.093 0.596 0.171 45 1.47 0.148
Interaction 0.005 8.3∙10-4 2.4∙10-4 1.4∙10-3 2.9∙10-4 45 2.84 0.007
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Table S4.4: Regression models fitted to the predicted change of free fatty acids (FFA), i.e., oleic acid or 
eicosapentaenoic acid (EPA); Ln(nmol ∙ mg protein-1 + 1), uptake in brush border membrane vesicles 
(BBMV) in the presence of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE). EPA is the reference 
level with value 0. Model criterion (MC) is the p-value for the model criteria (ANOVA; p < 0.05), b is 
the estimate for the Intercept and the slope for ‘FFA concentration’ of the regression models. Lower 
and Higher Cl: 95% confidence intervals, SE: associated standard errors, df: degrees of freedom and 
t-value. Within each model, p-values give significant differences among slopes. Linear model: y = 
Intercept + (bFFA concentration ∙ FFA concentration) where the intercept is the FFA uptake (Ln(nmol ∙ mg 
protein-1+ 1)) in the osmotic space of BBMV at 10 µM FFAs.
Transmembrane uptake of oleic acid or EPA (Ln(nmol ∙ mg protein-1+ 1)) in the presence of BaP
Organ FFA Estimator MC b Lower Cl Higher 
Cl
SE b df t-value p-value
Pyloric 
caeca
Oleic acid
Intercept  0.094 -0.196 0.384 0.139 21 0.68 0.507
FFA con-
centration < 0.001 9.2∙10
-4 4.2∙10-4 1.4∙10-3 2.4∙10-4 21 3.85 0.001
EPA Intercept  0.357 0.146 0.568 0.102 24 3.50 0.002
Proxi-
mal 
intesti-
ne
Oleic acid
Intercept  0.019 -0.260 0.299 0.134 21 0.14 0.887
FFA con-
centration < 0.001 1.7∙10
-3 1.2∙10-3 2.2∙10-3 2.3∙10-4 21 7.25 < 0.001
EPA Intercept  0.296 0.081 0.511 0.104 24 2.84 0.009
Distal 
intesti-
ne
Oleic acid
Intercept  0.058 -0.217 0.333 0.131 20 0.44 0.666
FFA con-
centration < 0.001 9.7∙10
-4 4.7∙10-4 1.5∙10-3 2.4∙10-4 20 4.07 < 0.001
EPA Intercept  0.202 0.072 0.333 0.062 19 3.26 0.004
Transmembrane uptake of oleic acid or EPA (Ln(nmol ∙ mg protein-1+ 1)) in the presence of BaP
Organ FFA Estimator MC b Lower Cl Higher 
Cl
SE b df t-value p-value
Pyloric 
caeca
Oleic acid
Intercept  0.365 0.032 0.699 0.159 21 2.29 0.034
FFA con-
centration < 0.001 1.3∙10
-3 7.7∙10-4 1.9∙10-3 2.7∙10-4 21 4.88 < 0.001
EPA
Intercept  0.211 -0.024 0.447 0.114 24 1.86 0.077
FFA con-
centration < 0.001 8.4∙10
-4 4.3∙10-4 1.2∙10-3 2.0∙10-4 24 4.28 < 0.001
Proximal 
intestine
Oleic acid
Intercept  0.351 -0.017 0.719 0.176 21 1.99 0.061
FFA con-
centration < 0.001 1.1∙10
-3 4.5∙10-4 1.7∙10-3 3.0∙10-4 21 3.59 0.002
EPA
Intercept  0.179 -0.117 0.475 0.143 24 1.25 0.224
FFA con-
centration 0.022 5.7∙10
-4 6.1∙10-5 1.1∙10-3 2.5∙10-4 24 2.32 0.030
Distal 
intestine
Oleic acid
Intercept  0.390 0.104 0.677 0.137 21 2.85 0.010
FFA con-
centration < 0.001 1.0∙10
-3 5.3∙10-4 1.5∙10-3 2.4∙10-4 21 4.35 < 0.001
EPA Intercept  0.210 0.042 0.379 0.081 24 2.58 0.017
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Table S4.5: Regression models fitted to the predicted benzo[a]pyrene (BaP) and phenanthrene (PHE) 
membrane partitioning following the effect of increasing concentrations of the free fatty acids (FFA), 
eicosapentaenoic acid (EPA) and oleic acid. EPA is the reference level with value 0. Model criterion 
(MC) is the p-value for the model criteria (ANOVA; p < 0.05), b is the estimate for the ‘Intercept’, 
slope for ‘FFA concentration’ and ‘Interaction (FFA concentration * Oleic acid)’ and the coefficient for 
‘Oleic acid’ of the regression models. Lower and Higher Cl: 95% confidence intervals, SE: associated 
standard errors, df: degrees of freedom and t-value. Within each model, p-values give significant 
differences among slopes. Linear model: y = Intercept + (bFFA concentration ∙ FFA concentration) + (binteraction 
∙ FFA concentration) + Oleic acid where the intercept is the PAH concentration (nmol ∙ mg protein-1) 
associated with the brush border membrane at 0 µM FFAs.
Membrane-associated BaP (nmol ∙ mg protein-1) with increasing concentrations of FFA
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca Intercept  0.375 0.321 0.429 0.027 59 13.85 < 0.001
Proximal 
intestine
Intercept  0.880 0.745 1.016 0.069 60 12.70 < 0.001
FFA con-
centration 0.080 9.8∙10
-5 -4.0∙10-5 2.4∙10-4 7.1∙10-5 60 1.39 0.173
Oleic acid 0.211 0.021 -0.191 0.233 0.102 60 0.20 0.841
Interaction 0.001 -4.1∙10-4 -6.1∙10-4 -2.1∙10-4 1.0∙10-4 60 -3.94 < 0.001
Distal 
intestine Intercept  0.316 0.223 0.409 0.047 58 6.77 < 0.001
Membrane-associated PHE (nmol ∙ mg protein-1) with increasing concentrations of FFA
Organ Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Intercept  0.080 0.025 0.134 0.028 60 2.87 0.006
FFA concen-
tration 0.288 -2.1∙10
-5 -6.0∙10-5 1.8∙10-5 2.0∙10-5 60 -1.04 0.303
Oleic acid 0.011 0.110 0.027 0.194 0.040 60 2.78 0.016
Proximal 
intestine
Intercept  0.217 0.148 0.287 0.035 60 6.14 < 0.001
FFA concen-
tration 0.646 -1.8∙10
-5 -9.5∙10-5 6.0∙10-5 3.9∙10-5 60 -0.45 0.657
Distal 
intestine
Intercept  0.036 -0.036 0.107 0.036 60 0.98 0.333
FFA concen-
tration 0.162 -3.9∙10
-5 -9.5∙10-5 1.7∙10-5 2.8∙10-5 60 -1.38 0.175
Oleic acid 0.027 0.121 0.012 0.231 0.052 60 2.34 0.036
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Table S4.6: Regression models fitted to the predicted change of benzo[a]pyrene (BaP) and phenanthrene 
(PHE) membrane partitioning following the effect of increasing concentrations of  the free fatty acids 
(FFA) eicosapentaenoic acid (EPA) and oleic acid. The designated FFA is the reference level with value 
0. Model criterion (MC) is the p-value for the model criteria (ANOVA; p < 0.05), b is the estimate for 
the ‘Intercept’ and slope for ‘FFA concentration’ of the regression models. Lower and Higher Cl: 95% 
confidence intervals, SE: associated standard errors, df: degrees of freedom and t-value. Within each 
model, p-values give significant differences among slopes. Linear model: y = Intercept + (bFFA concentration 
∙ FFA concentration) where the intercept is the PAH concentration (nmol ∙ mg protein-1) associated with 
the brush border membrane at 0 µM FFA.
Membrane-associated BaP (nmol ∙ mg protein-1) with increasing concentrations of EPA of oleic acid
Organ FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Oleic 
acid
Intercept  0.328 0.261 0.394 0.033 28 9.99 < 0.001
EPA Intercept  0.416 0.342 0.490 0.037 31 11.39 < 0.001
Proximal 
intestine
Oleic 
acid
Intercept  0.901 0.814 0.989 0.043 28 21.18 < 0.001
FFA con-
centration < 0.001 -3.1∙10
-4 -4.8∙10-4 -1.4∙10-4 8.5∙10-5 28 -3.66 0.001
EPA Intercept  0.908 0.772 1.043 0.067 32 13.59 < 0.001
Distal 
intestine
Oleic 
acid Intercept  0.253 0.175 0.331 0.038 27 6.63 < 0.001
EPA Intercept  0.296 0.179 0.414 0.058 31 5.13 < 0.001
Membrane-associated PHE (nmol ∙ mg protein-1) with increasing concentrations of EPA of oleic acid
Organ FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
Pyloric 
caeca
Oleic 
acid Intercept  0.184 0.101 0.268 0.041 28 4.51 < 0.001
EPA
Intercept  0.080 0.058 0.101 0.011 32 7.46 < 0.001
FFA con-
centration 0.032 -2.2∙10
-5 -4.0∙10-5 -3.7∙10-6 9.0∙10-6 32 -2.42 0.024
Proximal 
intestine
Oleic 
acid Intercept  0.316 0.242 0.391 0.036 28 8.72 < 0.001
EPA Intercept  0.212 0.158 0.267 0.027 32 7.87 < 0.001
Distal 
intestine
Oleic 
acid Intercept  0.146 0.034 0.258 0.055 28 2.67 0.014
EPA
Intercept  0.029 0.017 0.041 0.006 32 4.91 < 0.001
FFA con-
centration < 0.001 -1.6∙10
-5 -2.3∙10-5 -9.5∙10-6 3.5∙10-6 32 -4.71 < 0.001
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Figure S5.1: Effect of benzo[a]pyrene (BaP) solubilized in micelles composed of 10 mM bile salts 
without or with 10, 100 and 1000 µM eicosapentaenoic acid (EPA; A-C-E) or oleic acid (B-D-F) on 
transepithelial potential (TEP; A-B), short-circuit current (SCC; C-D) and transepithelial resistance 
(TER; E-F) of the proximal intestine. At t = 45 min, Ringer of the mucosal half-cell was replaced 
with mannitol Ringer (1st dotted vertical line). At t = 60 min, mannitol Ringer of the mucosal half-
cell was replaced with experimental treatments (2nd dotted vertical line). Control incubations are 
without the addition of BaP and FFA to the incubation medium. Points represent experimental data 
(mean ± 95% CI; n = 8). 
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Figure S5.2: Effect of phenanthrene (PHE) solubilized in micelles composed of 10 mM bile salts 
without or with 10, 100 and 1000 µM eicosapentaenoic acid (EPA; A-C-E) or oleic acid (B-D-F) on 
transepithelial potential (TEP; A-B), short-circuit current (SCC; C-D) and transepithelial resistance 
(TER; E-F) of the proximal intestine. At t = 45 min, Ringer of the mucosal half-cell was replaced 
with mannitol Ringer (1st dotted vertical line). At t = 60 min, mannitol Ringer of the mucosal half-
cell was replaced with experimental treatments (2nd dotted vertical line). Control incubations are 
without the addition of PHE and FFA to the incubation medium. Points represent experimental 
data (mean ± 95% CI; n = 8). 
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Figure S5.3: Effect of benzo[a]pyrene (BaP) solubilized in micelles composed of 10 mM bile salts 
without or with 10, 100 and 1000 µM eicosapentaenoic acid (EPA; A-C-E) or oleic acid (B-D-F) on 
transepithelial potential (TEP; A-B), short-circuit current (SCC; C-D) and transepithelial resistance 
(TER; E-F) of the distal intestine. At t = 45 min, Ringer of the mucosal half-cell was replaced with 
mannitol Ringer (1st dotted vertical line). At t = 60 min, mannitol Ringer of the mucosal half-cell 
was replaced with experimental treatments (2nd dotted vertical line). Control incubations are 
without the addition of BaP and FFA to the incubation medium. Points represent experimental 
data (mean ± 95% CI; n = 8). 
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Figure S5.4: Effect of phenanthrene (PHE) solubilized in micelles composed of 10 mM 
bile salts without or with 10, 100 and 1000 µM eicosapentaenoic acid (EPA; A-C-E) or 
oleic acid (B-D-F) on transepithelial potential (TEP; A-B), short-circuit current (SCC; C-D) 
and transepithelial resistance (TER; E-F) of the distal intestine. At t = 45 min, Ringer of the 
mucosal half-cell was replaced with mannitol Ringer (1st dotted vertical line). At t = 60 min, 
mannitol Ringer of the mucosal half-cell was replaced with experimental treatments (2nd 
dotted vertical line). Control incubations are without the addition of PHE and FFA to the 
incubation medium. Points represent experimental data (mean ± 95% CI; n = 8). 
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Table S5.1: Regression models fitted to the predicted accumulation of benzo[a]pyrene (BaP) and 
phenanthrene (PHE) in the mucosal and serosal layers of the proximal and distal intestine following 
the effect of increasing concentrations of eicosapentaenoic acid (EPA) and oleic acid. EPA is the 
reference level with value 0. Model criterion (MC) is the p-value for the model criteria and only used 
when significant (ANOVA; p < 0.05), b is the estimate for the ‘Intercept’, slope for ‘free fatty acid (FFA) 
concentration’ and ‘Interaction (FFA concentration * Oleic acid)’ and the coefficient for ‘Oleic acid’ of 
the regression models. Lower and Higher Cl: 95% confidence intervals, SE: associated standard errors, 
df: degrees of freedom and t-value. Within each model, p-values give significant differences among 
slopes. Linear model: y = Intercept + (bFFA concentration ∙ FFA concentration) + (binteraction ∙ FFA concentration) 
+ Oleic acid, where the intercept is the BaP or PHE accumulation (pmol ∙ g tissue-1) in the mucosal or 
serosal layer at 0 µM FFA.
PAH accumulation (pmol ∙ g tissue-1) in intestinal layers of the proximal intestine with increasing concentrations of FFAs
PAH Intestinal layers Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
BaP
Mucosa Intercept < 0.001 152.26 42.56 102.46 18.64 47 8.17 < 0.001
Serosa Intercept 0.007 10.04 2.55 7.70 1.40 48 7.19 < 0.001
PHE
Mucosa
Intercept < 0.001 290.85 234.52 347.18 28.89 49 10.07 < 0.001
FFA con-
centration  0.03 -0.02 0.09 0.03 49 1.19 0.239
Oleic acid  -80.36 -162.47 1.75 39.71 15 -2.02 0.061
Interaction < 0.001 -0.13 -0.21 -0.06 0.04 49 -3.56 < 0.001
Serosa
Intercept < 0.001 45.30 35.48 55.11 5.00 49 9.06 < 0.001
FFA con-
centration  -0.01 -0.01 2.3∙10
-3 3.8∙10-3 49 -1.34 0.186
Oleic acid < 0.001 -31.11 -45.05 -17.17 6.69 15 -4.65 < 0.001
PAH accumulation (pmol ∙ g tissue-1) in intestinal layers of the distal intestine with increasing concentrations of FFAs
PAH Intestinal layers Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
BaP
Mucosa Intercept  66.40 56.63 76.17 4.89 63 13.59 < 0.001
Serosa Intercept  27.60 21.46 33.75 3.07 63 8.98 < 0.001
PHE
Mucosa Intercept < 0.001 106.14 72.57 139.71 16.89 60 6.29 < 0.001
Serosa Intercept < 0.001 25.69 17.48 33.89 4.12 56 6.23 < 0.001
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Table S5.2: Regression models fitted to the predicted accumulation of free fatty acids (FFA) i.e., 
oleic acid or eicosapentaenoic acid (EPA), in the mucosal and serosal layers of the proximal and 
distal intestine in the presence of 1 µM benzo[a]pyrene (BaP) or phenanthrene (PHE). EPA is the 
reference level with value 0. Model criterion (MC) is the p-value for the model criteria (ANOVA; 
p < 0.05), b is the estimate for the ‘Intercept’, slope for ‘free fatty acid (FFA) concentration’ and 
the coefficient for ‘Oleic acid’ of the regression models. Lower and Higher Cl: 95% confidence 
intervals, SE: associated standard errors, df: degrees of freedom and t-value. Within each 
model, p-values give significant differences among slopes. Linear model: y = Intercept + 
(bFFA concentration ∙ FFA concentration) + Oleic acid, where the intercept is the FFA accumulation Ln(nmol ∙ 
g tissue-1) in the mucosal or serosal layer at 10 µM FFA.
FFA accumulation (Ln(nmol ∙ g tissue-1)) in intestinal layers of the proximal intestine in the presence of 1 µM PAH
PAH Intestinal layers Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
BaP
Mucosal
Intercept  0.33 0.12 0.54 0.10 48 3.14 0.003
FFA con-
centration < 0.001 1.6∙10
-3 1.3∙10-3 1.8∙10-3 1.4∙10-4 48 10.91 < 0.001
Oleic acid < 0.001 0.82 0.57 1.08 0.13 48 6.47 < 0.001
Serosal
Intercept  -0.18 -0.38 0.02 0.10 48 -1.77 0.083
FFA con-
centration < 0.001 1.6∙10
-3 1.2∙10-3 1.9∙10-3 1.7∙10-4 48 9.09 < 0.001
PHE
Mucosal
Intercept  0.24 0.02 0.45 0.11 51 2.23 0.031
FFA con-
centration < 0.001 1.4∙10
-3 1.1∙10-3 1.7∙10-3 1.4∙10-4 51 10.13 < 0.001
Oleic acid < 0.001 0.77 0.52 1.02 0.13 51 6.08 < 0.001
Serosal
Intercept -0.29 -0.54 -0.05 0.12 51 -2.39 0.021
FFA con-
centration < 0.001 1.6∙10
-3 1.3∙10-3 2.0∙10-3 1.6∙10-3 51 9.93 < 0.001
Oleic acid 0.004 -0.43 -0.73 -0.14 0.15 51 -2.96 0.005
FFA accumulation (Ln(nmol ∙ g tissue-1)) in intestinal layers of the distal intestine in the presence of 1 µM PAH
PAH Intestinal layers Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
BaP
Mucosal
Intercept  -0.06 -0.33 0.21 0.14 48 -0.45 0.655
FFA con-
centration < 0.001 1.5∙10
-3 1.1∙10-3 1.9∙10-3 1.9∙10-4 48 7.63 < 0.001
Oleic acid 0.001 0.57 0.22 0.92 0.17 48 3.27 0.002
Serosal
Intercept  -0.23 -0.46 1.3∙10-3 0.11 44 -2.01 0.051
FFA con-
centration < 0.001 1.6∙10
-3 1.2∙10-3 2.0∙10-3 2.1∙10-3 44 7.83 < 0.001
PHE
Mucosal
Intercept  -0.05 -0.26 0.17 0.11 60 -0.43 0.670
FFA con-
centration < 0.001 1.6∙10
-3 1.3∙10-3 1.9∙10-3 1.5∙10-4 60 10.75 < 0.001
Oleic acid < 0.001 0.56 0.29 0.82 0.13 60 4.20 < 0.001
Serosal
Intercept  -0.57 -0.74 -0.39 0.09 56 -6.33 < 0.001
FFA con-
centration < 0.001 1.8∙10-3 1.5∙10-3 2.1∙10-3 1.5∙10-4 56 11.75 < 0.001
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Table S5.3: Regression models fitted to the predicted transepithelial transfer of free fatty acids (FFA) 
i.e., oleic acid or eicosapentaenoic acid (EPA); Ln(µmol ∙ cm2  + 1) across the proximal intestine in 
the presence of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE). Transepithelial transfer of EPA 
or oleic acid with the concentration of 10 µM is the reference level with value 0. Model criterion 
(MC) is the p-value for the model criteria (ANOVA; p < 0.05), b is the estimate for the ‘Intercept’, 
slope for ‘Time’ and the coefficient for ‘FFA conc’ of the regression models. Lower and Higher Cl: 95% 
confidence intervals, SE: associated standard errors, df: degrees of freedom and t-value. Within each 
model, p-values give significant differences among slopes. Linear model: y = Intercept + (bTime ∙ Time) 
+ FFA conc, where the intercept is the transepithelial FFA transfer across the proximal intestine at 
60 min
Transepithelial transfer of FFA (Ln(µmol ∙ cm2+1)) in the presence of 1 µM BaP
FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
EPA
Intercept   -0.71 -0.87 -0.55 0.08 196 -8.57 < 0.001
Time < 0.001 5.5∙10-3 4.7∙10-3 6.3∙10-3 4.1∙10-4 196 13.32 < 0.001
FFA conc (100 µM)   0.28 0.16 0.40 0.06 196 4.61 < 0.001
FFA conc (1000 µM)   0.99 0.88 1.11 0.06 196 16.35 < 0.001
Oleic acid
Intercept   -0.47 -0.63 -0.31 0.08 128 -5.69 < 0.001
Time < 0.001 3.5∙10-3 2.7∙10-3 4.3∙10-3 4.2∙10-4 128 8.30 < 0.001
FFA conc (100 µM)   0.22 0.10 0.34 0.06 128 3.53 < 0.001
FFA conc (1000 µM)   0.80 0.68 0.92 0.06 128 12.73 < 0.001
Transepithelial transfer of FFA (Ln(µmol ∙ cm2+1)) in the presence of 1 µM PHE
FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
EPA
Intercept   -0.74 -0.88 -0.61 0.07 145 -10.92 < 0.001
Time < 0.001 5.5∙10-3 4.8∙10-3 6.2∙10-3 3.5∙10-4 145 15.52 < 0.001
FFA conc (100 µM)   0.48 0.38 0.58 0.05 145 9.38 < 0.001
FFA conc (1000 µM)   1.21 1.11 1.31 0.05 145 23.94 < 0.001
Oleic acid
Intercept   -0.43 -0.54 -0.32 0.06 172 -7.64 < 0.001
Time < 0.001 3.1∙10-3 2.5∙10-3 3.7∙10-3 3.0∙10-4 172 10.16 < 0.001
FFA conc (100 µM)   0.21 0.12 0.29 0.04 172 4.77 < 0.001
FFA conc (1000 µM)   0.66 0.58 0.75 0.04 172 15.00 < 0.001
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Transepithelial transfer of FFA (Ln(µmol ∙ cm2+1)) in the presence of 1 µM PHE
FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
EPA
Intercept  -0.51 -0.66 -0.37 0.07 196 -6.86 < 0.001
Time < 0.001 3.7∙10-3 3.1∙10-3 4.4∙10-3 3.3∙10-4 196 11.11 < 0.001
FFA conc (100 µM)  0.17 0.07 0.27 0.05 196 3.47 < 0.001
FFA conc (1000 µM)  0.76 0.66 0.86 0.05 196 15.48 < 0.001
Oleic 
acid
Intercept  -0.33 -0.46 -0.19 0.07 173 -4.70 < 0.001
Time < 0.001 2.6∙10-3 1.9∙10-3 3.2∙10-3 3.3∙10-4 173 7.91 < 0.001
FFA conc (10 µM)  0.17 0.08 0.27 0.05 173 3.53 < 0.001
FFA conc (100 µM)  0.53 0.43 0.62 0.05 173 10.88 < 0.001
FFA conc (1000 µM)  0.38 0.29 0.48 0.05 190 7.74 < 0.001
Table S5.4: Regression models fitted to the predicted transepithelial transfer of free fatty acids (FFA) 
i.e., oleic acid or eicosapentaenoic acid (EPA); Ln(µmol ∙ cm2  + 1) across the proximal intestine in the 
presence of 1 µM benzo[a]pyrene (BaP) and phenanthrene (PHE). Transepithelial transfer of EPA or 
oleic acid with the concentration of 10 µM is the reference level with value 0. Model criterion (MC) 
is the p-value for the model criteria (ANOVA; p < 0.05), b is the estimate for the ‘Intercept’, slope for 
‘Time’ and ‘Time2’ and thwe coefficient for ‘FFA conc’ of the regression models. Lower and Higher Cl: 
95% confidence intervals, SE: associated standard errors, df: degrees of freedom and t-value. Within 
each model, p-values give significant differences among slopes. Linear model: y = Intercept + (bTime 
∙ Time) + FFA conc; polynominal model: y = intercept + (bTime ∙ Time) + (bTime2 ∙ Time2) + bFFA conc where 
the intercept is the transepithelial FFA transfer across the distal intestine at 60 min
Transepithelial transfer of FFA (Ln(µmol ∙ cm2+1)) in the presence of 1 µM BaP
FFA Estimator MC b Lower Cl Higher Cl SE b df t-value p-value
EPA
Intercept  -0.59 -0.88 -0.30 0.15 171 -4.01 < 0.001
Time < 0.001 3.9∙10-3 -2.4∙10-4 8.1∙10-3 2.1∙10-3 171 1.84 0.068
Time2  1.0∙10-6 -1.3∙10-5 1.5∙10-5 7.1∙10-6 171 0.15 0.883
FFA conc (100 µM)  0.22 0.12 0.33 0.05 171 4.16 < 0.001
FFA conc (1000 µM)  0.74 0.64 0.85 0.05 171 13.78 < 0.001
Oleic 
acid
Intercept  -0.14 -0.30 0.01 0.08 190 -1.86 0.064
Time < 0.001 1.2∙10-3 5.1∙10-3 1.8∙10-3 3.3∙10-4 190 3.50 < 0.001
FFA conc (100 µM)  0.02 -0.07 0.11 0.05 190 0.43 0.666
FFA conc (1000 µM)  0.38 0.29 0.48 0.05 190 7.74 < 0.001
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Summary
The rapidly growing aquaculture has led to an increased pressure on the limited 
supply of marine aquafeed ingredients. Traditionally, marine fish oils and fishmeal 
have been used as the main feed ingredients in commercial feeds for carnivorous 
farmed fish species such as Atlantic salmon (Salmo salar). However, the rapidly 
growing aquaculture cannot continue to rely on fisheries for the supply of fish 
oil and fishmeal. There is therefore a need to develop alternative aquafeed 
ingredients, such as oil and meal from vegetable sources.
Replacing fish oils with vegetable oils alters the nutrient profile of aquafeeds. 
The use of vegetable oils increases dietary levels of monoene and omega-6 fatty 
acids. Contrary, levels of omega-3 long-chain polyunsaturated fatty acids (PUFAs) 
decrease. As a result of thermal processing of oil-containing seeds and grains, the 
inclusion of these oils in aquafeeds introduces contaminating polycyclic aromatic 
hydrocarbons (PAHs). 
The introduction of vegetable oils in aquafeeds has increased levels of PAHs, such 
as benzo[a]pyrene (BaP) and phenanthrene (PHE), in fillets of Atlantic salmon 
reared on these diets. BaP and PHE are lipophilic compounds that differ in their 
physico-chemical properties as well as their potential toxic actions. 
The intestine is the site where nutrients and contaminants are absorbed from the 
aquafeed diet and is also the primary site where nutrient-toxicant interactions 
take place. One of our first experiments showed that BaP and PHE entered 
intestinal enterocytes 6-12 h post-feeding in Atlantic salmon. Thereafter, they were 
both transported across the intestinal epithelium into the systemic circulation 
and distributed to various peripheral organs (e.g., liver). However, in an apical 
membrane vesicle preparation isolated from enterocytes, the largest fraction of 
BaP and PHE partitioned within the membrane rather than transferred across. The 
presence of PAHs in the plasma membrane of enterocytes could affect fluidity 
of the lipid bilayer, disturb membrane integrity and the function of integral 
membrane proteins. These effects are likely to interfere with nutrient uptake. 
The intestine is the first barrier for dietary PAH uptake and plays an important 
role in the metabolic breakdown of PAHs. BaP is an aryl hydrocarbon receptor 
agonist that induces cyp1a expression, an enzyme involved in the detoxification 
of xenobiotics. Cyp1a metabolizes BaP to derivatives that can bind to cellular 
proteins and/or DNA. Hence, BaP is less transferred from enterocytes into the 
systemic circulation compared to PHE. The activities of intracellular enzymes of 
the Cyp-family that are involved in the metabolic breakdown are an important 
determinant of the whole-body distribution of PAHs.
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Dietary lipids can affect the intestinal uptake of PAHs. In Atlantic salmon a 
vegetable oil-based diet decreased intestinal and peripheral PAH distribution 
compared with a fish oil-based diet. When ingested, the lipophilic nature of PAHs 
promotes their solubilization in oil droplets and micelles in the intestinal lumen. 
The solubility of PAHs is higher in micelles composed of long-chain fatty acids with 
a higher degree of unsaturated bonds (i.e., fish oil) than in micelles composed of 
more saturated shorter-chain fatty acids (i.e., vegetable oil). Oleic acid, a fatty acid 
derived from vegetable oil has a shorter chain length and less unsaturated bonds 
than the fish oil-derived fatty acid eicosapentaenoic acid (EPA). The dependence 
of PAH solubility on micelle composition can explain why the accumulation of 
PHE in the proximal intestine of rainbow trout (Oncorhynchus mykiss) in vitro 
was lower when co-exposed with micelles composed of oleic acid than EPA. This 
explains why a diet based on the vegetable oil-derived oleic acid reduces the 
accumulation of PHE in the proximal intestine in vivo as well as in vitro. 
BaP and PHE potently inhibited the hydrolysis of rapeseed oil by rainbow trout 
intestinal lipase, whereas fish oil hydrolysis was largely insensitive to inhibition. 
Since micelles composed of rapeseed oil contain lower concentrations of PAHs 
than fish oil-composed micelles, more PAHs would be freely available to inhibit 
lipase activity. The relative resistance of fish oil hydrolysis to PAHs is likely due 
to the increased partitioning of PAHs in fish oil-composed micelles leaving less 
PAHs free to directly interact with lipases. Therefore, the occurrence of PAHs in 
aquafeeds could decrease lipid digestion in vivo and negatively impact organismal 
energy metabolism. 
In a lipid-rich diet, less lipophilic compounds are absorbed by the intestinal 
epithelium. Indeed, transmembrane uptake of BaP in intestinal apical membrane 
vesicles had decreased more when co-exposed with increasing concentrations of 
micelles composed of EPA than with oleic acid micelles. Increasing concentrations 
of EPA and oleic acid, administrated as micelles, also decreased the unidirectional 
PHE flux across intact epithelium of the proximal intestine of rainbow trout in vitro. 
In this thesis several in vitro and in vivo models were used to investigate interactions 
between lipids, their hydrolysis products and PAHs at the level of enzymatic lipid 
hydrolysis, intestinal membrane transport, intestinal transepithelial uptake and 
peripheral distribution. In conclusion, lipid-PAH interactions depend upon the 
type of oil, lipid content, fatty acid composition and PAH congener. Therefore, the 
lipid composition and content of an aquafeed is an important determinant for 
PAH bioavailability. 
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Samenvatting
Traditioneel werden visolie en vismeel gebruikt als belangrijkste ingrediënten in 
commercieel visvoer voor carnivore vissen zoals de Atlantische zalm (Salmo salar). De 
aquacultuur blijft groeien en daarmee ook de vraag naar de beperkte hoeveelheid 
mariene visvoer ingrediënten. Daarom is het noodzakelijk om alternatieve 
ingrediënten te gaan gebruiken in visvoer, zoals bijvoorbeeld olie en eiwitten uit 
plantaardige bronnen. Het vervangen van visolie met plantaardige oliën verandert 
het nutriëntenprofiel van visvoer. Het gebruik van plantaardige oliën in visvoer 
verhoogt de concentratie van enkelvoudige onverzadigde vetzuurketens terwijl de 
concentratie van omega-3 meervoudig onverzadigde lange vetzuurketens afneemt. 
Naast het gewijzigde nutriëntenprofiel leidt de toevoeging van plantaardige oliën 
tot de introductie van de giftige polycyclische aromatische koolwaterstoffen (PAKs) 
die ontstaan tijdens het productieproces van visvoer.  
De introductie van PAKs in plantaardig visvoer heeft geleid tot verhoogde niveaus 
van PAKs als benzo[a]pyreen (BaP) en fenantreen (PHE) in filets van Atlantische 
zalm. BaP en PHE zijn lipofiele stoffen die verschillen in hun fysische-chemische 
eigenschappen, evenals in hun potentiële toxische acties.  
In de darm worden voedingsstoffen en toxische stoffen opgenomen uit het dieet. 
Daarnaast is het ook de primaire plaats waar interacties tussen voedingsstoffen 
en toxische stoffen kunnen plaatsvinden. In één van de eerste experimenten 
is geobserveerd dat BaP en PHE beide werden gedetecteerd in darmcellen 
(enterocyten) van Atlantische zalm, 6 tot 12 uur nadat ze waren gevoed. Daarna 
werden beide PAKs getransporteerd naar de bloedsomloop en verder gedistribueerd 
naar verschillende organen (zoals de lever). In membraanblaasjes, opgezuiverd uit 
de apicale celmembranen van darmcellen, zat de grootste fractie van BaP en PHE 
in het membraan, in plaats van over het membraan getransporteerd te worden. 
De PAKs die in het celmembraan van darmcellen zitten kunnen de bewegelijkheid 
van fosfolipiden in het membraan beïnvloeden en de membraanintegriteit en de 
functie van membraaneiwitten verstoren. Uiteindelijk kan dit leiden tot verstoring 
van de opname van voedingsstoffen.
De darm is de eerste barrière voor de opname van PAKs en speelt een belangrijke 
rol in de stofwisseling ervan. BaP stimuleert de genexpressie van cyp1a, een enzym 
dat betrokken is bij de afbraak van toxische stoffen. Wanneer BaP wordt afgebroken 
door Cyp1A kunnen er tussenvormen ontstaan die zeer reactief zijn en kunnen 
binden aan cellulaire eiwitten en/of DNA. BaP wordt meer gemetaboliseerd dan 
PHE wat als gevolg heeft dat BaP ook minder getransporteerd wordt door het 
darmepitheel dan PHE. De enzymatische activiteiten van eiwitten die betrokken 
zijn bij de metabolische afbraak van PAK zijn daarom belangrijke factoren die 
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meespelen tijdens de opname van PAKs uit de darm en daaropvolgend naar de 
perifere organen.   
Vetten die in het dieet aanwezig zijn kunnen de opname van PAKs in de darm 
beïnvloeden. Een dieet op basis van plantaardige oliën zorgde ervoor dat in 
Atlantische zalm zowel de concentraties van PAKs in de darm als in andere 
organen lager was dan wanneer de vissen werden gevoerd met een dieet op 
basis van visolie. De lipofiele aard van PAKs zorgt ervoor dat ze goed oplossen in 
oliedruppels en micellen in het lumen van de darm. De oplosbaarheid van PAKs 
is hoger in micellen die bestaan uit lange vetzuurketens en een hogere mate van 
onverzadigde verbindingen (zoals visolie) dan in micellen die voornamelijk bestaan 
uit verzadigde kortere vetzuurketens (zoals plantaardige olie). Oliezuur (oleïne), 
een vetzuur afgeleid uit plantaardige oliën, heeft een kortere vetzuurketen en 
minder onverzadigde verbindingen dan de visolie afgeleide eicosapentaeenzuur 
(EPA). Waarschijnlijk is dat de reden waarom de PHE accumulatie in de proximale 
darm van de regenboogforel (Oncorhynchus mykiss) lager was wanneer PAKs waren 
opgelost in micellen die bestonden uit oliezuur dan EPA.
BaP en PHE verminderden de hydrolyse van koolzaadolie door darmlipase in 
regenboogforellen. De hydrolyse van visolie daaren-tegen was grotendeels 
ongevoelig voor beide PAKs. Aangezien PAKs minder goed oplossen in micellen die 
bestaan uit koolzaadolie dan wanneer ze bestaan uit visolie, zijn er meer PAKs vrij 
beschikbaar om lipase activiteit te remmen. Dit betekent dat de aanwezige PAKs 
in plantaardig visvoer de vetvertering kunnen verlagen. Omdat vetten belangrijke 
energiebronnen zijn kan dit uiteindelijk negatieve gevolgen hebben voor het 
energiemetabolisme. 
In een vetrijk dieet worden lipofiele stoffen minder goed geabsorbeerd door het 
darmepitheel. De opname van BaP over het membraan in membraanblaasjes was 
verlaagd bij toenemende concentraties EPA en oliezuur, toegediend in de vorm 
van micellen. Daarnaast verlaagden de toenemende micel-concentraties EPA 
en oliezuur ook de PHE-flux over de het epitheel van de proximale darm van de 
regenboogforel in vitro.  
In dit proefschrift zijn verschillende in vitro en in vivo modellen gebruikt om de 
interacties tussen vetten, hun afbraakproducten en PAKs  te bekijken op het 
niveau van enzymatische hydrolyse, transport over het darmmembraan, over 
het gehele darmepitheel en de verdeling over perifere orgaan. Geconcludeerd 
kan worden dat interacties tussen PAKs en vetten afhankelijk zijn van het type 
vet (olie), de vetconcentratie, de vetzuursamenstelling en type PAK. Daarom is de 
vetzuursamenstelling en vetconcentratie van visvoer een belangrijke factor om de 
biologische beschikbaarheid van PAKs te beoordelen.
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